carbapenems has been researched along with Cross Infection in 886 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 20 (2.26) | 18.2507 |
| 2000's | 144 (16.25) | 29.6817 |
| 2010's | 570 (64.33) | 24.3611 |
| 2020's | 152 (17.16) | 2.80 |
| Authors | Studies |
|---|---|
| Akalın, H; Eser, ÖK; Gürpınar, Ö; Köksal, İ; Otlu, B; Özakın, C; Ünal, S; Zarakolu, P | 1 |
| Bakry, U; Diab, AA; El-Shqanqery, HE; Elanany, M; Elzayat, MG; Hassan, R; Jalal, D; Samir, O; Sayed, AA; Shalaby, L | 1 |
| Berglund, B; Bornefall, E; Dien, TM; Hanberger, H; Hoang, NTB; Khu, DTK; Larsson, M; Le, HT; Le, NK; Lundberg, L; Nilsson, LE; Nilsson, M; Olson, L; Tärnberg, M; Welander, J | 1 |
| Chen, J; Hu, Y; Huang, L; Liu, C; Lu, J; Qing, Y; Wang, Q; Zhang, R; Zhen, S; Zhou, H | 1 |
| Chandra, P; Cs, S; M, S; Mk, U; V, R | 1 |
| Etheredge, HR; Fabian, J; Gaylard, P; Lowman, W | 1 |
| Ding, J; Huang, Y; Jia, Y; Liu, H; Peng, J; Wu, D; Xiao, J | 1 |
| Choe, PG; Choi, EH; Choi, S; Jung, J; Kang, CK; Kim, E; Kim, NJ; Lee, HY; Lee, J; Lee, S; Oh, M; Park, WB | 1 |
| Bai, Y; Hao, Y; Jin, Y; Shao, C; Wang, Y | 1 |
| Cai, B; Kanakamedala, H; Pogue, JM; Zhou, Y | 1 |
| Hoffman, S; Lapp, Z; Snitkin, ES; Wang, J | 1 |
| Boggian, K; Filipovic, M; Flury, D; Haller, S; Kleger, GR; Kohler, P; Nolte, O; Scanferla, G; Schlegel, M; Seiffert, SN; Seneghini, M; Thoma, R; Vuichard Gysin, D | 1 |
| Gargalianos-Kakolyris, P; Kalofissoudis, Y; Kantzanou, M; Kotteas, E; Maltezou, HC; Michou, I; Moussas, N; Pantazis, N; Pantos, C; Papanikolopoulou, A; Syrigos, KN; Tountas, Y; Tsakris, A | 1 |
| Fortaleza, CMCB; Leite, GS; Oliveira, JDS; Pereira, MADM; Sampaio, NCFM | 1 |
| Farajzadeh Sheikh, A; Farshadzadeh, Z; Hashemzadeh, M; Heidari, R; Saki, M; Salmanzadeh, S | 1 |
| Chu, Y; Huang, X; Liu, X; Yue, H; Zhou, G | 1 |
| Bakhtiar, A; Chong, CW; Khalid, KE; Khan, RA; Tan, SY | 1 |
| Avendano, DH; Canavan, K; Eckardt, P; George, E; Guran, R; Himed, K; Kim, M; Miller, N; Ramirez, KHG | 1 |
| Cai, Y; Choudhury, S; Hoo, GSR; Koh, TH; Kwa, AL; Lim, TP; Marimuthu, K; Ng, OT; Quek, YC; Teo, JQ | 1 |
| ELshamy, RM; Oda, MS; Ramadan, RA; Saeed, MA | 1 |
| Chang, CC; Chang, JC; Chen, DS; Chen, LK; Chen, YT; Chu, HT; Jiang, HL; Li, YZ; Sankhla, D; Teh, SH; Tseng, CC; Wang, LS; Yang, HH | 1 |
| Chen, BH; Chen, CM; Chiou, CS; Ke, SC; Lai, YC; Lin, YP; Lu, MC; Tang, HL; Teng, RH; Wang, YW | 1 |
| Assous, MV; Ben-Chetrit, E; Bnaya, A; Tordgman, D; Wiener-Well, Y; Wolfovitz-Barchad, O; Yinnon, AM | 1 |
| Amatya, P; Baker, S; Basnyat, B; Dixit, SM; Dongol, S; Karkey, A; Manandhar, S; Nguyen, Q; Pham, DT; Rabaa, M | 1 |
| Cai, L; Chen, Y; Jiang, B; Ouyang, P; Peng, N; Tan, C; Tan, L; Wang, J; Wu, Y; Xie, L; Ye, J; Yuan, H | 1 |
| Kurihara, MNL; Mahmoud, FF; Mansano, MCT; Sales, RO; Silva, GD; Silva, KED; Simionatto, S | 1 |
| Chan, MC; Chen, CM; Chen, CY; Feng, JY; Liang, SJ; Lin, YC; Peng, CK; Sheu, CC; Wang, SH; Yang, KY; Zheng, ZR | 1 |
| Du, FL; Huang, QS; Liao, W; Liu, Y; Wan, LG; Wei, D; Xiang, TX; Xiong, Z; Zhang, S; Zhang, W | 1 |
| Ang, BSP; De, PP; Ho, BCH; Khong, WX; Marimuthu, K; Ng, OT; Ong, SWX; Ong, VYF; Rao, P; Sridatta, PSR; Thevasagayam, NM | 1 |
| Jarčuška, P; Porubčin, Š; Rovňáková, A; Zahornacký, O | 1 |
| Arvand, M; Becker, L; Brunke, MS; Konrat, K; Pfeifer, Y; Piening, B; Schaudinn, C; Schwebke, I | 1 |
| Chen, Y; Fu, Y; Han, X; Hu, H; Jiang, Y; Quan, J; Shi, Q; Wang, Q; Wu, X; Yu, Y; Zhou, J | 1 |
| Hagihara, M; Ichihara, T; Ikeda, Y; Kato, H; Maeda, M; Mikamo, H; Mizuno, T; Mutoh, Y; Ohta, A; Sukawa, M; Umemura, T; Yamada, T | 1 |
| Cruz-López, F; Garza-González, E; Maldonado-Garza, H; Martínez-Meléndez, A; Morfín-Otero, R; Villarreal-Treviño, L | 1 |
| Guo, G; Li, M; Li, P; Li, Q; Tan, Z; Wang, Z; Zhang, W; Zhou, L | 1 |
| Correa, NP; de Menezes, FG; de Sales, RO; Koga, PCM; Leaden, L; Marins, MM; Martino, MDV; Migliorini, LB; Mingorance, J; Severino, P; Toniolo, ADR | 1 |
| Chang, H; Lee, CM; Lee, MC; Lu, CH; Sun, FJ; Wu, AY | 1 |
| Choi, JS; Lee, JB | 1 |
| Alfandari, S; Bajolet, O; Blanchard, H; Colomb-Cotinat, M; Daniau, C; Dumartin, C; Lecuru, M; Simon, L | 1 |
| Aluvaala, J; Inwani, I; Kempf, VAJ; Masika, M; Museve, B; Musyoki, VM; Okutoyi, L; Schultze, TG; Stephan, C; Villinger, D; Wieters, I; Ziegler, AH | 1 |
| Hrynchuk, OB; Ishchak, OM; Kolesnik, AV; Rud, VO; Salmanov, AG; Terekhov, VA; Voloshynovych, NS | 1 |
| Chen, T; Chi, X; Ji, J; Meng, X; Xiao, Y; Xiong, L; Zheng, B; Zhou, Y | 1 |
| De Filippis, A; Della Rocca, MT; Finamore, E; Foglia, F; Galdiero, M; Manfredini, M; Melardo, C; Montella, F; Nastri, BM | 1 |
| Burnham, CD; Calix, JJ; Dantas, G; de Almeida, MCS; Potter, RF; Wallace, MA | 1 |
| Baum, JHJ; Eckmanns, T; Eisfeld, J; Gatermann, S; Haller, S; Hecht, J; Heinmüller, P; Knautz, D; Leuze, D; Pfennigwerth, N; Wagner-Wiening, C; Zimnitskaya, Y | 1 |
| Chen, J; Chen, Q; Gu, B; Li, J; Li, P; Lin, Y; Liu, X; Lyu, J; Song, H; Tian, B; Wang, K | 1 |
| Antelo, V; D'Alessandro, B; Galiana, A; Giménez, M; Grill, F; Iraola, G; Mason, CE; Parada, A; Puig, J; Riera, N; Risso, J; Salazar, C; Vieytes, M | 1 |
| Barchiesi, F; Brenciani, A; Carelli, M; Giovanetti, E; Leoni, F; Lleò, MM; Malerba, G; Morroni, G; Rocchegiani, E; Simoni, S; Veschetti, L; Vignaroli, C | 1 |
| Vithiya, G | 1 |
| Biehl, LM; Ket, JCF; Remmelzwaal, S; van Dijk, K; Vandenbroucke-Grauls, CMJE; Vehreschild, MJGT; Willems, RPJ | 1 |
| Ballesta, S; López, CE; López-Cerero, L; Pascual, A; Rojo-Martin, MD; Sánchez-Yebra, W | 1 |
| Abidi, K; Akova, M; Alsisi, A; Arvaniti, K; Aslan, AT; Barbier, F; Bassetti, M; Bracht, H; Buetti, N; Conway Morris, A; De Bus, L; De Waele, J; Elhadi, M; Ferrer, R; Gurjar, M; Hayashi, Y; Jeon, K; Leone, M; Lipman, J; Paiva, JA; Povoa, P; Qiu, H; Ruckly, S; Staiquly, Q; Tabah, A; Timsit, JF; Zand, F | 1 |
| Cai, L; Huang, W; Qiao, F; Zhang, W; Zong, Z | 1 |
| Deng, Y; Huang, W; Li, J; Qiao, F; Zhang, W; Zhu, S; Zong, Z | 1 |
| Cai, J; Goodman, KE; Klein, EY; Lessler, J; Levin, SR; Lin, G; Martínez, DA; Milstone, AM; Paul, R; Simner, PJ; Toerper, M | 1 |
| Fahy, S; Lucey, B; O'Connor, JA; Sleator, RD | 1 |
| Akbaş, T; Akdoğan, Ö; Akova, M; Aksoy, F; Akyol, A; Aslan, AT; Barbier, F; Batirel, A; Bayindir, Y; Bilir, Y; Buetti, N; Çeşme, U; Çolak, O; Dağ, O; Dindar, EK; Eroğlu, A; Erol, Ç; Ersöz, G; Ferlicolak, L; Gürbüz, Y; Guzeldağ, S; Kalem, AK; Karaali, R; Köylü, B; Öztürk, B; Ruckly, S; Selçuk, M; Staiquly, Q; Sungurtekin, H; Tabah, A; Timsit, JF; Timuroğlu, A; Tunay, B; Yilmaz, M | 1 |
| Arata-Bardet, J; Caspar, Y; Cebron, C; Martinod, M; Mortamet, G; Percheron, L; Smiljkovic, M | 1 |
| Jiang, J; Liu, X; Long, Y; Qiao, L; Wang, Q; Wu, J; Xu, T; Yang, Y; Yu, J; Zhang, B; Zuo, W | 1 |
| Chen, WC; Cheng, HY; Hung, CC; Lin, MH; Lin, YC; Shen, YC; Teng, CK | 1 |
| Loaiza, WM; Patiño, CCO; Ruiz, AKR; Vivas, MC | 1 |
| Aksay, O; Can, S; Çölkesen, F; Eroğlu, E; Erol, B; Kacar, F; Özdemir Armağan, Ş; Tarakçı, A | 1 |
| Behnke, M; Dinkelacker, A; Eisenbeis, S; Falgenhauer, J; Gastmeier, P; Häcker, G; Herold, S; Imirzalioglu, C; Jazmati, N; Käding, N; Kern, WV; Kramme, E; Mischnik, A; Peter, S; Piepenbrock, E; Rohde, AM; Rupp, J; Schneider, C; Schwab, F; Seifert, H; Steib-Bauert, M; Tacconelli, E; Trauth, J; Vehreschild, MJGT; Walker, SV | 1 |
| Fang, C; Li, J; Zhou, M; Zhou, Z | 1 |
| Jeon, K; Jeong, S; Lee, N; Park, MJ; Song, W | 1 |
| Fan, C; Gao, J; Li, H; Li, X; Lu, Y; Shen, M; Wu, X; Yu, J | 1 |
| Chang, SC; Chien, LJ; Fang, CT; Su, CH | 1 |
| Liu, M; Wang, R; Wang, X; Yi, N | 1 |
| Cao, B; Chang, K; Pu, D; Zhao, J; Zhuo, X | 1 |
| Dolma, KG; Gautam, D; Goyal, RK; Gupta, M; Khandelwal, B; Klangbud, WK; Mitsuwan, W; Nissapatorn, V; Pereira, MLG; Siyadatpanah, A; Wiart, C; Wilairatana, P | 1 |
| Batistão, D; Campos, PA; Ferreira, ML; Fuga, B; Gontijo-Filho, PP; Machado, LG; Melo, GN; Resende, DS; Ribas, RM; Rossi, I; Royer, S; Urzedo, JE | 1 |
| Bonten, MJM; Brun-Buisson, C; Plantinga, NL; Wittekamp, BHJ | 1 |
| Gupta, V; Lawrence, K; Murray, J; Olesky, M; Ye, G; Yu, K | 1 |
| Bilker, W; Bushman, F; Garrigan, C; Goldstein, EJC; Han, JH; Hofstaedter, CE; Jain, T; Kim, D; Lapp, Z; Lautenbach, E; Mattei, L; Nachamkin, I; Slayton, RB; Snitkin, ES; Tolomeo, P; Wise, J; Wolford, HM | 1 |
| Bonelli, RR; de Sousa, VS; Justo-da-Silva, LH; Kraychete, GB; Longo, LGA; Martins, IS; Moreira, BM; Rocha, JA; Superti, SV | 1 |
| Cotta, MO; Dulhunty, JM; Eriksson, L; Harris, P; Malacova, E; Milinovich, GJ; Vickers, ML | 1 |
| Eigenbrod, T; Gross, A; Günther, F; Heeg, K; Kocer, K; Mutters, NT; Nurjadi, D; Reuter, S; Zimmermann, S | 1 |
| Higuita-Gutiérrez, LF; Jiménez-Quiceno, JN; Vargas-Alzate, CA | 1 |
| Cao, JM; Chen, S; Hu, YY; Lv, HY; Wu, Z; Yang, Q; Zhang, R; Zhou, HW | 1 |
| Abbas, H; Al-Hamad, A; Alsubikhy, F; Darwish, D; Ghazawi, A; Hejles, H; Leskafi, H; Pal, T; Sonnevend, A | 1 |
| Bouza, E; Burillo, A; Muñoz, P | 1 |
| Arsava, EM; Aytaç, H; Bölek, EÇ; Metan, G; Metin, BC; Otlu, B; Tekin, İ; Ünal, S; Zarakolu, P | 1 |
| Fridkin, SK | 1 |
| Aznarte-Padial, P; Calleja-Hernández, MÁ; Expósito-Ruiz, M; Hidalgo-Tenorio, C; Jimenez-Morales, A; Sadyrbaeva-Dolgova, S | 1 |
| Abu-Hanna, J; Carmeli, Y; Lerner, AO; Schechner, V | 1 |
| Ding, Y; Heath, PT; Hsia, Y; Sharland, M; Wang, Y | 1 |
| Abner, S; Benin, AL; Dudeck, MA; Edwards, JR; Kallen, AJ; Karlsson, M; Magill, SS; Pollock, D; See, I; Soe, MM; Walters, MS; Weiner-Lastinger, LM | 1 |
| Choi, KH; Choi, N; Hong, JS; Kim, SJ; Lee, S; Roh, KH | 1 |
| AlAmri, AM; AlNimr, AM; AlQurayan, AM; Sebastian, T | 1 |
| Cai, HM; Chen, J; Fang, Y; Jin, YZ; Lv, Y; Wang, C; Wang, H; Wei, QD; Wu, YJ; Xiang, Q; Yu, H; Zeng, B | 1 |
| Benezit, F; Camus, C; Fillatre, P; Le Tulzo, Y; Massart, N; Moriconi, M | 1 |
| Castillo-Ramírez, S; Cevallos, MA; Colín-Castro, CA; Evans, BA; Franco-Cendejas, R; Graña-Miraglia, L; Hernández-Durán, M; López-Jácome, LE; Volkow-Fernández, P | 1 |
| Ainsworth, J; Crook, DW; Eyre, DW; German-Mesner, I; Mathers, AJ; Pannone, A; Peto, T; Sheppard, A; Sifri, CD; Stoesser, N; Vegesana, K; Walker, AS | 1 |
| Freire, MP; Levin, ASS; Salomão, MC | 1 |
| Brown, SM; Ferraro, J; Goodman, B; Jones, PB; Lopansri, B; Stenehjem, E; Subramanian, A; Webb, BJ | 1 |
| Al Nasser, W; Alghoribi, M; Aljohany, SM; Almohrij, SA; Almunif, S; Alothman, A; Alqahtani, S; Alsaedi, A; Alshamrani, MM; Arabi, Y; Balkhy, HH; Bonnie, HB; El Gammal, A; El-Saed, A | 1 |
| Calil, FF; de Azevedo Carazatto, PZ; Fortaleza, CMCB | 1 |
| Chang, FC; Huang, TS; Lee, CC; Lee, SS | 1 |
| Choi, JY; Jeong, H; Kim, MH; Lee, S; Ryu, CM; Sim, YM; Yong, D | 1 |
| Chen, C; Idris, A; Ma, C; Qu, X; Tao, Z; Wang, H; Yin, A; Yin, C | 1 |
| Anahtar, MN; Bramante, JT; Hawkins, FR; Herriott, IC; Hooper, DC; Huntley, MH; Kwon, DS; Pangestu, FK; Pierce, VM; Sater, MRA; Shenoy, ES; Suslak, D; West, LR | 1 |
| Bamford, C; Bhola, P; Chibabhai, V; Ismail, H; Mbelle, N; Nana, T; Perovic, O; Quan, V; Ramjathan, P; Singh-Moodley, A; Smith, M; Swe Swe-Han, K; Wadula, J; Whitelaw, A | 1 |
| Apisarnthanarak, A; Dissaneevate, S; Janjindamai, W; Maneenil, G; Pannaraj, PS; Thatrimontrichai, A | 1 |
| Bao, M; Fu, Y; Li, C; Su, S; Wang, Y; Yu, L; Zhang, J; Zhang, X; Zhao, Y | 1 |
| Bertani, AMJ; Bueno, MS; Camargo, CH; Cunha, MPV; de Barcellos, TAF; de Vasconcellos, FM; Ferreira, AM; Gonçalves, CR; Mondelli, AL; Montelli, AC; Sacchi, CT; Sadatsune, T; Sant'Ana, DA; Santos, CA; Tavares, LCB; Tiba-Casas, MR | 1 |
| Bhattacharjee, A; Bhowmik, D; Chakravarty, A; Chanda, DD; Chetri, S; Das, BJ | 1 |
| Dedeić-Ljubović, A; Granov, D; Salimović-Bešić, I | 1 |
| Baggs, J; Craig, M; Fiore, A; Hatfield, KM; Jernigan, JA; Kallen, A; McCarthy, N; McDonald, LC; Nelson, RE; Olubajo, B; Paul, P; Reddy, SC; Wolford, H | 1 |
| Bernardo, M; Bitterman, R; Carmeli, Y; Daikos, G; Daitch, V; Dishon-Benattar, Y; Durante-Mangoni, E; Friberg, LE; Iossa, D; Leibovici, L; Lellouche, J; Mouton, JW; Nutman, A; Paul, M; Skiada, A; Temkin, E; Theuretzbacher, U; Yahav, D; Zusman, O | 1 |
| Azevedo, A; Correia, S; Figueiredo Dias, P; Lima Alves, C; Neves, J; Paiva, JA; Rocha-Pereira, N; Shahriari, S; Teixeira, J | 1 |
| Gatermann, SG; Körber-Irrgang, B; Korte-Berwanger, M; Kresken, M; Pfennigwerth, N; Seifert, H | 1 |
| Abbo, LM; Bachman, WC; dePascale, D; Doi, Y; Fennie, K; Fowler, EL; Ibrahimou, B; Jimenez, A; Martinez, O; McElheny, CL; Munoz-Price, LS; Pekovic, V; Perez-Cardona, A; Sposato, K; Trepka, MJ | 1 |
| Aditianingsih, D; Goessens, WHF; Karuniawati, A; Klaassen, CHW; Saharman, YR; Sedono, R; Severin, JA; Verbrugh, HA | 1 |
| Amaral, SC; Conceição, FR; de Freitas, SB; Ferreira, MRA; Hartwig, DD; Moreira, C; Roloff, BC | 1 |
| Ascencio, F; Estrada-Garcia, MT; Garciglia Mercado, C; Gaxiola Robles, R; Gomez-Anduro, G; Silva-Sanchez, J | 1 |
| Alon, D; Chowers, M; Mudrik, H; Shitrit, P | 1 |
| Ayobami, O; Eckmanns, T; Markwart, R; Suwono, B; Willrich, N | 1 |
| Cares Network, OBOT; Chen, H; Li, H; Liu, Y; Wang, H; Wang, Q; Zhao, C | 1 |
| Abd-Alhalim, S; Al-Hassan, L; Albasha, AM; Alshaib, EF; Altayb, HN; Osman, EH | 1 |
| Daikos, GL; Hadjihannas, L; Karapanou, A; Miriagou, V; Psichogiou, M; Spyridopoulou, K; Sypsa, V; Tzouvelekis, L | 1 |
| Bai, H; Bao, H; Guo, T; Hai, Y; Jiao, Y; Li, H; Liu, W; Ren, W; Tian, J; Wang, M; Xing, H; Xu, B; Yang, H; Yang, L; Yang, Y; Zhang, K; Zhang, S; Zhao, Y | 1 |
| Bennett, JW; Galac, MR; Hinkle, K; Jones, AR; Julius, M; Kwak, YI; Lebreton, F; Lesho, EP; Maybank, R; Mc Gann, P; Ong, AC; Snesrud, E; Stam, J; Waterman, PE | 1 |
| Dong, L; Li, HY; Li, Z; Lin, XX; Liu, CX; Liu, PN; Ye, WJ | 1 |
| Alves, MZO; Asensi, MD; Bandeira, CS; Beck, DS; Cid, PA; Gomes Junior, SCS; Gomes, MZR; Lima, EM; Lourenço, ND; Marques, JA; Pinheiro, LHZ; Rodrigues, CAS; Santos, RQ; Tonhá, JPS | 1 |
| Alaguero, M; Escudero, D; Fernández, J; Quindós, B; Rodicio, MR; Rodríguez-Lucas, C; Vázquez, X | 1 |
| Cai, L; Gao, S; Huang, W; Kang, Y; Qiao, F; Tao, C; Wei, L; Zhu, S; Zong, Z | 1 |
| Chakraborty, T; Falgenhauer, J; Falgenhauer, L; Hauri, AM; Heinmüller, P; Imirzalioglu, C; Nordmann, P; Yao, Y | 1 |
| Giannella, M; Longshaw, C; Lopes, S; Manissero, D; McCool, R; Palacios-Baena, ZR; Rodríguez-Baño, J; Viale, P; Wilson, K | 1 |
| de Brito, CS; de Paula Menezes, R; Ferreira, ML; Gonçalves, IR; Gontijo-Filho, PP; Porto, JP; Ribas, RM; Urzedo, JE | 1 |
| Hu, F; Jia, P; Jin, X; Li, M; Qin, X; Tang, YW; Tenover, FC; Wu, S; Yang, Q; Yu, Y; Zhang, H | 1 |
| Atrouni, AA; B Halimeh, F; Dabboussi, F; Haenni, M; Hamze, M; Jamal, S; Lupo, A; M Diene, S; Madec, JY; Mallat, H; Moudani, W; Osman, M; Raad, EB; Rafei, R; Rolain, JM; Saras, E; Tom, JE | 1 |
| Gruninger, RJ; Horth, RZ; Nakashima, AK; Oakeson, KF; Rider, L; Rossi, A; Sangster, A; Schuckel, H; Smith, AR; Smith, L; Stewart, J; Vowles, M; Wagner, JM; Young, EL | 1 |
| Arias, J; Chew, D; Greeley, R; Innes, GK; Mehr, J; Perez, S; Walters, MS | 1 |
| Calfee, DP; Harris, AD; Johnson, JK; Magder, LS; Miller, LG; Morgan, DJ; Nguyen, MH; O'Hara, LM; Pineles, L; Rasko, DA | 1 |
| Belman, D; Ben-Chetrit, E; Benjaminov, O; Dadon, Z; Levin, PD; Taha, L; Wiener-Well, Y | 1 |
| Avcu, G; Cilli, F; Guner Ozenen, G; Kurugol, Z; Ozkinay, F; Sahbudak Bal, Z; Tekin, D; Umit, Z | 1 |
| Ani Caovilla Follador, F; Carolina Lucio, L; Elize Defante Ferreto, L; Fiorentin Vandresen, D; Paula Vieira, A; Pereira Bento Casaril, K; Pitt Benedetti, V; Shigueyasu Yamada, R; Viviane Buzanello Martins, C; Welter Wendt, G | 1 |
| Büchler, AC; Egli, A; Wicki Jauslin, M; Widmer, AF; Wüthrich, D | 1 |
| Jeong, IS; Lee, S; Seo, SM; Song, JY | 1 |
| Rhodes, NJ; Wunderink, RG | 1 |
| Altafini, DD; Costa, BB; Dos Santos Saalfeld, SM; Fedrigo, NH; Martinez, HV; Shinohara, DR; Tognim, MCB | 1 |
| Drabkina, IV; Gabrielyan, NI; Kisil, ОV; Kormilitsina, VG; Petrukhina, МI; Safonova, ТB; Saitgareev, RS; Sharapchenko, SО; Zakharevich, VМ | 1 |
| Banerjee, T; Barman, H; Das, A; Kumar, A; Sharma, S; Yadav, G | 1 |
| Chomnawang, MT; Houngsaitong, J; Kanathum, P; Khuntayaporn, P; Montakantikul, P; Thirapanmethee, K | 1 |
| Bacca, E; Bedini, A; Franceschini, E; Kaleci, S; Menozzi, M; Meschiari, M; Mussini, C; Orlando, G; Puzzolante, C; Santoro, A; Sarti, M; Selmi, S; Vecchi, E; Venturelli, C | 1 |
| Agard, A; Bos, J; Dale, JL; Ditto, G; Epstein, L; Franklin, P; Gasser, C; Glowicz, J; Hahn, R; Halpin, AL; Ham, DC; McAllister, GA; McKinsey, DS; McKinsey, JP; Poiry, M; Poteete, C; Turabelidze, G; Vagnone, PS; Vlachos, N; Zellmer, B | 1 |
| Chen, DK; Cui, ZG; Du, XL; Hu, JR; Li, XG; Xu, H; Zhou, HJ | 1 |
| Choi, MA; Choi, SM; Han, S; Jo, SJ; Kong, BK; Lee, R; Park, YJ | 1 |
| Mairena-Acuña, C; Peralta-Barquero, V; Pérez-Corrales, C | 1 |
| Joshi, SG; Nguyen, M | 1 |
| Buchan, BW; Graham, MB; Ledeboer, NA; Munoz-Price, LS; Reeme, A; Rivera, F; Valley, AM | 1 |
| Jalali, M; Jalali, Y; Payer, J; Sturdik, I | 1 |
| Boyd, DA; Dingle, T; Hoang, L; Lefebvre, B; Mataseje, LF; McGeer, A; Melano, RG; Mulvey, MR; Stuart, I; Walkty, A; Wilmer, A | 1 |
| Aditianingsih, D; Karuniawati, A; Qi, H; Saharman, YR; Sedono, R; Severin, JA; Verbrugh, HA | 1 |
| Aboalheja, W; Alon, T; Dickstein, Y; Eluk, O; Firan, I; Hussein, K; Putler, RKB; Warman, S | 1 |
| Cao, B; Gu, L; Lu, BH; Ma, LY; Su, JR; Wang, H; Wang, Q; Wang, XJ; Yang, CX; Zhang, AR; Zhang, JG; Zhao, JK; Zhou, CE | 1 |
| O'Toole, RF | 1 |
| Bergman, Y; Carroll, KC; Chambers, KK; Fisher, S; Simner, PJ; Tamma, PD; Yee, R | 1 |
| Ahn, SH; Cho, HK; Choi, HK; Choi, WS; Jeon, JH; Jung, JH; Kim, SH; Park, DW; Seo, M; Seok, H; Sung, SA | 1 |
| Chang, Y; Jiang, Y; Jing, M; Li, L; Qu, Y; Sun, M; Wang, X; Xiao, W; Xu, Q | 1 |
| Doughty, E; Feng, Y; Liu, Y; McNally, A; Tang, L; van Schaik, W; Wei, L; Wen, H; Wu, L; Zhu, S; Zong, Z | 1 |
| Chen, T; Fu, Y; Hua, X; Jiang, Y; Lan, P; Xu, Q; Yu, Y; Zhou, Z | 1 |
| Chen, C; Chen, YB; Wang, HB; Zhang, BL; Zhu, XY; Zhu, YH | 1 |
| Bacca, E; Busani, S; Di Pilato, V; Franceschini, E; Gimenez-Esparza, C; Girardis, M; Grottola, A; Gyssens, IC; Lòpez-Lozano, JM; Meschiari, M; Monnet, DL; Mussini, C; Orlando, G; Pecorari, M; Rossolini, GM; Sarti, M; Serio, L; Vecchi, E; Venturelli, C | 1 |
| Alp, E; Çetin, M; Elmali, F; Kaynar, L; Kürkçüoglu, CA; Metan, G; Yozgat, N | 1 |
| Adisetiyo, H; Aldrovandi, G; Didelot, X; Hemarajata, P; Hindler, J; Humphries, R; Kasarskis, A; Li, F; MacCannell, D; Rubin, Z; Russell, D; Sebra, R; Yang, S | 1 |
| Gomez-Simmonds, A; Uhlemann, AC | 1 |
| Budding, AE; Hoogewerf, M; Rozemeijer, W; Spoelstra-de Man, AM; Vloemans, J | 1 |
| Blom, D; Fogg, L; Haverkate, M; Hayden, MK; Hines, DW; Kemble, S; Lin, MY; Lolans, K; Lyles, RD; Moore, NM; Okamoto, K; Rhee, Y; Weiner, S; Weinstein, RA | 1 |
| Ang, B; Cai, Y; Chew, KL; Chow, A; Cuvin, CA; Fisher, DA; Goossens, H; Hsu, LY; Kurup, A; Kwa, AL; Lee, W; Liew, YX; Lim, CH; Ling, ML; Low, CY; Lye, DC; Marimuthu, K; Nguyen, VH; Oh, HM; Ooi, ST; Pada, SK; Tambyah, PA; Tan, JWC; Tan, TY; Tee, NW; Venkatachalam, I; Wang, Y; Wong, SY | 1 |
| Cherng, BPZ; Choon, RFK; De, PP; Deepak, RN; Fisher, D; Hsu, LY; Khong, WX; Koh, TH; Krishnan, PU; Kurup, A; Lam, CW; Lee, JJ; Lin, RTP; Ling, ML; Marimuthu, K; Ng, OT; Ong, RT; Ooi, ST; Pada, SK; Peng, BAS; Sim, NTW; Smitasin, N; Tan, EL; Tan, TY; Teo, J; Teo, YY; Thoon, KC; Van La, M; Venkatachalam, I; Young, B | 1 |
| Alikhani, MY; Aslani, MM; Bahador, A; Karimitabar, Z; Mahmoudi, H; Shahcheraghi, F; Solgi, H | 1 |
| Capone, A; Carattoli, A; D'Arezzo, S; Di Caro, A; Fortini, D; Nisii, C; Petrosillo, N; Venditti, C; Villa, L; Vulcano, A | 1 |
| Lodise, T; Ye, MJ; Zhao, Q | 1 |
| Pilmis, B; Timsit, JF; Zahar, JR | 1 |
| Bassetti, M; Carnelutti, A; Peghin, M; Righi, E | 1 |
| Antachopoulos, C; Karampatakis, T; Roilides, E; Tsakris, A | 1 |
| Blaylock, M; Browne, A; Clagon, S; DeBiasi, R; Dockery, B; Donegan, N; Hansen, K; Harmon, K; Harris, JE; Hooker, J; Iyengar, P; Jernigan, G; Kumar, P; Little, G; McFadden, M; Mirdamadi, J; Nelson, JA; Reuben, J; Sinatro, B; Song, X; Wagner, T; Walker, M; White, D; Wortmann, G; Yochelson, M | 1 |
| Bonomo, RA; Cadnum, JL; Domitrovic, TN; Donskey, CJ; Fuldauer, P; Kanwar, A; Koganti, S | 1 |
| Wilson, APR | 1 |
| Hollenberg, SM; Khan, ZA | 1 |
| Chen, CT; Chen, TL; Kuo, SC; Lee, YT; Liu, CP; Liu, YM; Wang, YC; Yang, YS | 1 |
| Aburajab, M; Ballard, DD; Dua, A; Dua, KS; Graham, MB; Khan, AH; Ledeboer, NA; Saeian, K; Smith, ZL | 1 |
| Cantara, M; Carroll, KC; Curless, MS; Maragakis, LL; Marrone, KA; Mehta, S; Rock, C; Simner, P | 1 |
| Lee, CH; Liu, JW; Ting, SW | 1 |
| Ben Jomàa-Jemili, M; Brasme, L; Chouchani, C; de Champs, C; Gharsa, H; Guillard, T; Limelette, A; Ouertani, R | 1 |
| Aurilio, C; Borgia, G; Fiore, M; Gentile, I; Leone, S; Maraolo, AE; Pace, MC; Passavanti, MB; Sansone, P | 1 |
| Aksu, HSZ; Candevir Ulu, A; Güven Gökmen, T; İnal, AS; Kibar, F; Kömür, S; Kurtaran, B; Kuşçu, F; Önlen, C; Taşova, Y; Yaman, A | 1 |
| Chang, J; Gohil, SK; Gombosev, A; Huang, SS; Singh, R; Steger, P; Tjoa, T; Zahn, M | 1 |
| El Bannah, AMS; Hassan, RMM; Nawar, NN; Salem, STB | 1 |
| Boinett, CJ; Ellington, MJ; Henson, SP; Kagia, N; Kariuki, S; Morpeth, SC; Mturi, N; Mwarumba, S; Nyongesa, S; Scott, JAG; Thomson, NR | 1 |
| Alcántar-Curiel, MD; Fernández-Vázquez, JL; Gayosso-Vázquez, C; Jarillo-Quijada, MD; Rivera-Benítez, C; Rosales-Reyes, R; Santos-Preciado, JI | 1 |
| Araujo, BF; Bueno, MFC; Cerdeira, LT; Cunha, MPV; de Oliveira Garcia, D; Francisco, GR; Gontijo-Filho, PP; Knöbl, T; Lincopan, N; Ribas, RM | 1 |
| Ali, S; Wilson, APR | 1 |
| Kousouli, E; Polimeri, K; Politi, L; Pournaras, S; Themeli-Digalaki, K; Tsakris, A; Vrioni, G; Zarkotou, O | 1 |
| Baffoe-Bonnie, AW; Brima, JK; Childress, JC; Fernandez-Cotarelo, MJ; Grgurich, D; Kerkering, TM; Mitkos, MC; Mukhopadhyay, B; Pearce, SN; Rao, J; Susanti, D | 1 |
| Arzate-Barbosa, P; Castro-Escarpulli, G; Ibarra, JA; Juárez-de la Rosa, KC; Lara-Hernández, A; Ostria-Hernandez, ML; Sakai, F; Vidal, JE | 1 |
| Grys, TE; Kohli, DR; Pannala, R | 1 |
| Bux, A; Durrani, MA; Indhar, F; Sohail, M | 1 |
| Chen, LY; Chuang, HC; Hsin, CY; Lee, YJ; Liu, HY; Tsao, LH | 1 |
| Bonten, MJM; Bootsma, MCJ; Dautzenberg, MJD; Derde, LPG; Gniadkowski, M; Gurieva, T | 1 |
| Gomez-Simmonds, A; McConville, TH; Sullivan, SB; Uhlemann, AC; Whittier, S | 1 |
| Bampi, JVB; Casagrande, JC; Cayô, R; Croda, J; da Silva, KE; de Almeida de Souza, GH; de Sales, RO; Gales, AC; Limiere, LC; Maciel, WG; Ramos, AC; Simionatto, S | 1 |
| Biggs, MJ; Bradley, CW; Garvey, MI; Gill, MJ; Holden, E | 1 |
| Cho, SY; Chung, DR; Ha, YE; Huh, K; Kang, CI; Kim, SH; Lee, NY; Peck, KR; Seok, H; Song, JH | 1 |
| Bias, TE; Ehrlich, GD; Emery, CL; Joshi, SG; Law, N; Raible, KM; Sen, B | 1 |
| Bae, IG; Baek, EH; Bak, MH; Cho, OH; Hong, J; Hong, SI; Jang, OJ; Park, KH | 1 |
| Becker, L; Borgmann, S; Pfeifer, Y; Rieß, B; Sagel, U; Siegmund, R | 1 |
| Cha, CJ; Jeon, JH; Jeong, BC; Kim, YB; Lee, CR; Lee, JH; Lee, SH; Park, KS | 1 |
| Hawken, SE; Newton, DW; Snitkin, ES; Washer, LL; Williams, CL | 1 |
| Adler, A; Ben-David, D; Carmeli, Y; Masarwa, S; Rubinovitch, B; Schwaber, MJ; Schwartz, D; Solter, E; Temkin, E | 1 |
| Akalın, H; Alışkan, HE; Aydın, G; Aydın, M; Azap, A; Azap, Ö; Başaran, S; Bilgin, H; Çakar, ŞE; Can, F; Çavuş, SA; Demir, NA; Demirkaya, H; Demiroğlu, YZ; Erdinç, Ş; Ergen, P; Ergönül, Ö; Hatipoğlu, Ç; Karakoç, Ç; Karaoğlan, I; Kaya, Ş; Keske, Ş; Memikoğlu, O; Menekşe, Ş; Mülazımoğlu, L; Tekin, S; Tezer, Y; Tümtürk, A; Ural, O; Yardımcı, C; Yılmaz, E | 1 |
| Lake, JG; Magill, SS; Milstone, AM; Saiman, L; See, I; Weiner, LM | 1 |
| Fraker, S; Hickok, J; Korwek, K; Poland, RE; Septimus, E; Watson, T | 1 |
| Chen, F; Liu, J; Liu, Y; Shen, L; Simner, P; Tamma, P; Yu, J | 1 |
| Caio, C; Gona, F; Maugeri, G; Mezzatesta, ML; Stefani, S; Zingali, T | 1 |
| Alfandari, S; Bertrand, X; Dumartin, C; Gauzit, R; Gbaguidi-Haore, H; Muller, A; Péfau, M; Rogues, AM | 1 |
| Beović, B; Daikos, GL; Durante-Mangoni, E; Kaye, KS; Papst, L; Paul, M; Pulcini, C; Raka, L; Rodríguez-Baño, J | 1 |
| Álvarez Montes, L; Bustamante, Z; Cerezales, M; Díaz Ríos, C; Gallego, L; Higgins, PG; Martínez-Martínez, L; Ocampo-Sosa, AA; Santos, J | 1 |
| Chan, FHW; Chan, TC; Chen, H; Chen, JHK; Cheng, VCC; Ho, PL; Mody, L; Ng, WC; So, SYC; Wong, ATY; Wong, SC; Wong, SCY; Yuen, KY | 1 |
| Ascher, DB; Cleland, H; Hawkey, J; Holt, KE; Judd, LM; Kostoulias, X; Padiglione, A; Peleg, AY; Spelman, DW; Wick, RR | 1 |
| Bartsch, SM; Huang, SS; Lee, BY; McKinnell, JA; Miller, LG; Mueller, LE; Wong, KF | 1 |
| Alavi-Moghaddam, M; Ghalavand, Z; Goudarzi, H; Houri, H; Nikmanesh, B; Salehi, B | 1 |
| Cohen, B; Furuya, EY; Jia, H; Larson, EL | 1 |
| Canteras, M; García Vázquez, E; Gómez, J; Hernández, A; Moreno Parrado, L; Simón, M; Yagüe, G | 1 |
| Gandra, S; Laxminarayan, R; Logan, LK; Trett, A; Weinstein, RA | 1 |
| Aldrovandi, G; Cheng, QJ; Hemarajata, P; Humphries, RM; Kim, S; Muthusamy, VR; Rubin, ZA; Russell, D; Trout, AM; Uslan, DZ; Yang, S; Zaroda, T | 1 |
| Ang, B; De, PP; Khong, WX; Lee, JJ; Marimuthu, K; Ng, DHL; Ng, OT; Poh, BF; Raj, MDR; Rao, P; Zhang, W | 1 |
| Asar, L; Both, A; Katchanov, J; Kluge, S; Klupp, EM; König, C; Maurer, FP; Rohde, H; Rothe, C | 1 |
| Alonso-Isa, M; Benítez-Sala, R; Garcia-Gonzalez, L; Gil-Moradillo, J; Justo-Quintas, J; Lara-Isla, A; Medina-Polo, J; Sopeña-Sutil, R; Tejido-Sanchez, A | 1 |
| Agoba, EE; Essack, SY; Govinden, U; Osei Sekyere, J; Peer, AKC | 1 |
| Akeda, Y; Asada, R; Hagiya, H; Kawahara, R; Nishi, I; Shanmugakani, RK; Tomono, K; Ueda, A; Yamamoto, N; Yoshida, H | 1 |
| Seliem, WA; Sultan, AM | 1 |
| Balkenende, EC; Blevins, AE; Chorazy, ML; Khader, K; Livorsi, DJ; Nair, R; Nelson, RE; Perencevich, EN; Samore, MH; Schweizer, ML | 1 |
| Adak, S; Bulagonda, EP; Khamari, B; Mahalingam, N; Manivannan, B; Siddaramappa, S | 1 |
| Deenen, R; Kaasch, AJ; Köhrer, K; Kolbe-Busch, S; MacKenzie, CR; Meyer, S; Pfeffer, K; Wendel, AF; Willmann, M | 1 |
| Annavajhala, MK; Giddins, MJ; Gomez-Simmonds, A; Hu, Y; Macesic, N; O'Malley, A; Torres, VJ; Toussaint, NC; Uhlemann, AC; Wang, Z; Whittier, S | 1 |
| Chen, C; Du, P; Hou, J; Huang, Y; Lu, X; Qin, T; Ren, H; Sui, W; Wang, L; Wang, M; Zhou, H | 1 |
| Araújo Pirez, L; Bado, I; Cordeiro, NF; Delgado-Blas, JF; García-Fulgueiras, V; Gaudio, M; Gonzalez-Zorn, B; Gutiérrez, C; Medina, JC; Papa-Ezdra, R; Rieppi, G; Seija, V; Vignoli, R | 1 |
| Carling, PC | 1 |
| Abu Sin, M; Claus, H; Eckmanns, T; Feig, M; Koppe, U; Kroll, LE; Noll, I; Schneider, M; von Laer, A | 1 |
| Avendano, EE; Chan, J; Merchant, S; Puzniak, L; Raman, G | 1 |
| Faghri, J; Moghadampour, M; Rezaei, A | 1 |
| Angeletti, S; Antonelli, F; Cella, E; Ciccozzi, M; Coppola, R; De Flora, C; De Florio, L; Dedej, E; Dicuonzo, G; Ferraro, E; Fogolari, M; Francescato, F; Incalzi, RA; Pascarella, S; Prosperi, M; Spoto, S | 1 |
| Fan, W; Nathanson, BH; Shorr, AF; Sulham, K; Zilberberg, MD | 1 |
| Alexandrova, I; Danilov, G; Ershova, K; Ershova, O; Fursova, N; Kurdyumova, N; Savin, I; Shifrin, M; Sokolova, E; Wong, D; Zelman, V | 1 |
| Brannigan, ET; Davies, F; Dyakova, E; Holmes, AH; Knight, GM; Mookerjee, S; Otter, JA | 1 |
| Beader, N; Bedenić, B; Bielen, L; Franolić, I; Lukić-Grlić, A; Meštrović, T; Mihaljević, S; Zarfel, G | 1 |
| Aziz, FN | 1 |
| Ehricht, R; Hellmark, B; Jass, J; Khan, FA; Söderquist, B | 1 |
| Haghi, F; Kashefieh, M; Shirmohammadlou, N; Zeighami, H | 1 |
| Al-Tawfiq, JA; Eljaaly, K; Enani, MA | 1 |
| Chen, Z; Kang, M; Li, M; Liu, M; Song, Q; Wu, L; Xie, Y; Zhao, D | 1 |
| Bassis, C; Cisneros, EC; Dangana, T; Fogg, L; Hayden, MK; Lin, MY; Lolans, K; Moore, NM; Okamoto, K; Rhee, Y; Schoeny, M; Seekatz, A; Shimasaki, T; Weinstein, RA; Yelin, RD; Young, VB | 1 |
| Kano, KI; Nishiyama, K; Shime, N | 1 |
| Amaratunga, K; Boyd, DA; Bryce, E; Embree, J; Katz, K; Kibsey, P; Langley, JM; Lavallee, C; Mataseje, LF; Mitchell, R; Mulvey, MR; Pelude, L; Roscoe, D; Simor, AE; Taylor, G; Turgeon, N | 1 |
| Cho, EB; Choi, SH; Chung, JW; Lee, MK | 1 |
| Gent, JF; Halpin, AL; Harris, AD; Johnson, JK; Kong, Y; Pettigrew, MM; Pineles, L | 1 |
| Barth, AL; Martins, AF; Niada, M; Nunes, LS; Pagano, M | 1 |
| Abrar, S; Ain, NU; Bukhari, SS; Haider, MH; Hussain, S; Iftikhar, A; Rasheed, F; Riaz, S | 1 |
| Dimov, S; Mitov, I; Savov, E; Sirakov, I; Stoeva, T; Stratev, A; Strateva, T | 1 |
| Hu, F; Li, Y; Su, J; Wang, M; Xu, S; Xu, X; Zhu, D | 1 |
| Feng, Y; Huang, W; Lin, J; Liu, L; Qiao, F; Tang, G; Zong, Z | 1 |
| Assous, MV; Ben-Chetrit, E; Benenson, S; Bier, L; Broyer, C; Cohen, MJ; Kopuit, P; Lesho, E; Levin, PD; McGann, PT; Snesrud, E; Wiener-Well, Y | 1 |
| Buer, J; Dopadlik, D; Erlemann, I; Herbstreit, F; Kribben, A; Krull, M; Rath, P; Ross, B; Tyczynski, B; Wiegard-Szramek, I | 1 |
| Earl, AM; Fodor, AA; Manson, AL; Mulder, HP; Passaretti, C; Sautter, RL; Spencer, MD; Winglee, K | 1 |
| Malecki, M; Mattner, F; Otchwemah, R; Sakka, SG; Tellez-Castillo, CJ; Wendel, AF | 1 |
| de Azevedo, FKSF; de Sousa, ATHI; Dutra, V; Hahn, RC; Mello, CM; Nakazato, L; Pepato, MA; Souto, FJD; Takahara, DT | 1 |
| Chen, L; Chen, Y; Chen, Z; Gao, S; Wu, H; Xu, Z | 1 |
| Gaind, R; Jain, M; Rani, V; Sen, MK; Sharma, A; Suri, JC | 1 |
| Ertis, DH; Jessup, A; Sertkaya, A; Wong, HH | 1 |
| Antona, C; Bandi, C; Brilli, M; Comandatore, F; Dichirico, B; Gismondo, MR; Piazza, A; Ridolfo, A; Rimoldi, SG; Romeri, F | 1 |
| Martínez-Martínez, L | 1 |
| Li, J; Wang, Z; Zhao, D; Zuo, Y | 1 |
| Ibrahim, ME | 1 |
| Akkoyunlu, Y; Aslan, T; Daskaya, H; Durdu, B; Hakyemez, IN; Meric Koc, M; Sumbul Gultepe, B | 1 |
| Barrios-Camacho, H; Bocanegra-Ibarias, P; Duran-Bedolla, J; Garza-González, E; Garza-Ramos, U; Hernández-Castro, R; Lozano, L; Morfín-Otero, R; Silva-Sanchez, J | 1 |
| Gu, Q; Huang, J; Li, L; Li, M; Liu, J; Qu, H; Sun, J; Tan, R; Wang, J; Wang, X; Wu, J; Zhao, Y | 1 |
| Chia, BY; Chlebicki, MP; Ee, RP; Kwa, AL; Lee, W; Liew, YX; Oon, LL; Teo, JQ | 1 |
| Huang, M; Liang, Q; Xu, Z; Yan, C | 1 |
| Huang, W; Zong, Z | 1 |
| Barth, AL; de Lima-Morales, D; Gomes Dias, CA; Mott, MP; Paim, TG; Raro, OHF; Riche, CVW; Teixeira, UF; Waechter, FL | 1 |
| Coolen, JPM; Ghamati, MR; Hopman, J; Kenters, N; Mehtar, S; Meijer, C; Morshuis, WJ; van Crevel, R; van den Heuvel, MM; Verhagen, AFTM; Voss, A; Wertheim, HFL | 1 |
| Zaki, AOBAMES | 1 |
| Akram, N; Ali, A; Bokhari, H; Humayun, A; Iqbal, T; Kamran, R; Kumar, A; Saleem, S; Siddiqui, FM | 1 |
| Daikos, GL; Miriagou, V; Piperaki, ET; Tzouvelekis, LS | 1 |
| DePestel, DD; DeRyke, CA; Gupta, V; Merchant, S; Murray, J; Puzniak, L; Srinivasan, A; Ye, G | 1 |
| Fu, Y; Ren, D; Yang, Q; Yao, Y; Yu, Y; Zhou, H; Zhou, J; Zhu, B | 1 |
| Fang, Q; Feng, P; Feng, Y; Wang, X; Zong, Z | 1 |
| Bello-Toledo, H; Cerdeira, L; Domínguez-Yévenes, M; Esposito, F; González-Rocha, G; Lima, CA; Lincopan, N; Morales-León, F; Opazo-Capurro, A; Quezada-Aguiluz, M; San Martín, I | 1 |
| Leelakanok, N; Soontaros, S | 1 |
| Arcadipane, A; Arena, G; Campanella, O; Conaldi, PG; Douradinha, B; Gioè, S; Gridelli, B; Grossi, P; Gruttadauria, S; Hazen, B; Luca, A; Martucci, G; Medaglia, A; Mularoni, A; Tuzzolino, F | 1 |
| Fan, X; Guo, Y; Hu, K; Mensah, SD; Wang, Y; Zhang, J; Zhang, X; Zhao, Y | 1 |
| Allou, N; Allyn, J; Aujoulat, T; Ferdynus, C; Lair, T; Lugagne, N; Miltgen, G; Teysseyre, L | 1 |
| Amadori, F; Bartoletti, M; Bassetti, M; Carannante, N; Ceccarelli, G; Corcione, S; De Rosa, FG; Del Bono, V; Di Caprio, G; Giacobbe, DR; Giannella, M; Granata, G; Losito, AR; Menichetti, F; Mussini, C; Peghin, M; Petrosillo, N; Russo, A; Santoro, A; Segala, FV; Tascini, C; Tumbarello, M; Vena, A; Venditti, M; Viale, P; Viscoli, C | 1 |
| Lai, RW; Leung, EC; Leung, PH | 1 |
| Epson, E; Horwich-Scholefield, S; Rizzo, K | 1 |
| Li, J; Ma, W; Sun, S; Wang, D; Yu, C | 1 |
| Baldolli, A; de La Blanchardière, A; Isnard, C; Perron, J; Saint-Lorant, G | 1 |
| Al Saif, S; Aljohany, SM; Alshaalan, M; AlShehri, A; Balkhy, HH; El-Metwally, A; El-Saed, A; Hijazi, O | 1 |
| Azougagh, K; Barbier, F; Boulain, T; Boutrot, M; Guinard, J | 1 |
| Akeda, Y; Chaihongsa, N; Chiaranaicharoen, S; Hagiya, H; Hamada, S; Hamaguchi, S; Kerdsin, A; Malathum, K; Oishi, K; Okada, K; Santanirand, P; Sirichot, S; Tomono, K; Yamamoto, K; Yamamoto, N; Yoshida, H | 1 |
| Boyd, S; Dubendris, H; Gable, P; Greene, S; Kornegay, R; MacFarquhar, J; Walters, M | 1 |
| Boyer, A; Cockenpot, T; Dubois, V; Gruson, D; Lasheras, A; M'Zali, F; Prevel, R | 1 |
| Fujisawa, M; Kitano, H; Matsubara, A; Ohge, H; Shigemura, K; Teishima, J | 1 |
| Chang, KC; Kuo, HY; Liou, ML; Liu, CC; Lu, CW; Tang, CY | 1 |
| Kaniga, K; Lee, M; Redman, R; Rice, DA | 1 |
| Fanti, KS; Garcia, DO; Levin, AS; Mostardeiro, M; Pereira, GH | 1 |
| García, P; Gutiérrez, C; Labarca, J; Moraga, M; Román, JC; Sanhueza, F; Wozniak, A | 1 |
| Huang, L; Sun, L; Yan, Y | 1 |
| Falagas, ME; Kapaskelis, A; Karageorgopoulos, DE; Tansarli, GS | 1 |
| Bell, JM; Gillespie, EE; Korman, TM; Kotsanas, D; Li, HY; Snook, K; Stuart, RL; Wijesooriya, WR; Williams, N; Wright, L | 1 |
| Chen, JH; He, YQ; Liu, S; Wan, YF; Xu, CQ; Ye, ML; Zheng, YL; Zhou, LY | 1 |
| Citerio, G; Fiori, L; Patruno, A | 1 |
| Cooper, MA; Espedido, BA; Gosbell, IB; Grimmond, SM; Jensen, SO; Steen, JA; van Hal, SJ; Ziochos, H | 1 |
| Abbott, I; Bhuiyan, S; Cerqueira, GM; Peleg, AY | 1 |
| Alba, L; Clock, SA; Kubin, CJ; Saiman, L; Tabibi, S; Whittier, S | 1 |
| Nanas, S; Papas, V; Pitsiolis, T; Platsouka, E; Pratikaki, M; Roussos, C; Routsi, C; Sotiropoulou, C; Tsakris, A | 1 |
| Chen, T; Lü, X; Wang, X; Yu, R; Zong, Z | 1 |
| Álamo, I; Artiles, F; Castillo-Vera, J; Chamizo, FJ; Gilarranz, R; Juan, C; Oliver, A | 1 |
| Alvis, N; Amado, C; Cañon, O; Castañeda, C; de la Hoz, FP; Einarson, TR; Kawai, K; Lemos, EV; Leon, Y; Quevedo, E | 1 |
| Chida, K; Harada, M; Inui, N; Matsuo, Y; Nakamura, Y; Suda, T; Wajima, T | 1 |
| Bonnin, RA; Cuzon, G; Nordmann, P; Poirel, L | 1 |
| Carroll, KC; Perl, TM; Savard, P; Wilson, LE | 1 |
| Munoz-Price, LS; Quinn, JP | 1 |
| Anderson, KF; Banach, DB; Calfee, DP; Kitchel, B; LaBombardi, V; Patel, G; Phillips, M; Poliansky Blash, S; Sharma, S; Srinivasan, A; Swaminathan, M | 1 |
| Chamberlain, D; Hendershot, J; Irvine, M; Massoud, N; Vettese, N; Wimer, S | 1 |
| Thamlikitkul, V; Tiengrim, S | 1 |
| Cho, IH; Choi, SW; Chung, SY; Gurung, M; Heo, JY; Jang, CW; Jee, HS; Kim, HS; Lee, JC; Lee, JH; Lee, YC; Moon, SY; Rho, JS; Yu, BH | 1 |
| Bogan, C; Marchaim, D | 1 |
| Asticcioli, S; Caltagirone, MS; Daturi, R; Debiaggi, M; Labonia, M; Matti, C; Migliavacca, R; Navarra, A; Nucleo, E; Piazza, A; Spalla, M | 1 |
| Anais, L; Bonnin, RA; Decousser, JW; Emirian, A; Jansen, C; Merle, JC; Nordmann, P; Poirel, L | 1 |
| Henderson, DK; Palmore, TN | 2 |
| Bozkurt, F; Dal, T; Dayan, S; Deveci, Ö; Tekin, A; Tekin, R | 1 |
| Shorr, AF; Zilberberg, MD | 1 |
| Basso, M; Costa, SF; DalBen, MF; Garcia, CP; Jarvis, WR; Levin, AS; Lobo, RD; Oliveira, MS; Toscano, CM | 1 |
| Chen, TL; Fung, CP; Ku, WW; Kung, CH; Kuo, SC; Lee, CH; Lee, YT; Tseng, CP; Wang, FD; Wu, PF | 1 |
| Hasan, B; Olsen, B; Perveen, K; Zahra, R | 1 |
| Chu, YZ; Deng, QL; Dong, F; Fu, WL; Hu, BJ; Hu, YJ; Hu, ZD; Ji, P; Jin, YF; Li, Y; Liu, WE; Lü, XJ; Lü, Y; Meng, L; Pan, SY; Pei, FY; Wang, S; Xu, XL; Xue, F; Yang, B; Yang, J; Yang, YJ; Yu, YS; Zhang, XZ; Zhao, JH; Zhao, WS; Zhou, L | 1 |
| Karagouni, AD; Katsifas, EA; Liakopoulos, A; Mavroidi, A; Miriagou, V; Petinaki, E; Theodosiou, A | 1 |
| Majewski, P; Michalska, AD; Ojdana, D; Sacha, PT; Tryniszewska, E; Wieczorek, P | 1 |
| Taylor, B; Taylor, SP | 1 |
| Bülbüller, N; Cekin, AH; Cekin, Y; Durmaz, R; Karagöz, A; Kızılateş, F; Oztoprak Çuvalcı, N | 1 |
| Duan, X; Wu, H; Xu, J; Zhou, Q | 1 |
| Burgess, DS; Lawson, KA; Lee, GC | 1 |
| Bosnak, VK; Karaoglan, I; Mete, AO; Namiduru, M; Zer, Y | 1 |
| Hu, F; Qin, X; Yang, Y; Zhu, D | 1 |
| Barba, MJ; Bou, G; Merino, M; Poza, M; Roca, I; Sousa, MD; Vila, J | 1 |
| Guclu, E; Karabay, O; Ogutlu, A; Tuna, N; Utku, AC; Yahyaoglu, M | 1 |
| Jung, S; Kim, J; Kim, JS; Kim, SI; Lee, JY; Park, KG; Park, YJ; Song, W; Yu, JK | 1 |
| Aktas, F; Dizbay, M; Guzel Tunccan, O; Karasahin, O | 1 |
| Chen, R; Chen, Y; Guo, L; Han, L; Han, X; Luo, Y; Tian, S; Yang, J; Ye, L; Zhao, J; Zhao, Q | 1 |
| Chen, Y; Guo, L; Guo, S; Han, L; Luo, Y; Song, Y; Sun, G; Yang, J; Ye, L; Zhou, G | 1 |
| Chong, YP; Choo, EJ; Chung, JW; Jeon, MH; Kim, DM; Kim, T; Kim, YS; Lee, HK; Moon, C; Park, SY; Peck, KR | 1 |
| Abdalhamid, B; Hassan, H; Itbaileh, A; Shorman, M | 1 |
| Ambretti, S; Arghittu, M; Bua, G; Cariani, L; Colombo, R; Gaibani, P; Landini, MP; Lombardo, D; Sambri, V; Torresani, E | 1 |
| Fan, H; Lu, Y; Pan, L; Shi, Y; Sun, K; Yan, Y; Yang, H | 1 |
| Hurst, H; Landry, J | 1 |
| Boehme, M; Brennan, BM; Buckley, BO; Coyle, JR; Finks, J; Kaye, KS; Malani, AN; Marchaim, D; Mollon, N; Pogue, JM; Sundin, DR; VerLee, KE; Washer, LL | 1 |
| Arao, RF; Beldavs, ZG; Buser, GL; Cunningham, MC; Furuno, JP; Leitz, A; Pfeiffer, CD; Poissant, T; Thomas, A; Townes, JM | 1 |
| Bamberg, WM; Barron, MA; Epson, EE; Gould, CV; Janelle, SJ; Kallen, AJ; Kitchel, B; Limbago, BM; MacCannell, DR; Pisney, LM; Rasheed, JK; Wendt, JM | 1 |
| Alluri, KC; Bhargava, A; Datla, S; Diviti, S; Haider, S; Hayakawa, K; Kaye, KS; Kuchipudi, V; Lephart, PR; Marchaim, D; Muppavarapu, KS; Silverman, E | 1 |
| Arheart, KL; Cleary, T; Depascale, D; Fajardo-Aquino, Y; Kett, DH; Munoz-Price, LS; Namias, N; Pizano, L; Rosa, R | 1 |
| Harper, JE; Kallen, AJ; Limbago, BM; Lynfield, R; Pereira, EC; Shaw, KM; Vagnone, PM | 1 |
| Agodi, A; Barchitta, M; Bellocchi, P; Castiglione, G; Giaquinta, L; Poulou, A; Quattrocchi, A; Romeo, MA; Santangelo, C; Tsakris, A; Voulgari, E; Vrioni, G | 1 |
| Chang, PC; Chen, YY; Lai, CC; Liu, WL; Tan, CK; Tang, HJ | 1 |
| Batailler, P; Cheong Sing, JS; Ducki, S; Forli, A; Maillet, M; Mallaret, MR; Marfaing, S; Pelloux, I; Vancoetsem, K | 1 |
| Andrasevic, AT; Butic, I; Goic-Barisic, I; Jelic, M; Novak, A; Radic, M; Rubic, Z; Tonkic, M | 1 |
| Fang, X; Gong, M; Xia, J; Xu, Y; Zhang, D; Zhou, Y | 1 |
| Baud, FJ; Deye, N; Marcadé, G; Mégarbane, B; Raskine, L; Rousseau, H; Vicaut, E; Vodovar, D | 1 |
| Gartzonika, C; Levidiotou-Stefanou, S; Politi, L; Priavali, E; Tsakris, A; Voulgari, E; Vrioni, G | 1 |
| Emaneini, M; Jabalameli, F; Mirsalehian, A; Neyestanaki, DK; Rezagholizadeh, F; Taherikalani, M | 1 |
| Akcali, A; Bozkurt-Guzel, C; Ozbek-Celik, B; Savage, PB | 1 |
| Arslan, U; Kus, H; Tuncer, I; Turk Dagi, H | 1 |
| Ahn, JY; Ann, HW; Choi, H; Choi, JY; Han, SH; Jeon, Y; Jeong, SJ; Kim, JH; Kim, JK; Kim, JM; Kim, MH; Kim, SB; Ku, NS; Lee, K; Song, JE; Song, YG; Yong, D | 1 |
| Alfandari, S; Blondiaux, N; Boussekey, N; Chiche, A; Delannoy, PY; Georges, H; Gois, J; Leroy, O; Melliez, H; Meybeck, A; Patoz, P; Senneville, E | 1 |
| Caccuri, F; Caruso, A; Corbellini, S; De Francesco, MA; Fiorentini, S; Gelmi, M; Giagulli, C | 1 |
| Asensi, MD; Carvalho, KR; Carvalho-Assef, AP; Chagas, TP; de Oliveira Santos, IC | 1 |
| Stock, I | 1 |
| Adler, A; Ben-David, D; Carmeli, Y; Masarwa, S; Mishali, H; Schwaber, MJ | 1 |
| Cox, HL; Enfield, KB; Gosseling, MF; Hazen, KC; Huq, NN; Kundzins, JR; Lewis, JD; Low, DJ; Mathers, AJ; Sifri, CD; Slitt, G; Toney, DM; Zapata, HJ | 1 |
| Badal, RE; Biedenbach, DJ; Bouchillon, SK; Hackel, M; Hoban, DJ; Nga, TT; Phuong, DM; Phuong, NT; Phuong, TT | 1 |
| Braun, T; Carmeli, Y; Edgar, R; Glick, R; Hoshen, M; Nutman, A; Temkin, E | 1 |
| Broucqsault-Dedrie, C; Laurans, C; Ledez, R; Meybeck, A; Nottebaert, S; Nyunga, M; Vachée, A; Vanbaelinghem, C; Verheyde, I; Waes, S | 1 |
| Lye, DC; Ng, TM; Nikolaou, M; Tam, VH; Tan, MW | 1 |
| Acar, A; Aktas, Z; Budak, S; Erdem, H; Gorenek, L; Oncul, O; Ozyurt, M; Turhan, V | 1 |
| Banerjee, P; Singh, G | 1 |
| Asadollahi, K; Emaneini, M; Jabalameli, F; Kalantar-Neyestanaki, D; Taherikalani, M | 1 |
| Sirijatuphat, R; Thamlikitkul, V | 1 |
| Abbasi, SA; Day, KM; Paterson, DL; Perry, JD; Raza, MW; Sartor, AL; Sidjabat, HE | 1 |
| Bigot, S; Bouldouyre, MA; Bukreyeva, I; Ceci, JM; Daroukh, A; Delaunay, C; Maisonneuve, L; Porcheret, H; Raisin, J; Siddhoun, N | 1 |
| Anderson, DJ; Chen, LF; Fowler, VG; Hazen, KC; Huslage, K; Jones, CD; Lewis, SS; Moehring, RW; Moore, ZS; Sexton, DJ; Thaden, JT | 1 |
| Beldavs, ZG; Pfeiffer, CD | 1 |
| Kumar, A; Nirupam, N; Rai, Y; Randhawa, VS; Saili, A | 1 |
| Leonard, DA; Mitchell, JM | 1 |
| Barišić, I; Hirschl, AM; Mitteregger, D; Noehammer, C; Wiesinger-Mayr, H | 1 |
| Guzmán-Blanco, M; Labarca, JA; Salles, MJ; Seas, C | 1 |
| Harris-Brown, TM; Havers, SM; Paterson, DL; Rogers, BA | 1 |
| Bae, IG; Baek, EH; Bak, MH; Cho, OH; Kim, S; Park, KH | 1 |
| Barozzi, A; Ciccarese, V; Gagliotti, C; Giordani, S; Giovinazzi, A; Moro, ML; Pietrantonio, AM; Pinelli, G; Sarti, M | 1 |
| Bou, G; Cano, ME; Fernández-Cuenca, F; Garnacho-Montero, J; Gato, E; Martínez-Martínez, L; Miguel Cisneros, J; Pascual, A; Rodríguez-Baño, J; Ruíz de Alegría, C; Tomás, M; Vila, J; Villar, M | 1 |
| Bernaschi, P; Bertaina, A; Carletti, M; Ciofi Degli Atti, M; García-Fernández, A; Locatelli, F; Luzzi, I; Raponi, M; Sisto, A | 1 |
| Zurawski, RM | 1 |
| Hampton, T | 1 |
| Arwady, MA; Avillan, JJ; Black, S; Conover, C; Conway, J; Epstein, L; Frias, M; Gribogiannis, M; Guh, AY; Hunter, JC; Kallen, AJ; Kitchel, B; Laufer, AS; Limbago, BM; Lonsway, D; MacCannell, D; Moulton-Meissner, H; Noble-Wang, J; Pacilli, M; Rasheed, JK; Stein, L; Tsai, V; Vernon, M | 1 |
| Dal Forno, NL; Hörner, R; Meneghetti, BH; Righi, RA; Salla, A; Seibert, G | 1 |
| Bandi, C; Carretto, E; Comandatore, F; Corbella, M; Dalla Valle, C; Epis, S; Farina, C; Gaiarsa, S; Gaibani, P; Labonia, M; Landini, MP; Marone, P; Pongolini, S; Sambri, V; Sassera, D; Scaltriti, E | 1 |
| Chmura, A; Ciszek, M; Deborska-Materkowska, D; Durlik, M; Izdebski, R; Kosykowska, E; Mlynarczyk, A; Mlynarczyk, G; Paczek, L; Sawicka-Grzelak, A; Szymanek-Majchrzak, K; Walter de Walthoffen, S | 1 |
| Egea, P; Fernández-Cuenca, F; Galán-Sánchez, F; Guerrero-Lozano, I; Pascual, Á; Rodríguez-Iglesias, M | 1 |
| Behnke, M; Gastmeier, P; Geffers, C; Maechler, F; Peña Diaz, LA; Schröder, C | 1 |
| Li, J; Mukhopadhyay, A; Tambyah, PA; Vasudevan, A; Yuen, EG | 1 |
| Bi, J; Chen, X; Li, Y; Peng, Y; Shi, J; Yao, Z; Ye, X | 1 |
| Barbarini, D; Brovarone, F; Capatti, C; Carretto, E; Colla, R; Moro, ML; Perilli, M; Russello, G | 1 |
| Alcántar-Curiel, MD; Fernández-Vázquez, JL; García-Torres, LF; Gayosso-Vázquez, C; Giono-Cerezo, S; González-Chávez, MI; Jarillo-Quijada, MD; Morfín-Otero, R; Rodríguez-Noriega, E; Santos-Preciado, JI | 1 |
| Chongsuvivatwong, V; Chusri, S; McNeil, E; Silpapojakul, K; Singkhamanan, K | 1 |
| Ahn, S; Han, WD; Kim, ES; Kim, HB; Kim, NH; Kim, TS; Park, KU; Seo, HK; Shin, MJ; Song, KH; Yoo, JS | 1 |
| Almirante, B; López-Cerero, L | 1 |
| Miró, E; Navarro, F; Oteo, J; Pérez-Vázquez, M | 1 |
| Bou, G; Castillo, FJ; Seral, C; Vila, J | 1 |
| Paño Pardo, JR; Pintado, V; Ramos Ramos, JC; Serrano Villar, S | 1 |
| Asensio, Á; Cantero, M; Shaw, E; Vergara-López, S | 1 |
| Boyd, D; Bryce, E; Embree, J; Fuller, J; Gravel, D; Katz, K; Kibsey, P; Kuhn, M; Langley, J; Mataseje, L; Mitchell, R; Mulvey, M; Roscoe, D; Simor, A; Taylor, G; Thomas, E; Turgeon, N | 1 |
| Aşik, G; Ayyildiz, A; Berktaş, M; Çiftci, İH; Gül, M; Koçoğlu, ME; Kurtoğlu, MG; Öksüz, L; Özdemir, M; Sesli Çetin, E; Seyrek, A; Yağci, S | 1 |
| Abram, M; Bedenic, B; Bubonja-Sonje, M; Matovina, M; Skrobonja, I | 1 |
| Aksu, HS; Bozkurt, S; Candevir Ulu, A; Gürel, D; Inal, AS; Kibar, F; Kılıç, F; Kömür, S; Kurtaran, B; Taşova, Y; Yaman, A; Yapıcı Çiçekdemir, H | 1 |
| Fu, Y; Xie, W; Xu, M; Zhou, H; Zhou, J | 1 |
| Beader, N; Bedenić, B; Godič-Torkar, K; Grisold, AJ; Luxner, J; Veir, Z; Vranić-Ladavac, M; Zarfel, G | 1 |
| Dua, KS; Edmiston, CE; Khan, AH; Massey, BT; Oh, YS; Saeian, K; Smith, ZL | 1 |
| Dong, D; Huang, L; Huang, S; Huang, Y; Li, H; Liu, W; Tong, Y; Wang, X; Wei, X; Yan, X; Yang, Z; Yuan, J; Zhao, X; Zou, D | 1 |
| Huang, SF; Pu, SL; Sun, JD; Yang, SS; Zhang, CM; Zhang, LP | 1 |
| Ambretti, S; Bartoletti, M; Callea, E; Cavalli, M; Cristini, F; De Palma, A; Giannella, M; Gibertoni, C; Lewis, RE; Masina, R; Moro, ML; Mosci, D; Puggioli, MC; Tedeschi, S; Tumietto, F; Venturi, S; Viale, P | 1 |
| Ghebremedhin, B; Rasche, K; Yayan, J | 1 |
| Abu-Hanna, J; Adler, A; Carmeli, Y; Cohen Percia, S; Kazma Matalon, M; Lerner, A | 1 |
| Bassetti, M; Cavallo, R; Corcione, S; De Rosa, FG; Di Perri, G | 1 |
| Dong, Y; Huang, Y; Jiao, Y; Li, Q; Liu, J; Liu, R; Qin, Y; Shang, Y | 1 |
| Chang, FY; Chen, TL; Chiu, CH; Fung, CP; Kuo, SC; Lee, YT; Lin, JC; Sun, JR; Wang, YC; Yang, YS; Yin, T | 1 |
| Barin, J; Martins, AF; Pagano, M; Zavascki, AP | 1 |
| Azimi, L; Lari, AR; Soroush, S; Taherikalani, M | 1 |
| Abdallah, M; Charles, C; Cortes, C; Landman, D; Olafisoye, O; Quale, J; Urban, C | 1 |
| Kindgen-Milles, D; Kolbe-Busch, S; Lorenz, C; MacKenzie, CR; Pfeffer, K; Ressina, S; Schulze-Röbbecke, R; Wendel, AF | 1 |
| Carvalhaes, CG; Cayô, R; Croda, J; Gales, AC; Patussi Correia Sacchi, F; Ramos da Silva, AC; Rodrigues-Costa, F; Silva, KE; Simionatto, S | 1 |
| Al-Agamy, MH; Amin, MA; El Din Ashour, S; El-Mahallawy, HA; Zafer, MM | 1 |
| Jin, X; Liu, Y; Lu, J; Lu, Y; Wu, J; Wu, S; Wu, W | 1 |
| Gangcuangco, LM; Saul, ZK | 1 |
| Chang, YJ; Chen, CH; Lin, LC; Liu, CE; Soon, MS | 1 |
| Hirose, Y; Ishikawa, H; Kamata, K; Kanemoto, K; Shiotani, S; Suzuki, H; Suzuki, M; Tokuda, Y | 1 |
| Fedorowsky, R; Liberman, D; Lipkin, V; Masarwa, S; Peles-Bortz, A; Rubinovitch, B | 1 |
| Botziori, C; Kakasi, E; Koteli, A; Meletis, G; Oustas, E | 1 |
| Aksu, N; Alaçam, S; Baran, I; Kurşun, Ş; Mumcuoğlu, İ; Sarı, B | 1 |
| Nordmann, P; Pitout, JD; Poirel, L | 1 |
| Blood, A; Buising, KL; Chang, LW; Cocks, J; Cronin, K; Greenough, J; Howden, BP; Jeremiah, CJ; Kwong, J; Poy Lorenzo, YS; Waters, MJ | 1 |
| Guo, W; Li, J; Shan, K; Xu, B | 1 |
| Chia, JH; Hsu, PC; Kuo, AJ; Lee, CH; Lee, MH; Su, TY; Ye, JJ | 1 |
| Balicer, RD; Berlin, A; German, L; Gluzman, I; Henig, O; Hoshen, MB; Neuberger, A; Paul, M; Shapira, C; Weber, G | 1 |
| Deutsch, RF; Nailor, MD; Ross, JW | 1 |
| Chung, YK; Kang, BS; Kang, HJ; Kim, HS; Kim, JS; Lee, HJ; Lee, JA; Lee, SS; Park, EY; Shin, KS | 1 |
| Ardanuy, C; Ayats, J; Cubero, M; Cuervo, G; Dominguez, MÁ; Gallego, L; Liñares, J; Martí, S; Peña, C; Pujol, M; Sevillano, E; Tubau, F | 1 |
| Heo, ST; Jeon, H; Lee, JC; Lee, YC; Nicholas, A; Selasi, GN; Yoo, JR | 1 |
| Kollef, MH; Shorr, AF; Zilberberg, MD | 1 |
| Castro, J; Latibeaudiere, R; Munoz-Price, LS; Namias, N; Rosa, R | 1 |
| Barišić, Z; Goic-Barisic, I; Hrenović, J; Kaliterna, M; Kaliterna, V; Tonkić, M | 1 |
| Arwady, MA; Cheng-Leidig, R; Driscoll, M; Gao, W; Lin, MY; Runningdeer, E; Tang, AS; Trick, WE; Weinstein, RA | 1 |
| Kiratisin, P; Netikul, T | 1 |
| Bobadilla-Del Valle, M; Cervera-Hernandez, ME; Cruz-Hervert, LP; Galindo-Fraga, A; García-García, L; Leal-Vega, F; Martinez-Gamboa, A; Niembro-Ortega, MD; Ponce-de-Leon, A; Sifuentes-Osornio, J; Torres-Gonzalez, P | 1 |
| Angeletti, S; Avola, A; Cella, E; Crea, F; De Florio, L; Dicuonzo, G; Fagioni, M; Lo Presti, A; Vitali, MA | 1 |
| Gandra, S; Laxminarayan, R; Logan, LK; Renschler, JP; Weinstein, RA | 1 |
| Kaye, KS; Pogue, JM | 1 |
| Goodman, KE; Milstone, AM; Simner, PJ; Tamma, PD | 1 |
| Hagiya, H; Ogawa, H; Otsuka, F; Takahashi, Y; Yamamoto, A | 1 |
| Barbadora, K; Ferrelli, JG; Green, M; Nowalk, A; Roberts, TL; Stillwell, T; Weissman, SJ | 1 |
| Giardina, R; Haley, VB; Hazamy, PA; Knab, R; Lutterloh, E; Mayer, CL; Tsivitis, M | 1 |
| Chan, R; Chapin, KC; Cunha, CB; Kassakian, SZ; Mermel, LA; Tenover, FC; Ziakas, P | 1 |
| Juan, C; López-Causapé, C; Mikucionyte, G; Mulet, X; Oliver, A; Vitkauskiene, A; Zamorano, L | 1 |
| Barbier, F; Boulain, T; Bret, L; Guigon, A; Guinard, J; Poignant, S; Poisson, DM | 1 |
| Ang, B; Chia, G; Fong, PB; Kum, JQ; Marimuthu, K | 1 |
| Cao, B; Chen, H; Chen, X; Chu, Y; Guo, P; Hu, B; Hu, Z; Jin, Y; Liao, K; Liu, W; Liu, Y; Luo, Y; Su, D; Tian, B; Wang, H; Wang, Y; Wang, Z; Xu, X; Zeng, J; Zhang, F; Zhang, R; Zhao, C; Zhou, C; Zhou, H; Zhuo, C; Zou, M | 1 |
| Endo, S; Kamoshida, G; Kikuchi, H; Kikuchi-Ueda, T; Mu, X; Nakano, A; Nakano, R; Ono, Y; Tansho-Nagakawa, S; Ubagai, T; Yano, H | 1 |
| Buckeridge, DL; Fontela, PS; Fortin, É; Platt, RW; Quach, C | 1 |
| Firouzi, R; Pouladfar, G; Pourabbas, B | 1 |
| Barbier, F; Clec'h, C; Darmon, M; Dumenil, AS; Essaied, W; Garrouste-Orgeas, M; Laurent, V; Lemiale, V; Lucet, JC; Marcotte, G; Mourvillier, B; Pommier, C; Ruckly, S; Schwebel, C; Souweine, B; Timsit, JF; Zahar, JR | 1 |
| Borlaug, G; Kram, JJ; Safdar, N; Sethi, A | 1 |
| Cui, L; Lu, J; Zhao, J | 1 |
| Berrio, I; Castro, B; Maldonado, N; Manjarrés, M; Robledo, C; Robledo, J | 1 |
| Cardoso, CL; Menegucci, TC; Moreira, RR; Tognim, MC; Viana, GF; Zago, MC; Zarpellon, MN | 1 |
| Cacioni, M; Mencacci, A; Merlini, L; Monari, C; Nardelli, E; Repetto, A; Vecchiarelli, A | 1 |
| Jia, X; Li, Y; Pang, F; Zhao, Q | 1 |
| Chi, K; Naryzhny, I; Silas, D | 1 |
| Bartsch, SM; Cao, C; Huang, SS; Jernigan, JA; Kallen, AJ; Kim, DS; Lee, BY; McKinnell, JA; Miller, LG; Slayton, RB; Wong, KF | 1 |
| Cheon, S; Kim, MJ; Kim, YS; Moon, JY; Yun, SJ | 1 |
| Bedouch, P; Bernard, S; Chapuis, C; Foroni, L; Pavese, P; Stahl, JP; Van Hollebeke, M | 1 |
| Cipolla, A; D'Abramo, A; De Angelis, M; Favaro, M; Ferretti, G; Gizzi, F; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Vullo, V | 1 |
| de Avila, RA; Safdar, N; Tischendorf, J | 1 |
| Carroll, KC; Gniadek, TJ; Simner, PJ | 1 |
| Aktar, F; Balık, H; Ertuğrul, S; Güneş, A; Karabel, D; Köşker, M; Tan, İ; Tekin, R; Ülgen, C; Yolbaş, I | 1 |
| Chang, PC; Chao, CM; Chen, JJ; Chuang, YC; Hsieh, CF; Lai, CC; Lin, YH; Tang, HJ | 1 |
| Dai, H; Hu, Y; Li, L; Ping, Y; Xu, H; Yan, X | 1 |
| Berbel Caban, A; Bueno, MX; Cleary, T; dePascale, D; Doi, Y; Kett, DH; Masuda, E; Munoz-Price, LS; Namias, N; Sfeir, M; Shimose, LA; Spychala, CN | 1 |
| Çöl, A; Dedeić-Ljubović, A; Hukic, M; Salimović-Bešić, I | 1 |
| Abushaheen, A; Garbati, MA; Sakkijha, H | 1 |
| Altindis, M; Demiray, T; Koroglu, M; Ozbek, A | 1 |
| Bernardeschi, G; Malcarne, P; Ripoli, A; Sbrana, F; Tascini, C | 1 |
| Abdollahi, A; Aliramezani, A; Boroumand, MA; Douraghi, M; Ghalavand, Z; Ghourchian, S; Mohammadzadeh, M; Nateghi Rostami, M; Rahbar, M; Zeraati, H | 1 |
| Bertrand, X; Couppie, P; Demar, M; Djossou, F; Hommel, D; Kallel, H; Mahamat, A; Moreau, B; Nacher, M; Simonnet, C | 1 |
| Grigoras, C; Kalbasi, A; Karanika, S; Mylonakis, E; Paudel, S | 1 |
| Ada, B; Ahmed, SS; Aktas, Z; Alp, E; Bagirova, F; Baran, I; Dinc, G; Ersoy, Y; Esen, S; Guven, TG; Hopman, J; Hosoglu, S; Koksal, F; Melchers, W; Parlak, E; Ulu-Kilic, A; Voss, A; Yalcin, AN; Yilmaz, G | 1 |
| Bonomo, RA; Chain, PS; Davenport, KW; Jacobs, MR; Johnson, SL; Perez, F; Ramazani, A; Ramirez, MS; Sherratt, DJ; Tolmasky, ME; Traglia, GM; van Duin, D; Xie, G | 1 |
| Domínguez Jiménez, MC; Vergara-López, S | 1 |
| Abdallah, M; Bratu, S; Collins, B; Cortes, C; Ghitan, M; Landman, D; Olafisoye, O; Quale, J; Urban, C | 1 |
| Betts, J; Liakopoulos, A; Mevius, D; Oikonomou, O; Phee, LM; Wareham, DW | 1 |
| Clarkson, L; Hanberger, H; Hf, W; Hoang, BTN; Khu, DTK; Lam, YM; Larsson, M; Le, HT; Le, NK; Nadjm, B; Nguyen, KV; Nguyen, TH; Nilsson, LE; Rydell, U; Thai, TQ; Vo, VT; Vu, DTV; Vu, PD | 1 |
| Cao, B; Chen, H; Li, H; Liu, Y; Wang, H; Wang, Q; Wang, R; Wang, X; Xian, H; Yao, X; Zhang, Y; Zhao, C | 1 |
| Borlaug, G; Davis, JP; Elbadawi, LI; Gulvik, CA; Gundlach, KM; Kallen, A; Monson, T; Walters, MS; Warshauer, D | 1 |
| Jiménez, JN; Parra, OL; Vanegas, JM | 1 |
| Abdesselam, K; Amaratunga, K; Boyd, DA; Bryce, E; Embree, J; Gravel, D; Katz, K; Kibsey, P; Langley, J; Mataseje, LF; Mitchel, R; Mulvey, MR; Roscoe, D; Simor, AE; Taylor, G; Turgeon, N; Vachon, J | 1 |
| Bamford, C; Du Plessis, A; Eley, B; Malande, OO; Rip, D | 1 |
| Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N | 1 |
| Heo, ST; Jeon, H; Kim, YJ; Kwon, HI; Lee, JC; Na, SH; Nicholas, A; Oh, MH; Selasi, GN | 1 |
| Gupta, M; Singh, SK | 1 |
| Bel Haj Khalifa, A; Bouallègue, O; Boujâafar, N; Chaouch, C; Haenni, M; Madec, JY; Mansour, W; Messaoudi, A; Naija, W; Saras, E | 1 |
| Bartoletti, M; Cavina, A; Cristini, F; Giannella, M; Liverani, A; Pederzini, R; Pignanelli, S; Tedeschi, S; Toni, L; Trapani, F; Tumietto, F; Viale, P | 1 |
| Fu, Y; Liu, R; Pan, Z; Zhang, P; Zhou, H; Zhou, J | 1 |
| Falco, A; Franco, E; Guzmán, A; Ramos, Y; Takiff, H | 1 |
| Gould, IM; Lawes, T; Lopez-Lozano, JM; Macartney, G; Nebot, CA; Sinclair, C; Subbarao-Sharma, R; Wares, KD | 1 |
| Biglari, S; Hanafiah, A; Lopes, BS; Mohd Puzi, S; Rahman, M; Ramli, R | 1 |
| Chao, CM; Chen, CC; Chuang, YC; Huang, HL; Lai, CC; Tang, HJ | 1 |
| Aslam, S; Kotton, CN; Kumar, D; Logan, C; Mehta, SR | 1 |
| Fu, L; Huang, M; Liu, WJ; Wang, GX; Wu, Y; Zeng, J; Zhang, JP; Zhou, YS | 1 |
| Dahdouh, E; Daoud, Z; Hajjar, M; Suarez, M | 1 |
| Baggiani, A; Barnini, S; Casini, B; Costa, AL; Cristina, ML; Privitera, G; Selvi, C; Tagliaferri, E; Totaro, M; Valentini, P | 1 |
| Badolato, E; Bamberg, WM; de Man, T; Halpin, A; Janelle, SJ; Kallen, A; Knutsen, J; Limbago, B; Walters, M; Xavier, K | 1 |
| Chen, LK; Chen, YT; Ho, GJ; Ho, YH; Lin, TY; Tseng, CC; Wang, LS; Wang, LY | 1 |
| Bilker, WB; Goldstein, EJ; Han, JH; Lautenbach, E; Tolomeo, P; Wise, J | 1 |
| Brandt, C; Hogardt, M; Jozsa, K; Kempf, VA; O'Rourke, F; Reinheimer, C; Wichelhaus, TA | 1 |
| Bao, CM; Chen, FH; Chen, SM; Cui, EB; Huang, J; Li, T; Liu, X; Ning, NZ; Qu, F; Wang, H; Zhang, JL | 1 |
| Abdeltwab, NM; El-Domany, RA; El-Magd, MA; Emara, M; Moustafa, WH | 1 |
| Ardebili, A; Mardaneh, J; Razavi Nikoo, H | 1 |
| Aykac, K; Basaranoglu, ST; Cengiz, AB; Ceyhan, M; Kara, A; Karahan, S; Ozsurekci, Y; Sancak, B | 1 |
| Ebara, H; Hagiya, H; Haruki, Y; Kondo, E; Otsuka, F | 1 |
| Duan, J; Fu, C; Gong, R; Huang, X; Li, C; Liu, S; Liu, Y; Meng, X; Wu, A; Xiong, X; Zhang, Y; Zhou, P | 1 |
| Birren, BW; Cerqueira, GC; Chapman, SB; Cosimi, LA; Dekker, JP; Delaney, ML; Earl, AM; Ernst, CM; Feldgarden, M; Ferraro, MJ; Grad, YH; Hanage, WP; Hooper, DC; Huang, SS; Hung, DT; Kim, D; Kirby, JE; Murphy, CI; O'Brien, TF; Onderdonk, AB; Peterson, EM; Reis-Cunha, JL; Shea, TP; Wortman, JR; Young, S; Zeng, Q | 1 |
| Alonso-Isa, M; Benítez-Sala, R; García-Rojo, E; Gil-Moradillo, J; González-Padilla, DA; Justo-Quintas, J; Lara-Isla, A; Medina-Polo, J; Passas-Martínez, JB; Sopeña-Sutil, R; Tejido-Sánchez, Á | 1 |
| Janse van Rensburg, S; Lekalakala, MR; Mbelle, N; Tshisevhe, VS; Tshuma, N | 1 |
| Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P | 1 |
| Akeda, Y; Aoki, K; Hagiya, H; Ishii, Y; Nishi, I; Sakamoto, N; Tomono, K; Yamamoto, N; Yoshida, H | 1 |
| Detsis, M; Karanika, S; Mylonakis, E | 1 |
| Bajolet, O; Barbe, C; Brasme, L; De Champs, C; Guillard, T; Limelette, A; Muggeo, A; Thierry, A; Vernet-Garnier, V | 1 |
| Fernando, MM; Gunathilake, MP; Luke, WA; Miththinda, JK; Premaratna, R; Sebastiampillai, BS; Silva, FH; Wickramasinghe, RD | 1 |
| Baker, S; Duong, HHT; Nga, TVT; Tuan Anh, N; Tuan, HM; Tuan, NS; Vinh Chau, NV; Y, DM | 1 |
| Cheong, EYL; Crook, DW; Gottlieb, T; Kizny Gordon, AE; Kotay, S; Mathers, AJ; Peto, TEA; Stoesser, N; Walker, AS | 1 |
| An, JH; Jang, HC; Jeong, JH; Jung, SI; Kang, SJ; Kim, SH; Kim, YH; Moon, JE; Park, KH | 1 |
| Antachopoulos, C; Geladari, A; Iosifidis, E; Karampatakis, T; Karyoti, A; Papanikolaou, V; Politi, L; Roilides, E; Tsakris, A; Tsiatsiou, O | 1 |
| Alberg, T; Blix, HS; Eriksen, HM; Holen, Ø; Neteland, MI; Smith, I | 1 |
| Carmeli, Y; Friedman, ND; Schwaber, MJ; Walton, AL | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Friedland, I; Kaniga, K; Ketter, N; Lee, M; Lobo, SM; Niederman, M; Prokocimer, P; Réa-Neto, A; Schroeder, E | 1 |
| Choi, CH; Heo, ST; Jeong, YG; Jin, JS; Kim, JW; Kim, SJ; Lee, JC; Lee, YC | 1 |
| Bojkova, K; Higgins, PG; Seifert, H; Stoeva, T | 1 |
| Bhalekar, P; Dogra, J; Kulkarni, M; Kulkarni, N; Varaiya, A | 1 |
| Hsueh, PR; Huang, YT; Liao, CH; Lin, HY; Liu, CY; Yen, LC | 1 |
| Anupurba, S; Garg, A; Gaur, A; Mohapatra, TM; Prakash, P | 1 |
| Huang, L; Sun, L; Xia, T; Xu, G | 1 |
| Brown, NM; Burnstein, RM; Enoch, DA; Enoch, LM; Gillham, MI; Matta, B; Moore, L; Sule, O; Summers, C; Thaxter, R | 1 |
| Calfee, D; Jenkins, SG | 1 |
| Cao, JR; Luo, YP; Shen, DX; Wei, X; Yan, ZQ | 1 |
| Choi, SH; Chung, JW; Jeon, MH; Jeong, JY; Kim, YS; Kwak, YG; Lee, SO; Woo, JH | 1 |
| Boo, TW; Crowley, B; Walsh, F | 1 |
| Goff, DA; Mangino, JE; Schafer, JJ | 1 |
| Micek, ST; Neuner, EA; Ritchie, DJ | 1 |
| Chen, BL; Song, H; Wang, HY; Xin, XY; Xu, ZK; Zhang, JF; Zhao, HB | 1 |
| Khan, L; Nadkarni, AS; Schliep, T; Zeana, CB | 1 |
| Bonatti, H; Brassinga, AK; Cox, HL; Hazen, KC; Kitchel, B; Mathers, AJ; Patel, JB; Pruett, TL; Sawyer, RG; Sifri, CD; Wispelwey, B | 1 |
| Higuchi, W; Takano, T; Yamamoto, T | 1 |
| Chen, CM; Ke, SC; Liu, PY; Wu, HJ; Wu, LT | 1 |
| Chen, YL; Chen, YS; Hsiao, YS; Hsu, NS; Lin, HH; Wu, CH | 1 |
| Giakoupi, P; Maltezou, H; Pappa, O; Polemis, M; Saroglou, G; Vatopoulos, A | 1 |
| Dedhia, HV; McKnight, R | 1 |
| Al Hashem, G; Dehrab, N; Jamal, W; Rotimi, VO; Salama, M; Shahin, M | 1 |
| Finkelstein, R; Hussein, K; Kassis, I; Mashiach, T; Oren, I; Sprecher, H | 1 |
| Martínez-Lamas, L; Moldes, L; Regueiro, BJ; Treviño, M; Varón, C | 1 |
| Alhajhusain, A; El Solh, AA | 1 |
| Botelho Garcia, L; Bronharo Tognim, MC; Cardoso, CL; Dias Siqueira, VL; dos Santos Saalfeld, SM; Fukita Viana, G | 1 |
| Costa, SF; Levin, AS; Mostachio, AK; Rossi, F; van der Heidjen, I | 1 |
| Brümmer, S; de Grahl, C; Halle, E; Higgins, PG; Kohlenberg, A; Piening, BC; Rüden, H; Seifert, H; Sohr, D | 1 |
| Mandell, L | 1 |
| Restrepo, MI | 1 |
| File, TM; Redman, R | 1 |
| Amin, A | 1 |
| Donaldson, AD; Fisher, DA; Liang, LJ; Razak, L; Tambyah, PA | 1 |
| Chang, HH; Cheong, HS; Choi, JY; Chung, DR; Heo, ST; Jung, DS; Jung, SI; Kim, SW; Ko, KS; Lee, H; Park, KH; Park, YK; Peck, KR; Song, JH | 1 |
| Chalevelakis, G; Damala, M; Falagas, ME; Michalopoulos, A; Rafailidis, P; Virtzili, S | 1 |
| Costa, SF; Dalben, MF; Garcia, CP; Levin, AS; Lobo, RD; Oliveira, MS; Toscano, CM | 1 |
| Giannouli, M; Tomasone, F; Triassi, M; Tsakris, A; Zarrilli, R | 1 |
| Ergin, A; Eser, OK; Hasçelik, G | 1 |
| Chen, H; Chen, M; Sun, H; Wang, H; Xu, Y; Yang, Q | 1 |
| Cheek, E; Citron, DM; Cubbon, M; Gerding, DN; Lippett, S; Llewelyn, M; Price, J; Sambol, SP | 1 |
| Bahram, F; Emaneini, M; Fatolahzadeh, B; Feizabadi, MM; Mehdi, FM; Mohammad, E; Morovat, T; Setareh, S; Soroush, S; Taherikalani, M | 1 |
| Fisher, AC; Jenkins, SG; Kaniga, K; Nicholson, SC; Peterson, JA | 1 |
| Cuzon, G; Naas, T; Nordmann, P | 1 |
| Guery, BP | 1 |
| Akhras, K; Caro, JJ; Kongnakorn, T; Merchant, S; Mwamburi, M; Nathwani, D | 1 |
| Andremont, A; Barbier, F; Giakkoupi, P; Lucet, J; Ruppé, E; Vatopoulos, A; Wildenberg, L; Wolff, M | 1 |
| Chang, HT; Chen, IS; Chou, MY; Hsueh, PR; Huang, WK; Jean, SS; Ko, WC; Lee, WS; Lin, CF; Liu, CY; Liu, YC; Shyr, JM; Teng, LJ; Wang, JH; Wu, JJ | 1 |
| Halle, E; Kohlenberg, A; Kola, A; Rüden, H; Sohr, D; van der Linden, P; Vögeler, S; Weist, K; Weitzel-Kage, D | 1 |
| Allworth, AM; Doidge, M; George, N; Goh, HM; Lipman, J; Marshall, P; Nimmo, GR; O'Brien, K; Paterson, DL; Schembri, MA; Terry, M; Woods, M | 1 |
| Bencini, S; Bosi, A; Casalone, E; Cecconi, D; Donnarumma, F; Fanci, R; Indorato, C; Mannino, R; Mastromei, G; Monnanni, R; Nicoletti, P; Pecile, P; Sergi, S | 1 |
| Sekar, U; Shanthi, M | 2 |
| Giamarellou, H; Markaki, V; Nanas, S; Paniara, O; Platsouka, E; Pratikaki, M; Roussos, C; Routsi, C; Sotiropoulou, C; Vrettou, C | 1 |
| Diraphat, P; Phumisantiphong, U; Siripanichgon, K; Uaratanawong, S; Utrarachkij, F | 1 |
| Ben-David, D; Keller, N; Maor, Y; Rahav, G; Regev-Yochay, G; Shachar, D; Smollan, G; Tal, I; Zlotkin, A | 1 |
| Della-Latta, P; Lo, A; Stratton, C; Tang, YW; Verrall, R; Williams, J | 1 |
| Babics, A; Boytchev, I; Cuzon, G; Fortineau, N; Gayral, F; Naas, T; Nordmann, P | 1 |
| Lin, R; Nandy, P; Samtani, MN | 1 |
| Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ | 1 |
| Brás, Nde J; Clemente, WT; Coutinho, RL; Jesus, LA; Lima, SS; Moreira, RL; Neves, FA; Rezende, EM; Romanelli, RM | 1 |
| Furtado, GH; Medeiros, EA; Onita, JH; Perdiz, LB; Wey, SB | 1 |
| Arikan Akan, O; Dolapci, I; Karahan, ZC; Sahin, F; Tekeli, A; Us, E | 1 |
| Cantarelli, VV; Lopes, FS; Martins, AF; Prates, CG; Ramos, F; Superti, SV; Zavascki, AP | 1 |
| Adams, MD; Bajaksouzian, S; Bonomo, RA; Decker, BK; Dul, MJ; Ecker, DJ; Endimiani, A; Hujer, KM; Jacobs, MR; Perez, F; Ray, AJ; Salata, RA; Toltzis, P; Wallace, CJ; Windau, A | 1 |
| Otük, G; Ozbek, B | 1 |
| Canteras, M; Fernández-Rufete, A; García-Vázquez, E; Gómez, J; Hernández-Torres, A; Herreroa, JA; Ruiz, J; Yagüe, G | 1 |
| Fujita, M; Ishikura, H; Kitamura, T; Matsumoto, T; Toyoshima, H; Watanabe, K; Yoshimura, C | 1 |
| Baumann, F; Falcot, V; Lacassin, F; Le Hello, S; Mikulski, M | 1 |
| Chang, SC; Chen, YS; Hsu, LY; Hsu, MS; Ko, WC; Lau, YJ; Lauderdale, TL; Liao, CH; Lin, SY; Liu, JW; Liu, KS; Sheng, WH; Tsai, TY; Wang, LH | 1 |
| Bindayna, KM; Jamsheer, AE; Senok, AC | 1 |
| Antoniadou, E; Kontopoulou, K; Koteli, A; Kriti, M; Protonotariou, E; Sofianou, D; Vasilakos, K | 1 |
| Baig, M; Lavin, MA; Mohapatra, S; Munoz-Price, LS; Penugonda, S; Quinn, JP; Schreckenberger, P; Vais, D; Weinstein, RA; Welbel, S; Zembower, T | 1 |
| Aujard, Y; Bingen, E; Biran, V; Doit, C; Gaudin, A; Mariani-Kurdjian, P | 1 |
| De Waele, JJ; Deja, M; Diaz, E; Guven, M; Koulenti, D; Lisboa, T; Mañez, R; Martin-Loeches, I; Putensen, C; Rello, J; Ulldemolins, M | 1 |
| Bogiel, T; Gospodarek, E; Jachna-Sawicka, K; Kwiecińska-Piróg, J | 1 |
| Markou, F; Pitiriga, V; Poulou, A; Pournaras, S; Ranellou, K; Spanakis, N; Tsakris, A | 1 |
| Giasnetsova, T; Gritsi-Gerogianni, N; Iosifidis, E; Karapanagiotou, A; Mouloudi, E; Protonotariou, E; Roilides, E; Sofianou, D; Tsioka, A; Zagorianou, A | 1 |
| Bonten, MJ; Kluytmans, J; Kulberg, BJ | 1 |
| Basso, M; Costa, SF; Dulley, FL; Fonseca, GH; Fu, L; Guimarães, T; Levin, AS; Paez, J; Rossi, F | 1 |
| Feizabadi, MM; Mahamadi-Yeganeh, S; Mahboobi, M; Mirafshar, SM; Mirsalehian, A; Nili, F; Yadegarinia, D | 1 |
| Bae, IK; Jeong, SH; Lee, J; Lee, K; Lee, Y | 1 |
| Cöloğlu, D; Dolapçı, I; Karahan, ZC; Mumcuoğlu, I; Tekeli, A; Ulusoy, M; Us, E | 1 |
| Akşit, F; Aybey, AD; Kiremitçi, A; Nayman Alpat, S; Ozgüneş, I; Usluer, G | 1 |
| Buron, JA; Cerrato, SG; Garau, J; Rello, J; Rodriguez, JA; Rossolini, GM; Zaragoza, R | 1 |
| Nordmann, P | 1 |
| Bernabeu, S; Nordmann, P; Poirel, L; Revathi, G | 1 |
| Bheemreddy, S; Blunden, C; Bonomo, RA; Chen, TY; Chopra, T; Dhar, S; Endimiani, A; Hafeez, W; Hothi, J; Hujer, AM; Kaye, KS; Lephart, PR; Marchaim, D; Moshos, J; Navon-Venezia, S; Perez, F; Pogue, JM; Reid, D; Rudin, S; Salimnia, H; Shango, M; Slim, J | 1 |
| García, MI; Martínez, MJ; Sánchez, EG; Sánchez, JE | 1 |
| Aguado, JM | 1 |
| Goulenok, TM; Majed, K; Monchi, M | 1 |
| Arend, LN; Levin, AS; Penteado-Filho, SR; Pilonetto, M; Rymsza, AM; Tuon, FF | 1 |
| Cai, J; Liu, J; Wu, D | 1 |
| Carmeli, Y; Israeli, A; Lev, B; Rubinovitch, B; Schwaber, MJ; Shalit, I; Smollan, G; Solter, E | 1 |
| Garg, A; Vashishtha, VM | 1 |
| Flamm, RK; Korten, V; Laeuffer, JM; Morrissey, I; Mutters, R; Nordmann, P; Picazo, JJ; Quintana, A; Seak, JC | 1 |
| Afzal, O; Haider, S; Hasan, R; Irfan, S; Mehraj, J; Memon, B; Siddiqui, SZ; Turton, JF; Zafar, A | 1 |
| He, B; Liu, ZY; Yao, B; Zhang, J; Zhou, QT | 1 |
| Aznar, E; García-Lozano, T; Gimeno, C; Lorente, P | 1 |
| Hong, KW; Jeong, H; Kang, MW; Kim, SI; Kim, YJ; Kim, YR; Park, YJ; Wie, SH | 1 |
| Gastal, SL; Goldani, LZ; Gorniak Lovatto, C; Jacoby, T; Konkewicz, L; Kuplich, NM; Lisboa, T; Nagel, FM; Pires dos Santos, R; Pires Machado, D; Pires, MR | 1 |
| Barbeito, G; Crespo, C; García-Riestra, C; Navarro, D; Regueiro, BJ; Treviño, M | 1 |
| Fujisawa, S; Goto, H; Ishigatsubo, Y; Ito, M; Kanamori, H; Kaneko, T; Miyazawa, N; Morita, S; Ono, S; Watanuki, Y; Yamaguchi, N | 1 |
| Chen, P; Chen, Y; Hu, Z; Liu, D; Shi, Y; Wang, H; Wang, Z; Zhao, X | 1 |
| Akalın, H; Akova, M; Arman, D; Aygen, B; Başaran, S; Bayramoğlu, G; Dizbay, M; Dokuzoğuz, B; Eraksoy, H; Esener, H; Hasçelik, G; Köksal, I; Korten, V; Oğünç, D; Sınırtaş, M; Söyletir, G; Sümerkan, B; Tünger, A; Ulusoy, S; Yalçın, AN | 1 |
| Carbonne, A; Coignard, B; Jarlier, V; Thiolet, JM; Vaux, S | 1 |
| Benenson, S; Block, C; Cohen, MJ; Gross, I; Levin, PD; Moses, AE; Schwartz, C; Weiss, Y | 1 |
| Avazashvili, N; Chikviladze, D; Gachechiladze, Kh; Metreveli, D; Mikeladze, M; Nozadze, T | 1 |
| Göttig, S; Higgins, PG; Hunfeld, KP; Pfeifer, Y; Seifert, H; Wichelhaus, TA; Wilharm, G; Witte, W; Zander, E | 1 |
| Cabot, G; Cantón, R; Del Campo, R; García-Castillo, M; Morosini, MI; Oliver, A; Riera, E; van Mansfeld, R; Willems, R | 1 |
| Cristina, ML; Orlando, P; Ottria, G; Perdelli, F; Sartini, M; Spagnolo, AM | 1 |
| Chen, S; Hu, F; Liu, Y; Wang, H; Zhang, Y; Zhu, D | 1 |
| Anunnatsiri, S; Tonsawan, P | 1 |
| Ben-David, D; Gal-Mor, O; Keller, N; Kordevani, R; Maor, Y; Marzel, A; Rahav, G; Tal, I | 1 |
| Merino, P; Picazo, JJ; Rodríguez-Avial, C; Rodríguez-Avial, I | 1 |
| Ichiyama, S; Igawa, J; Iinuma, Y; Kondo, T; Matsushima, A; Nagao, M; Saito, T; Takakura, S; Takaori-Kondo, A; Yamashita, K | 1 |
| Dijkshoorn, L; Hsu, LY; Khoo, CT; Koh, TH; Ng, SY; Ooi, EE; Tan, TT; Tan, TY; Van Der Reijden, TJ | 1 |
| Bordon, JM; Clark, RB; Karlowsky, JA; Master, RN; Ramirez, J | 1 |
| Chayakul, P; Garey, KW; Pattharachayakul, S; Santimaleeworagun, W; Tansakul, P; Wongpoowarak, P | 1 |
| Chong, Y; Hong, HL; Jeong, SH; Kang, JO; Kim, JS; Kim, MN; Lee, K; Park, YJ; Shin, JH; Yong, D | 1 |
| Garcia, DO; Levin, AS; Mostardeiro, M; Ogassavara, CT; Pereira, GH | 1 |
| Bedenić, B; Budimir, A; Franolić-Kukina, I; Herljević, Z; Higgins, PG; Vraneš, J | 1 |
| Crowley, B; Fenelon, C; Fenelon, LE; FitzGerald, SF; Flynn, A; Murphy, V; O'Brien, DJ; Roche, C; Rose, L; Schaffer, K; Wrenn, C | 1 |
| Esterly, JS; Griffith, M; Malczynski, M; Postelnick, MJ; Qi, C; Scheetz, MH | 1 |
| Choi, JY; Jung, SI; Kim, DH; Kim, SH; Ko, KS; Park, KH; Park, YK | 1 |
| Bardenstein, R; Ciobotaro, P; Nadir, E; Oved, M; Zimhony, O | 1 |
| Bustamante, Z; Fernández, E; Gallego, L; Rosales, I; Sevillano, E; Umaran, A; Zabalaga, S | 1 |
| Agodi, A; Barchitta, M; Giaquinta, L; Koumaki, V; Politi, L; Romeo, MA; Spanakis, N; Tsakris, A; Valenti, G; Voulgari, E | 1 |
| Chen, S; Guo, Y; Hu, F; Liu, Y; Xu, X; Zhang, Y; Zhu, D | 1 |
| Borer, A; Eskira, S; Livshiz-Riven, I; Nativ, R; Peled, N; Riesenberg, K; Saidel-Odes, L; Schlaeffer, F; Sherf, M | 2 |
| Adams-Haduch, JM; Bogdanovich, T; Doi, Y; Halstead, DC; Marschall, J; Onuoha, EO; Pasculle, AW; Rhee, D; Spellberg, BJ; Tian, GB; Urban, CM | 1 |
| Cook, PP; Gooch, M; Rizzo, S | 1 |
| Arch, O; Ariza, J; Dominguez, MA; Gavaldá, L; Juan, C; Oliver, A; Peña, C; Pujol, M; Sora, M; Suarez, C; Tubau, F | 1 |
| Jung, SI; Kim, SH; Ko, KS; Park, KH; Park, YK | 1 |
| Alvarez-Avello, J; Asensio, A; Azañedo, L; Balandín-Moreno, B; Campos, J; Cuevas, O; Fernández-Romero, S; Isidoro, B; Muñoz-Algarra, M; Oteo, J; Sáez, D; Sánchez-Romero, I; Vindel, A | 1 |
| Sóki, J; Soyletir, G; Toprak, NU; Uzunkaya, OD | 1 |
| Chen, CP; Chen, TL; Chiang, MC; Fung, CP; Kuo, SC; Lee, YT; Yang, SP | 1 |
| Dong, L; Li, HY; Wang, ZY; Zhang, TQ | 1 |
| Canteras, M; García-Vázquez, E; Gómez, J; Hernández-Torres, A; Ruiz, J; Yagüe, G | 1 |
| Jomantienė, D; Macas, A; Sakalauskas, R; Skrodenienė, E; Vitkauskienė, A | 1 |
| Kempf, M; Rolain, JM | 1 |
| Bourigault, C; Caroff, N; Corvec, S; Crémet, L; Guillouzouic, A; Juvin, ME; Lepelletier, D; Reynaud, A | 1 |
| Decker-Burgard, S; Laeuffer, J; Morrissey, I; Mutters, R; Seifert, H; Valenza, G | 1 |
| Apisarnthanarak, A; Mundy, LM | 1 |
| Al Johani, SM; Al-Ahdal, MN; Al-Qahtani, AA; Alothman, A; Altayeb, HT; Arabi, Y; Balkhy, HH; El-Saed, A; Francis, C; Sallah, M | 1 |
| Bille, E; Carbonnelle, E; Cattoir, V; Corvec, S; Fihman, V; Illiaquer, M; Jacquier, H; Jaureguy, F; Le Monnier, A; Tankovic, J; Zahar, JR | 1 |
| Akduman, D; Aktas, E; Aydemir, H; Celebi, G; Keskin, AS; Oztoprak, N; Piskin, N; Sumbuloglu, V | 1 |
| Baris, H; Cakir, N; Celen, M; Kurt, H; Laeuffer, J; Leblebicioglu, H | 1 |
| Al-Hubail, M; Al-Sweih, NA; Rotimi, VO | 1 |
| Cai, JC; Chen, GX; Hu, YY; Sun, Q; Zhang, R; Zhou, HW | 1 |
| De Jesús, A; Hernández, L; Marcano, D; Torres, L | 1 |
| Bakšytė, G; Dambrauskienė, A; Macas, A; Sakalauskas, R; Skrodenienė, E; Vitkauskienė, A | 1 |
| Babu, E; Bäcker, M; Bratu, S; Kelly, P; Landman, D; Olawole, O; Quale, J; Shah, N | 1 |
| Chongthaleong, A; Davies, T; Garcia, J; Kiratisin, P; Lagamayo, E; Roberts, S; Tan, TY | 1 |
| Boyd, DA; Bryce, E; Embree, J; Gravel, D; Katz, K; Kibsey, P; Kuhn, M; Mataseje, LF; Mounchili, A; Mulvey, MR; Roscoe, D; Simor, A; Taylor, G; Thomas, E; Turgeon, N | 1 |
| Cai, Y; Kwa, AL; Lee, W; Tan, TT; Tan, TY; Tang, S; Teo, J | 1 |
| De Waele, JJ; Lipman, J; Paterson, DL; Roberts, JA; Udy, AA | 1 |
| Cornaglia, G; Nordmann, P | 1 |
| Akóva, M; Cantón, R; Carmeli, Y; Giske, CG; Glupczynski, Y; Gniadkowski, M; Livermore, DM; Miriagou, V; Naas, T; Nordmann, P; Rossolini, GM; Samuelsen, Ø; Seifert, H; Woodford, N | 1 |
| Akova, M; Carmeli, Y; Daikos, GL; Tzouvelekis, L | 1 |
| Benouda, A; Elouennass, M; Hays, C; Nordmann, P; Poirel, L | 1 |
| Farajnia, S; Higgins, PG; Nahaei, MR; Peymani, A; Seifert, H | 1 |
| Aleo, A; Bonura, C; Brunelli, T; Degl'Innocenti, R; Fasciana, T; Mammina, C; Nastasi, A; Pesavento, G | 1 |
| Hsueh, PR; Lee, YJ; Lin, YC; Liu, HY; Wu, HH | 1 |
| Carvalhaes, CG; da Silva, GL; de Alcântara, LR; Elias, LS; Gales, AC; Sandri, AM; Tavares Soares, SP; Zavascki, AP | 1 |
| Cheng, A; Hsueh, PR; Huang, YT; Lee, YC; Liao, CH; Liu, CY; Tsai, HY | 1 |
| Chang, FY; Chang, SC; Chi, CL; Chien, LJ; Hsiung, CA; Su, CH; Wang, JT; Yu, HT | 1 |
| Choi, JY; Jung, SI; Kim, DH; Ko, KS; Song, JH; Thamlikitkul, V | 1 |
| Asari, S; Kurokawa, N; Miwa, Y; Miyawaki, K; Seki, M; Tomono, K | 1 |
| Catania, MR; Del Pezzo, M; Lambiase, A; Piazza, O; Rossano, F; Tufano, R | 1 |
| Angeli, P; Gatta, A; Piano, S; Romano, A; Rosi, S | 1 |
| Barin, J; Barth, AL; Machado, AB; Martins, AF; Pagano, M | 1 |
| Bulanda, M; Chmielarczyk, A; Gosiewski, T; Heczko, P; Higgins, PG; Romaniszyn, D; Seifert, H; Synowiec, E; Wojkowska-Mach, J; Zander, E | 1 |
| Alberti, S; Beceiro, A; Cabot, G; Juan, C; Moyá, B; Oliver, A; Zamorano, L | 1 |
| Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Tang, HJ; Toh, HS; Wang, JH; Yu, KW | 1 |
| Gu, HT; Huang, YF; Lu, XX; Pang, J; Sui, WJ; Wang, HL; Wang, JR; Wang, M | 1 |
| Huang, WF; Jiang, W; Liu, H; Xiao, DW; Yang, YC; Zhong, M | 1 |
| Casella, T; de Almeida, MT; de Lucca Oliveira, MG; Nogueira, MC; Nogueira, ML; Polotto, M; Rúbio, FG | 1 |
| Brun-Buisson, C; Derde, LP; Legrand, P; Lesprit, P; Razazi, K; Verachten, M | 1 |
| Aleo, A; Bonura, C; Di Bernardo, F; Fasciana, T; Mammina, C; Palma, DM; Saporito, MA; Sodano, C; Tetamo, R; Verde, MS | 1 |
| Henderson, DK; Palmore, TN; Segre, JA; Snitkin, ES; Stock, F; Thomas, PJ; Zelazny, AM | 1 |
| Hukić, M; Siširak, M | 1 |
| Chen, CH; Chen, JB; Chuang, FR; Lee, CH; Lee, CT; Li, SH; Wu, CH; Yang, CC | 1 |
| Jiang, WY; Li, FQ; Li, XY; Liu, Y; Wan, LG; Yang, JH | 1 |
| Asghari, B; Azimi, L; Gholami, A; Lari, AR; Owlia, P | 1 |
| Baqi, M; Borgia, S; Chung, C; Eshaghi, A; Lastovetska, O; Low, DE; McGeer, A; Melano, RG; Pantelidis, R; Patel, SN; Ricci, G; Richardson, D; Sawicki, R; Xiong, J | 1 |
| Gan, HM; Lean, SS; Suhaili, Z; Thong, KL; Yeo, CC | 1 |
| Chang, SC; Dong, SX; Wang, JT | 1 |
| Cerniauskiene, K; Dambrauskiene, A; Rimdeika, R; Sakalauskas, R; Vitkauskiene, A | 1 |
| Ahmed, S; Cherabuddi, K; Chundi, V; Hayden, MK; Lin, MY; Lolans, K; McNally, M; Norris, A; Odeh, R; Prabaker, K; Weinstein, RA | 1 |
| Cabral, AB; Lopes, AC; Maciel, MA; Melo, Rde C | 1 |
| Grover, N; Khajuria, A; Kumar, M; Praharaj, AK | 1 |
| Alrabaa, SF; Baluch, A; Greene, JN; Karlapalem, C; Kelker, D; Martin, S; Montero, J; Nguyen, P; Sams, K; Sanderson, R; Sandin, RL; Thompson, P | 1 |
| Cao, J; Dai, W; Huang, S; Sun, S; Zhang, L | 1 |
| Dai, W; Huang, S; Sun, S; Yang, P; Zhang, L; Zhang, X | 1 |
| Apisarnthanarak, A; Warren, DK | 1 |
| Balode, A; Dumpis, U; Karah, N; Karlsone, A; Miklasevics, E; Samuelsen, Ø; Saule, M; Sundsfjord, A | 1 |
| Daikos, G; Katerelos, P; Kontopidou, F; Maltezou, HC; Roilides, E; Theodoridou, M | 1 |
| Lipman, J; Roberts, JA | 1 |
| Dassey, D; Marquez, P; Mascola, L; Terashita, D | 1 |
| Bonomo, RA; Chavda, KD; Chen, L; Jacobs, MR; Kreiswirth, BN; Levi, MH; Melano, RG | 1 |
| Finkelstein, R; Hussein, K; Kassis, I; Neuberger, A; Oren, I; Raz-Pasteur, A; Shachor-Meyouhas, Y | 1 |
| Cacci, LC; Coelho-Souza, T; Costa-Lourenço, AP; Dalla-Costa, L; de Figueiredo, MP; de Freitas, WV; de Matos, JA; Dias, RC; Ferreira, AL; Girão, VB; Maralhães, AC; Martins, IS; Martins, N; Moreira, BM; Nouér, SA; Riley, LW; Santoro-Lopes, G | 1 |
| Camargo, TZ; Correa, L; Gales, AC; Marra, AR; Martino, MD; Pasternak, J; Scherer, PF; Silva, CV; Siqueira, I | 1 |
| Kim, JD; Kwon, NY; Pai, HJ | 1 |
| Amicosante, G; Colì, A; Docquier, JD; Lombardi, G; Luzzaro, F; Perilli, M; Riccio, ML; Rossolini, GM; Toniolo, A | 1 |
| Aygün, G; Demirkiran, O; Dikmen, Y; Mete, B; Oztürk, R; Urkmez, S; Utku, T; Yaşar, H; Yilmaz, M | 1 |
| Farrag, N; Holliman, R; Manuel, RJ; Shin, GY | 1 |
| Isaacs, RD; Shah, PM | 1 |
| Ariza, J; Dominguez, MA; Gudiol, F; Peña, C; Pujol, M; Verdaguer, R | 1 |
| Bagattini, M; Barretta, E; Crispino, M; Di Popolo, A; Triassi, M; Villari, P; Zarrilli, R | 1 |
| Kong, HS; Xu, GY; Xu, XW; Yang, Q; Yu, YS; Zhong, BY | 1 |
| Oliver, A | 1 |
| Calvo, F; Canduela, MJ; Gallego, L; Martín, G; Pujana, I; Sevillano, E; Umaran, A | 1 |
| Bernabeu-Wittel, M; García-Curiel, A; Jiménez-Mejías, ME; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C | 1 |
| Inglima, K; Kornblum, J; Livermore, DM; Painter, RE; Palepou, MF; Shungu, D; Silver, LL; Suber, DF; Tierno, PM; Tysall, L; Ward, E; Woodford, N; Young, K | 1 |
| Cereda, RF; Gales, AC; Melo, RS; Silva, CF; Torres, PL; Vilarinho, DS | 1 |
| Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W | 1 |
| Kollef, MH | 1 |
| Dubouix, A; Héritier, C; Marty, N; Nordmann, P; Poirel, L | 1 |
| Boldur, I; Carmeli, Y; Lazarovitch, T; Ostfeld, I; Paul, M; Pitlik, S; Rubinovitch, B; Samra, Z; Shula, H; Siegman-Igra, Y; Weinberger, M | 1 |
| Beceiro, A; Bou, G; Canle, D; Cartelle, M; Cisneros, JM; del Mar Tomas, M; Llinares, P; Molina, F; Pertega, S; Villanueva, R | 1 |
| Alam, M; Bratu, S; Eramo, A; Haag, R; Landman, D; Quale, J; Recco, R | 1 |
| Akcay, MN; Aktas, F; Altoparlak, U; Celebi, D; Ozkurt, Z | 1 |
| Tellado, JM; Wilson, SE | 1 |
| Church, DL; Conly, JM; Elsayed, S; Gregson, DB; Laupland, KB; Louie, TJ; Parkins, MD; Pitout, JD | 1 |
| Barth, AL; Gaspareto, PB; Gonçalves, AL; Martins, AF; Zavascki, AP | 1 |
| Rossolini, GM | 1 |
| Bell, JM; Franklin, C; Peleg, AY; Spelman, DW | 1 |
| Chen, WH; Hsueh, PR; Luh, KT | 1 |
| Chiu, S; Chou, YH; Huang, YC; Lien, RI; Lin, TY | 1 |
| Amyes, S; Brown, S | 1 |
| Baraniak, A; Bossaert, L; Demey, HE; Gniadkowski, M; Goethaert, K; Goossens, H; Ieven, M; Jansens, H; Jorens, PG; Lammens, C; Van Herck, K; Van Looveren, M | 1 |
| Owens, RC; Rice, L | 1 |
| Chayakulkeeree, M; Junsriwong, P; Keerasuntonpong, A; Thamlikitkul, V; Tribuddharat, C | 1 |
| Iredell, JR; Sintchenko, V | 1 |
| Katsifa, H; Kontodimou, A; Polemis, M; Tsorlini, H; Tzouvelekis, LS; Vatopoulos, AC; Vourli, S | 1 |
| Koulenti, D; Rello, J | 1 |
| Benjamin, DK; Cotten, CM; Goldberg, RN; McDonald, S; Poole, K; Stoll, B | 1 |
| Aguilar, J; Almela, M; Balasso, V; López, F; Marco, F; Martínez, JA; Mensa, J; Pozo, L; Soriano, A | 1 |
| Foustoukou, M; Héritier, C; Lebessi, E; Nordmann, P; Patsoura, A; Poirel, L | 1 |
| Falagas, ME; Horianopoulou, M; Kanellopoulou, M; Lambropoulos, S; Legakis, NJ; Tsakris, A | 1 |
| Agapova, ED; Aleksandrova, IA; Beloborodova, NV; Il'ina, VN; Ivanova, SF; Marusina, NE; Multykh, IG; Polikarpova, SV; Reshed'ko, GK; Riabkova, EL; Skal'skiĭ, SV; Suborova, TN; Toropova, IA; Turkutiukov, VB; Vostrikova, TIu; Zdzitovetskiĭ, DE | 1 |
| Kawano, R; Kikuchi, T; Kuraishi, H; Marumo, K; Nagashima, G; Nemoto, H; Taguchi, K; Tazawa, S; Ugajin, K; Yamanaka, M | 1 |
| Fraser, VJ; Fridkin, SK; Kollef, MH; Merz, LR; Warren, DK | 1 |
| Craig, JC; Iredell, JR; Playford, EG | 1 |
| Falagas, ME; Manta, KG; Siempos, II; Vardakas, KZ | 1 |
| Luczak, M; Marchel, H; Towner, KJ; Wroblewska, MM | 1 |
| Budak, A; Geza, G; Nowak, P; Oleksiak, D; Skałkowska, M; Targosz, A | 1 |
| Bratu, S; Brooks, S; Burney, S; Gupta, J; Kochar, S; Landman, D; Quale, J | 1 |
| Bagattini, M; Casillo, R; Crivaro, V; Cuccurullo, S; Di Popolo, A; Galdieri, N; Mattei, A; Ragone, E; Triassi, M; Tripodi, MF; Utili, R; Zarrilli, R | 1 |
| Furukawa, K | 1 |
| Cassone, A; Di Sora, F; Dionisi, AM; Gallo, S; Longo, B; Luzzi, I; Monaco, M; Montella, F; Pantosti, A; Placanica, P; Rezza, G; Tarasi, A; Volpe, I | 1 |
| Giamarellos-Bourboulis, E; Koutsoukou, A; Kraniotaki, H; Mentzelopoulos, SD; Nanas, S; Paniara, O; Platsouka, E; Pratikaki, M; Roussos, C; Routsi, C; Zakynthinos, SG; Zervakis, D | 1 |
| Bauer, F; Benca, J; Grey, E; Huttova, M; Kovac, M; Ondrusova, A; Rudinsky, B; Sramka, M | 1 |
| Bauer, F; Benca, J; Beno, P; Huttova, M; Kisac, P; Kovac, M; Ondrusova, A; Rudinsky, B; Sramka, M | 1 |
| Markova, B; Marteva-Proevska, Y; Mitov, I; Ouzounova-Raykova, V; Strateva, T; Todorova, A | 1 |
| Jankovic, SM; Radonjic, V | 1 |
| Chen, M; Guo, P; Sun, H; Wang, H; Xu, Y; Yang, Q; Zhu, Y | 1 |
| Weigelt, JA | 1 |
| Quinn, JP; Torres, JA; Villegas, MV | 1 |
| Chemaly, RF; Ghanem, G; Hachem, R; Jiang, Y; Raad, I | 1 |
| Bouza, E; Cercenado, E; Coll, P; Gutiérrez, O; Juan, C; Navarro, F; Oliver, A; Pérez, JL | 1 |
| Avlamis, A; Daikos, GL; Kosmidis, C; Paniara, O; Platsouka, E; Psichogiou, M; Stefanou, I; Tassios, PT; Toutouza, M; Tzouvelekis, LS; Xanthaki, A | 1 |
| Blommaert, L; De Beer, T; De Regt, J; Lacor, P; Lauwers, S; Piérard, D; Soetens, O; Wybo, I | 1 |
| Rogers, TR; Walsh, F | 1 |
| Cherkashin, EA; Galeeva, EV; Ivanov, DV; Krapivina, IV; Sidorenko, SV; Veshutova, NS | 1 |
| Yoshida, A | 1 |
| Deptuła, A; Gierlotka, K; Gospodarek, E; Michalska, A | 1 |
| Levi, K; Towner, KJ; Vlassiadi, M | 1 |
| Endimiani, A; Paterson, DL | 1 |
| Jayashree, M; Mathew, JL; Ray, P; Singhi, S | 1 |
| Gianneli, D; Loli, A; Miriagou, V; Tzelepi, E; Tzouvelekis, LS | 1 |
| Bouallegue, O; Mansour, W; Nordmann, P; Poirel, L | 1 |
| Arango, AI; Bravo, P; Gonzalez, EB; Mantilla, JR; Nuñez, JC; Pulido, IY; Reguero, MT; Saavedra, SY; Valenzuela, EM | 1 |
| Joseph, J; Rodvold, KA | 1 |
| Ivanov, DV | 1 |
| Chang, K; Chen, YH; Chiang, WG; Huang, LY; Hwang, IJ; Lian, ST; Lin, CL; Lin, SF; Lu, PL; Siu, LK | 1 |
| Giamarellou, H; Kanellakopoulou, K | 1 |
| Siegel, RE | 1 |
| Costa, SF; Grinbaum, RS; Levin, AS; Oliveira, MS; Prado, GV | 1 |
| Budak, F; Dundar, D; Eroglu, C; Gacar, G; Kasap, M; Kolayli, F; Meric, M; Vahaboglu, H | 1 |
| Arribas, JL; Asensio, A; Calbo-Torrecillas, F; Cantón, R; Herruzo, R; Sáenz, MC; Vaqué, J | 1 |
| Khantipong, M; Pupaibool, J; Suankratay, C | 1 |
| Luczak, M; Marchel, H; Sawicka-Grzelak, A; Sivan, A; Wroblewska, MM | 1 |
| Bloos, F | 1 |
| Chen, TL; Cho, WL; Fung, CP; Shaio, MF; Wu, RC | 1 |
| Vatopoulos, A | 1 |
| Cho, DT; Jin, JS; Kim, J; Kim, JW; Lee, JC; Lee, YC; Nho, SO; Oh, JY; Seol, SY | 1 |
| Brisse, S; Diancourt, L; Dijkshoorn, L; Krízová, L; Maixnerová, M; Nemec, A; van den Broek, P; van der Reijden, TJ | 1 |
| Galanakis, N; Giamarellou, H; Voutsinas, D | 1 |
| Beuscart, C; Mouton, YJ | 1 |
| Baldassarre, R; Comunale, L; Poletti, G; Tallarigo, C | 1 |
| Arakawa, Y; Ichiyama, S; Ito, H; Kato, N; Nakashima, K; Ohsuka, S; Ohta, M; Senda, K; Shimokata, K | 1 |
| Grausova, S; Koren, P; Krcmery, V; Krupova, I; Kukuckova, E; Kunova, A; Lacka, J; Spanik, S; Trupl, J | 1 |
| Garau, J; Martínez Lacasa, J | 1 |
| Bouza, E; Peláez, T | 1 |
| Arakawa, Y; Ichiyama, S; Ito, H; Kato, N; Kurokawa, H; Ohsuka, S; Ohta, M; Senda, K; Shibayama, K; Shimokata, K; Yagi, T | 1 |
| Blanquer, J; Cobo, L; Corcia, S; Daguerre, M; de Latorre, FJ; Del Nogal, F; Garau, J; León, C; Net, A; Rello, J | 1 |
| Kaku, M | 1 |
| Arakawa, Y | 1 |
| Eltahawy, AT | 1 |
| Amyes, SG | 1 |
| Garau, J | 1 |
| Ardanuy, C; Benedí, VJ; Domínguez, MA; Hernández-Allés, S; Liñares, J; Martínez-Martínez, L | 1 |
| Mokaddas, EM; Sanyal, SC | 2 |
| Allerberger, F; Reisinger, EC | 1 |
| Joly-Guillou, ML | 1 |
| Dolezal, M; Kachlik, P; Kedzierska, J | 1 |
| Bou, G; Cerveró, G; Domínguez, MA; Martínez-Beltrán, J; Quereda, C | 1 |
| Hsiung, A; Kiffer, C; Mendes, C; Mimica, I; Oplustil, C; Sinto, S; Zoccoli, C | 1 |
| Cornaglia, G; Fontana, R; Lauretti, L; Mazzariol, A; Rossolini, GM | 1 |
| Aschbacher, R; De Fina, G; Lang, A; Meyer, R; Paluselli, P; Rizza, F; Zelger, P | 1 |
| Forward, KR; Gales, AC; Jones, RN; Liñares, J; Sader, HS; Verhoef, J | 1 |
| Aoki, T; Kashiwabara, N; Kojimabara, M; Kosenda, T; Maeda, J; Niitsuma, K; Saitoh, M; Tomizawa, M | 1 |
| Akova, M; Gür, D; Kocagöz, S; Köseoğlu , O | 1 |
| Gibb, AP; Krulicki, W; Livermore, DM; Louie, TJ; Moore, RA; Palepou, MF; Tribuddharat, C; Woodford, N | 1 |
| Bion, J; Das, I; Elliott, T; Hill, D; Lambert, P; Noy, M | 1 |
| Sidorenko, SV | 1 |
| Beloborodov, VB | 1 |
96 review(s) available for carbapenems and Cross Infection
| Article | Year |
|---|---|
Multidrug-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests | 2022 |
The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literatu
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Candida auris; Candidiasis; Carbapenems; COVID-19; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Infection Control; Male; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Switzerland | 2022 |
Impact of hospital environmental cleaning with a potassium peroxymonosulphate-based environmental disinfectant and antimicrobial stewardship on the reduction of hospital-onset Clostridioides difficile infections.
Topics: Anti-Infective Agents; Antimicrobial Stewardship; Carbapenems; Clostridioides difficile; Clostridium Infections; Cross Infection; Disinfectants; Hospitals; Humans; Potassium; Sodium Chloride; Sodium Hypochlorite | 2022 |
Contamination of healthcare environment by carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Delivery of Health Care; Humans; Microbial Sensitivity Tests | 2022 |
Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysis.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence; Regression Analysis; Vancomycin-Resistant Enterococci | 2023 |
Hospital Reservoirs of Multidrug Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests | 2023 |
Comparative efficacy and safety of non-polymyxin antibiotics against nosocomial pneumonia, complicated intra-abdominal infection, or complicated urinary tract infection: A network meta-analysis of randomised clinical trials.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Gram-Negative Bacterial Infections; Healthcare-Associated Pneumonia; Humans; Intraabdominal Infections; Network Meta-Analysis; Randomized Controlled Trials as Topic; Urinary Tract Infections | 2023 |
Bacterial Resistance in Hospital-Acquired Infections Acquired in the Intensive Care Unit: A Systematic Review.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Escherichia coli; Hospitals; Humans; Methicillin-Resistant Staphylococcus aureus | 2023 |
"Superbugs" with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: the rise of such emerging nosocomial pathogens in China.
Topics: Anti-Bacterial Agents; Carbapenems; China; Cross Infection; Hospitals; Humans; Klebsiella pneumoniae | 2023 |
Modifiable risk factors for multidrug-resistant Gram-negative infection in critically ill burn patients: a systematic review and meta-analysis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Burns; Carbapenems; Cephalosporins; Critical Illness; Cross Infection; Drug Resistance, Multiple; Gram-Negative Bacterial Infections; Humans; Hydrotherapy; Intensive Care Units; Penicillins; Respiration, Artificial; Risk Factors; Urinary Catheters; Vascular Access Devices | 2019 |
Risk stratification for multidrug-resistant Gram-negative infections in ICU patients.
Topics: beta-Lactam Resistance; Carbapenems; Carrier State; Critical Illness; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Mass Screening; Prognosis; Risk Assessment; Risk Factors | 2019 |
Advances in Data-Driven Responses to Preventing Spread of Antibiotic Resistance Across Health-Care Settings.
Topics: Carbapenems; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans | 2019 |
Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Genes, Bacterial; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Neonatal Sepsis | 2019 |
Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review.
Topics: Carbapenems; Case-Control Studies; Cross Infection; Dialysis; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Length of Stay; Prospective Studies; Respiration, Artificial; Retrospective Studies; Risk Factors | 2021 |
Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital-acquired infections: a scientific review.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests | 2021 |
The interface between COVID-19 and bacterial healthcare-associated infections.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Community-Acquired Infections; COVID-19; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Pandemics | 2021 |
Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Genomics; Host-Pathogen Interactions; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Plasmids; Serogroup; Virulence Factors | 2017 |
[Carbapenem-resistant bacteria transferred to the Netherlands: patients colonised during hospitalisation in Romania].
Topics: Adult; Anti-Bacterial Agents; Bacteria; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Hospitalization; Humans; Intensive Care Units; Male; Netherlands; Romania; Young Adult | 2017 |
How Should We Treat Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae?
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intensive Care Units; Pneumonia; Pneumonia, Ventilator-Associated; Risk Factors | 2017 |
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae?
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Nebulizers and Vaporizers; Pneumonia; Pneumonia, Ventilator-Associated; Renal Insufficiency; Risk Factors | 2017 |
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in Greece: an extended review (2000-2015).
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Greece; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction; Sequence Analysis, DNA | 2017 |
Sparing carbapenem usage.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Utilization; Formularies, Hospital as Topic; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans | 2017 |
Valvular Heart Disease in Adults: Infective Endocarditis.
Topics: Anti-Bacterial Agents; Blood Culture; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Echocardiography; Endocarditis; Endocarditis, Bacterial; Gentamicins; Heart Valve Prosthesis; Humans; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Vancomycin | 2017 |
Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Carbapenems; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Hospitals; Humans; Liver Cirrhosis; Methicillin; Methicillin-Resistant Staphylococcus aureus; Peritonitis; Practice Guidelines as Topic; Pseudomonas aeruginosa; Treatment Outcome; Vancomycin-Resistant Enterococci | 2017 |
Antimicrobial Resistance of Hypervirulent
Topics: Bacteremia; Bacterial Capsules; Bacterial Proteins; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Hydroxamic Acids; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Molecular Epidemiology; Phylogeography; Serogroup; Urinary Tract Infections; Virulence; Virulence Factors | 2017 |
A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Hospitals; Humans; Incidence; Long-Term Care; United States | 2018 |
Wastewater drains: epidemiology and interventions in 23 carbapenem-resistant organism outbreaks.
Topics: Bacterial Infections; Carbapenems; Cross Infection; Disease Outbreaks; Drainage, Sanitary; Drug Resistance, Bacterial; Equipment Contamination; Hospitals; Humans; Infection Control; Wastewater; Water Microbiology | 2018 |
Risk factors for hospitalized patients with resistant or multidrug-resistant
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Critical Care; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Risk Factors; Vancomycin | 2018 |
Impact of carbapenem versus non-carbapenem treatment on the rates of superinfection: A meta-analysis of randomized controlled trials.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Pneumonia; Randomized Controlled Trials as Topic; Risk Factors; Superinfection; Treatment Outcome | 2018 |
Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Prevalence; Risk Factors; Saudi Arabia | 2019 |
Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Observational Studies as Topic; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Treatment Outcome | 2019 |
Association between carbapenem-resistant Enterobacteriaceae and death: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Humans; Odds Ratio; Risk Factors | 2019 |
Current status of countermeasures for infectious diseases and resistant microbes in the field of urology.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; Carbapenems; Catheter-Related Infections; Cell Wall; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Gonorrhea; Humans; Microbial Sensitivity Tests; Practice Guidelines as Topic; United States; Urinary Tract Infections; Urology; World Health Organization | 2019 |
Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Hospital Costs; Humans; Methicillin-Resistant Staphylococcus aureus | 2013 |
Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Disease Management; Epidemiological Monitoring; Humans; Polymyxins; Porins | 2013 |
Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2013 |
The role of antimicrobial stewardship in curbing carbapenem resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Transmission, Infectious; Drug Prescriptions; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Health Policy; Humans; Infection Control; Organizational Policy; Pseudomonas aeruginosa; Pseudomonas Infections | 2013 |
[Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Germany; Humans | 2014 |
Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Humans; Incidence; Latin America; Population Surveillance; Pseudomonas aeruginosa; Pseudomonas Infections | 2016 |
Carbapenem-resistant enterobacteriaceae: occult threat in the intensive care unit.
Topics: Anti-Bacterial Agents; Carbapenems; Critical Care Nursing; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Infection Control; Intensive Care Units; Minocycline; Sepsis; Tigecycline | 2014 |
Epidemiology of infections caused by carbapenemase-producing Enterobacteriaceae: reservoirs and transmission mechanisms.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clone Cells; Commerce; Community-Acquired Infections; Cross Infection; Disease Reservoirs; Drug Resistance, Multiple, Bacterial; Endemic Diseases; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Humans; Infection Control; International Cooperation; Travel | 2014 |
Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Community-Acquired Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Evolution, Molecular; Forecasting; Global Health; Humans; Infection Control; International Cooperation; Spain | 2014 |
Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Comorbidity; Cross Infection; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Endemic Diseases; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Postoperative Complications; Prognosis; Risk Factors; Superinfection; Travel | 2014 |
Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Checklist; Cross Infection; Diagnostic Tests, Routine; Disease Reservoirs; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Health Facilities; Humans; Infection Control; National Health Programs; Population Surveillance; Residential Facilities; Spain | 2014 |
Nosocomial pneumonia caused by carbapenem-resistant Raoultella planticola: a case report and literature review.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Comorbidity; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tomography, X-Ray Computed | 2015 |
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Drug Therapy, Computer-Assisted; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Minocycline; Risk Factors; Tigecycline | 2015 |
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clone Cells; Conjugation, Genetic; Cross Infection; DNA Transposable Elements; Gene Expression Regulation, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Porins; Recombination, Genetic | 2015 |
Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Infection Control; Microbial Sensitivity Tests; Risk Factors; United States | 2015 |
Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Communicable Disease Control; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Gene Expression; Gene Transfer, Horizontal; Humans; Molecular Epidemiology; Mutation; Plasmids; United States | 2016 |
Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic review.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Prevalence; Risk Assessment | 2016 |
Carbapenem-Resistant Non-Glucose-Fermenting Gram-Negative Bacilli: the Missing Piece to the Puzzle.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Transmission, Infectious; Gene Transfer, Horizontal; Humans; Infection Control; Pseudomonas aeruginosa; Pseudomonas Infections | 2016 |
Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Hospitals; Humans; Intensive Care Units; Klebsiella; Klebsiella Infections; Length of Stay; Methicillin-Resistant Staphylococcus aureus; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections | 2016 |
Systematic Review of Antimicrobial Resistance of Clinical Acinetobacter baumannii Isolates in Iran: An Update.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Iran; Meropenem; Microbial Sensitivity Tests; Minocycline; Polymyxin B; Rifampin; Thienamycins; Tigecycline | 2017 |
ICU Acquisition Rate, Risk Factors, and Clinical Significance of Digestive Tract Colonization With Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Gastrointestinal Tract; Hospitalization; Humans; Incidence; Intensive Care Units; Risk Factors | 2017 |
The Hospital Water Environment as a Reservoir for Carbapenem-Resistant Organisms Causing Hospital-Acquired Infections-A Systematic Review of the Literature.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Disease Outbreaks; Disease Reservoirs; Disinfection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Equipment and Supplies, Hospital; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Pseudomonas aeruginosa; Pseudomonas Infections; Water Microbiology; Water Supply | 2017 |
Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.
Topics: Carbapenems; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Guidelines as Topic; Humans; Infection Control; Sentinel Surveillance | 2017 |
Doripenem: a new addition to the carbapenem class of antimicrobials.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Urinary Tract Infections | 2009 |
New antibiotics for healthcare-associated pneumonia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Cross Infection; Doripenem; Glycopeptides; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pseudomonas Infections; Pyrimidines; Staphylococcal Infections; Teicoplanin | 2009 |
Doripenem: position in clinical practice.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Cross Infection; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas Infections | 2009 |
Update on the treatment of Pseudomonas aeruginosa pneumonia.
Topics: Anti-Bacterial Agents; Biomedical Research; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Pneumonia, Bacterial; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections | 2009 |
Doripenem: a new carbapenem in the treatment of nosocomial infection.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Humans; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections | 2009 |
Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Humans | 2009 |
Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Clinical Trials, Phase III as Topic; Cross Infection; Doripenem; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2009 |
[KPC carbapenemases: what is at stake in clinical microbiology?].
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; R Factors; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Species Specificity; Substrate Specificity | 2010 |
[Doripenem: need for a new carbapenem].
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Burkholderia cepacia; Carbapenems; Clinical Trials as Topic; Cross Infection; Doripenem; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Humans; Nervous System Diseases; Peritonitis; Pneumonia, Bacterial; Pseudomonas aeruginosa; Urinary Tract Infections | 2009 |
[Gram-negative bacteriae with resistance to carbapenems].
Topics: beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Oxacillin | 2010 |
[Available carbapenems: Properties and differences].
Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Biological Availability; Carbapenems; Cell Wall; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Drug Interactions; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Substrate Specificity; Tissue Distribution | 2010 |
[Role of new carbapenems in nosocomial intraabdominal infection].
Topics: Abdomen; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Humans; Multicenter Studies as Topic; Postoperative Complications; Pseudomonas Infections; Randomized Controlled Trials as Topic; Soft Tissue Infections | 2010 |
Role and impact of carbapenem in nosocomial infections.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Cross Infection; Dosage Forms; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans; Patents as Topic | 2011 |
Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Carrier State; Colistin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Europe; Gene Transfer, Horizontal; Humans | 2012 |
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Evolution, Molecular; Female; Humans; Male; Prevalence; Time Factors | 2012 |
Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; Disease Outbreaks; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infection Control; Risk Factors | 2012 |
Ertapenem, the first of a new group of carbapenems.
Topics: Animals; beta-Lactams; Carbapenems; Clinical Trials as Topic; Cross Infection; Ertapenem; Humans; Lactams | 2003 |
Appropriate use of the carbapenems.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections | 2004 |
Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems.
Topics: Algorithms; Anti-Bacterial Agents; Carbapenems; Clinical Trials as Topic; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Pneumonia, Bacterial; Practice Guidelines as Topic; Risk Factors; Severity of Illness Index | 2004 |
Empiric treatment of nosocomial intra-abdominal infections: a focus on the carbapenems.
Topics: Abdominal Cavity; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Cross Infection; Humans; Surgical Wound Infection; Treatment Outcome | 2005 |
OXA (beta)-lactamases in Acinetobacter: the story so far.
Topics: Acinetobacter; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Genes, Bacterial; Humans | 2006 |
Hospital-based strategies for combating resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Infection Control | 2006 |
Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care.
Topics: Acinetobacter Infections; Administration, Inhalation; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Methicillin Resistance; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Practice Guidelines as Topic; Pseudomonas Infections; Respiration, Artificial; Vancomycin | 2006 |
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aminoglycosides; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; Humans; Immunocompetence; Intensive Care Units; Meropenem; Pneumonia, Bacterial; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiration, Artificial; Survival Rate; Thienamycins; Treatment Outcome | 2007 |
[Importance of appropriate carbapenem use to reduce carbapenem--resistant Pseudomonas aeruginosa].
Topics: Carbapenems; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Utilization; Humans; Japan; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors | 2007 |
Empiric treatment options in the management of complicated intra-abdominal infections.
Topics: Anti-Bacterial Agents; Carbapenems; Community-Acquired Infections; Cross Infection; Doripenem; Drug Resistance, Bacterial; General Surgery; Humans; Internal Medicine; Minocycline; Peritoneal Cavity; Peritonitis; Risk Factors; Severity of Illness Index; Surgical Wound Infection; Tigecycline | 2007 |
Current concepts in antibiotic-resistant gram-negative bacteria.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Biological Transport; Carbapenems; Cell Membrane Permeability; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Intensive Care Units; Mutation; Porins; Sentinel Surveillance | 2007 |
[Attention-getting cross infections: Extended-spectrum beta-lactamase-producing bacterial infections].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Proteus; Proteus Infections | 2007 |
Optimizing therapy for infections caused by enterobacteriaceae producing extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Treatment Outcome | 2007 |
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Patient Selection; Pneumonia, Bacterial; Respiratory Tract Infections; Severity of Illness Index; Thienamycins; Treatment Outcome | 2008 |
Current therapies for pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic | 2008 |
Emerging gram-negative antibiotic resistance: daunting challenges, declining sensitivities, and dire consequences.
Topics: beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; Humans | 2008 |
High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece--a review of the current evidence.
Topics: beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Europe; Greece; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae | 2008 |
[Multicenter comparative study of meropenem vs. imipenem in the intramuscular treatment of hospital infections of the urinary tract].
Topics: Adult; Aged; Carbapenems; Chi-Square Distribution; Cilastatin; Cross Infection; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Protease Inhibitors; Thienamycins; Urinary Tract Infections | 1995 |
[The role of carbapenems in the treatment of nosocomial infection].
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cross Infection; Drug Therapy, Combination; Humans; Imipenem; Meningitis, Bacterial; Meropenem; Pneumonia, Bacterial; Skin Diseases, Infectious; Thienamycins | 1997 |
[Emerging and drug-resistant infectious diseases--penicillin resistant Streptococcus pneumoniae infections].
Topics: 4-Quinolones; Anti-Infective Agents; Carbapenems; Cross Infection; Humans; Penicillin Resistance; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae | 1997 |
[Emerging and drug-resistant infectious diseases--carbapenem resistant bacterial infections].
Topics: Alcaligenes; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Microbial; Humans; Klebsiella pneumoniae; Pseudomonas aeruginosa; Pseudomonas putida; Serratia marcescens | 1997 |
Clinical strategies for serious infection: a European perspective.
Topics: Bacterial Infections; beta-Lactam Resistance; Carbapenems; Cross Infection; Europe; Humans; Prevalence | 1998 |
[Broad-spectrum beta-lactamases. Clinical significance and detection methods].
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cross Infection; Enzyme Inhibitors; Genes, Bacterial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction | 2001 |
[A choice of antibacterial chemotherapy for nosocomial infections caused by pathogens producing broad-spectrum beta-lactamases].
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Clinical Trials as Topic; Cross Infection; Humans | 2001 |
14 trial(s) available for carbapenems and Cross Infection
| Article | Year |
|---|---|
The effects of topical antibiotics on eradication and acquisition of third-generation cephalosporin and carbapenem-resistant Gram-negative bacteria in ICU patients; a post hoc analysis from a multicentre cluster-randomized trial.
Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cohort Studies; Cross Infection; Cross-Over Studies; Drug Resistance, Bacterial; Female; Gastrointestinal Tract; Gram-Negative Bacteria; Humans; Intensive Care Units; Male; Middle Aged; Mouthwashes | 2020 |
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes.
Topics: Aged; Aged, 80 and over; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 2020 |
Clinical impact of endemic NDM-producing Klebsiella pneumoniae in intensive care units of the national referral hospital in Jakarta, Indonesia.
Topics: Adult; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Female; Humans; Indonesia; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Pharynx; Prospective Studies; Rectum | 2020 |
Role of Hand Hygiene Ambassador and Implementation of Directly Observed Hand Hygiene Among Residents in Residential Care Homes for the Elderly in Hong Kong.
Topics: Acinetobacter; Aged; Aged, 80 and over; Carbapenems; Cross Infection; Enterobacteriaceae; Female; Guideline Adherence; Hand Disinfection; Hand Hygiene; Hand Sanitizers; Homes for the Aged; Hong Kong; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections | 2018 |
Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Female; Humans; Imipenem; Intraabdominal Infections; Male; Meropenem; Ofloxacin; Pneumonia; Thienamycins; Treatment Outcome; Urinary Tract Infections | 2013 |
Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Microbial Sensitivity Tests; Pilot Projects; Treatment Outcome | 2014 |
Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Carbapenems; Cross Infection; Doripenem; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Prospective Studies; Tazobactam; Treatment Outcome | 2008 |
Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Critical Illness; Cross Infection; Female; Fosfomycin; Humans; Infusions, Intravenous; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2010 |
Population pharmacokinetics of doripenem based on data from phase 1 studies with healthy volunteers and phase 2 and 3 studies with critically ill patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bayes Theorem; Carbapenems; Creatinine; Critical Illness; Cross Infection; Doripenem; Female; Humans; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Nonlinear Dynamics; Pneumonia, Bacterial; Pyelonephritis; Renal Insufficiency; Urinary Tract Infections; Young Adult | 2010 |
Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility.
Topics: Anti-Bacterial Agents; Carbapenems; Creatinine; Critical Illness; Cross Infection; Doripenem; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intensive Care Units; Male; Middle Aged; Monte Carlo Method; Obesity; Pneumonia, Bacterial | 2013 |
High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Critical Illness; Cross Infection; Drug Therapy, Combination; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2006 |
Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Carbapenems; Ceftazidime; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Drug Tolerance; Hospitalization; Humans; Meropenem; Middle Aged; Respiratory Tract Infections; Sepsis; Thienamycins; Time Factors; Treatment Outcome; Urinary Tract Infections | 1995 |
[Multicenter comparative study of meropenem vs. imipenem in the intramuscular treatment of hospital infections of the urinary tract].
Topics: Adult; Aged; Carbapenems; Chi-Square Distribution; Cilastatin; Cross Infection; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Protease Inhibitors; Thienamycins; Urinary Tract Infections | 1995 |
Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Thienamycins | 1997 |
777 other study(ies) available for carbapenems and Cross Infection
| Article | Year |
|---|---|
In-vitro activity of fosfomycin against
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cancer Care Facilities; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Egypt; Hospitals, Pediatric; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Whole Genome Sequencing | 2021 |
Clonal spread of carbapenem-resistant Klebsiella pneumoniae among patients at admission and discharge at a Vietnamese neonatal intensive care unit.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Feces; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Patient Admission; Patient Discharge; Phylogeny; Prospective Studies; Vietnam; Whole Genome Sequencing | 2021 |
Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Gastrointestinal Microbiome; Genome, Bacterial; Humans; Interspersed Repetitive Sequences; Intestines; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections | 2021 |
The novel application and effect of an ultraviolet light decontamination strategy on the healthcare acquisition of carbapenem-resistant Enterobacterales in a hospital setting.
Topics: Carbapenems; Cross Infection; Decontamination; Delivery of Health Care; Disinfection; Hospitals; Humans; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Ultraviolet Rays | 2022 |
Impact of carbapenem-resistant Acinetobacter baumannii infections on acute pancreatitis patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pancreatitis; Retrospective Studies | 2022 |
Reduction in the acquisition rate of carbapenem-resistant Acinetobacter baumannii (CRAB) after room privatization in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Humans; Intensive Care Units; Privatization | 2022 |
Using Whole Genome Sequencing to Trace, Control and Characterize a Hospital Infection of IMP-4-Producing
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Tertiary Care Centers; Whole Genome Sequencing | 2021 |
Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Carbapenems; Cost of Illness; Cross Infection; Hospitals; Humans; Intensive Care Units; Retrospective Studies | 2022 |
regentrans: a framework and R package for using genomics to study regional pathogen transmission.
Topics: Carbapenems; Cross Infection; Databases, Genetic; Drug Resistance, Multiple, Bacterial; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Phylogeny; Software; Whole Genome Sequencing | 2022 |
Central-line-associated bloodstream infections, multi-drug-resistant bacteraemias and infection control interventions: a 6-year time-series analysis in a tertiary care hospital in Greece.
Topics: Adult; Bacteremia; Carbapenems; Catheter-Related Infections; Cross Infection; Disinfectants; Greece; Humans; Incidence; Infection Control; Intensive Care Units; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Tertiary Care Centers | 2022 |
Acquisition of carbapenem-resistant gram-negative bacilli among intensive care unit (ICU) patients with no previous use of carbapenems: Indirect population impact of antimicrobial use.
Topics: Anti-Bacterial Agents; Carbapenems; Cohort Studies; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units | 2022 |
Antibiotic resistance, biofilm production ability and genetic diversity of carbapenem-resistant Pseudomonas aeruginosa strains isolated from nosocomial infections in southwestern Iran.
Topics: Anti-Bacterial Agents; Biofilms; Carbapenems; Colistin; Cross Infection; Drug Resistance, Microbial; Genetic Variation; Humans; Iran; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2022 |
Risk factors for and clinical outcomes of ceftazidime-avibactam-resistant carbapenem-resistant Klebsiella pneumoniae nosocomial infections: a single-center retrospective study.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cross Infection; Drug Combinations; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors | 2022 |
Correlation between antibiotic consumption and the occurrence of multidrug-resistant organisms in a Malaysian tertiary hospital: a 3-year observational study.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Inappropriate Prescribing; Klebsiella; Klebsiella Infections; Malaysia; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Tertiary Care Centers | 2022 |
Containment of a carbapenem-resistant Acinetobacter baumannii complex outbreak in a COVID-19 intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; COVID-19; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units | 2022 |
Predictors and Outcomes of Healthcare-Associated Infections Caused by Carbapenem-Nonsusceptible Enterobacterales: A Parallel Matched Case-Control Study.
Topics: Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Delivery of Health Care; Humans | 2022 |
A comparative study on nosocomial and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis at a university hospital.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Hospitals, University; Humans; Liver Cirrhosis; Microbial Sensitivity Tests; Peritonitis | 2022 |
Preoptimized phage cocktail for use in aerosols against nosocomial transmission of carbapenem-resistant Acinetobacter baumannii: A 3-year prospective intervention study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aerosols; Anti-Bacterial Agents; Bacteriophages; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Prospective Studies | 2022 |
A nosocomial salmonellosis outbreak caused by bla
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Salmonella; Salmonella enterica; Salmonella Infections; Serogroup; Taiwan | 2022 |
Rate and Risk Factors for Carbapenem Resistant Acinetobacter baumannii Clinical Infections in Colonized Patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia; Retrospective Studies; Risk Factors | 2022 |
A fatal outbreak of neonatal sepsis caused by mcr-10-carrying Enterobacter kobei in a tertiary care hospital in Nepal.
Topics: Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Enterobacter; Enterobacteriaceae Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Neonatal Sepsis; Nepal; Tertiary Care Centers | 2022 |
Characteristics of ST11 KPC-2-producing carbapenem-resistant hypervirulent Klebsiella pneumoniae causing nosocomial infection in a Chinese hospital.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Tertiary Care Centers | 2022 |
High lethality rate of carbapenem-resistant Acinetobacter baumannii in Intensive Care Units of a Brazilian hospital: An epidemiologic surveillance study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Hospitals; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2022 |
Clinical outcome of nosocomial pneumonia caused by Carbapenem-resistant gram-negative bacteria in critically ill patients: a multicenter retrospective observational study.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Cross Infection; Gram-Negative Bacteria; Healthcare-Associated Pneumonia; Humans; Retrospective Studies | 2022 |
Nosocomial transmission and rearrangement of large resistance-virulence hybrid plasmids between two bacteremic ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae strains with low fitness cost.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Virulence | 2022 |
Genomic surveillance uncovers ongoing transmission of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Genomics; Humans; Microbial Sensitivity Tests; Phylogeny; Retrospective Studies | 2023 |
Gram-Negative Rods on Inanimate Surfaces of Selected Hospital Facilities and Their Nosocomial Significance.
Topics: beta-Lactamases; Carbapenems; Cross Infection; Gram-Negative Bacteria; Hospitals; Humans | 2022 |
Tolerance of biofilm of a carbapenem-resistant Klebsiella pneumoniae involved in a duodenoscopy-associated outbreak to the disinfectant used in reprocessing.
Topics: Bacteria; Biofilms; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Disease Outbreaks; Disinfectants; Duodenoscopy; Humans; Klebsiella pneumoniae; Peracetic Acid | 2022 |
Epidemiological Characteristics of OXA-232-Producing Carbapenem-Resistant Klebsiella pneumoniae Strains Isolated during Nosocomial Clonal Spread Associated with Environmental Colonization.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Disinfectants; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Combing Immunoinformatics with Pangenome Analysis To Design a Multiepitope Subunit Vaccine against Klebsiella pneumoniae K1, K2, K47, and K64.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Docking Simulation; Vaccines, Subunit | 2022 |
The Gastrointestinal Load of Carbapenem-Resistant Enterobacteriacea Is Associated With the Transition From Colonization to Infection by
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2022 |
Association between Antimicrobial Consumption and the Prevalence of Nosocomial Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae in a Tertiary Hospital in Northern Taiwan.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Doripenem; Escherichia coli; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Prevalence; Retrospective Studies; Taiwan; Tertiary Care Centers | 2022 |
Effect of an isolation-coping programme on patients isolated for colonization or infection with multi-drug-resistant organisms: a quasi-experimental study.
Topics: Adaptation, Psychological; Carbapenems; Cross Infection; Gram-Positive Bacterial Infections; Humans; Prevalence; Vancomycin-Resistant Enterococci | 2022 |
Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France.
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Cross Infection; Delivery of Health Care; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Nitrofurantoin; Ofloxacin; Penicillins; Urinary Tract Infections | 2022 |
Genomic transmission analysis of multidrug-resistant Gram-negative bacteria within a newborn unit of a Kenyan tertiary hospital: A four-month prospective colonization study.
Topics: Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Genomics; Humans; Infant; Infant, Newborn; Kenya; Klebsiella pneumoniae; Phylogeny; Prospective Studies; Tertiary Care Centers | 2022 |
HEALTHCARE-ASSOCIATED TUBO-OVARIAN INFECTIONS IN UKRAINE: RESULTS OF A MULTICENTER STUDY (2020-2022).
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cohort Studies; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Methicillin; Pseudomonas aeruginosa; Staphylococcus aureus; Ukraine; Vancomycin | 2022 |
Small wards in the ICU: a favorable measure for controlling the transmission of carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Hospitals; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Phylogeny; Retrospective Studies | 2022 |
Bloodstream infections and antibiotic resistance patterns: a six-year surveillance study from southern Italy.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Microbial; Escherichia coli; Humans; Italy; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Sepsis | 2023 |
Outpatient Clonal Propagation and Rapid Regional Establishment of an Emergent Carbapenem-Resistant Acinetobacter baumannnii Lineage Sequence Type 499Pas.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Outpatients | 2023 |
An Outbreak of Carbapenem-Resistant Acinetobacter baumannii in Multiple Federal States in Germany.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Germany; Humans | 2022 |
Clonal Spread of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 in Chinese Pediatric Patients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Cross Infection; East Asian People; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2022 |
Human microbiota drives hospital-associated antimicrobial resistance dissemination in the urban environment and mirrors patient case rates.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hospitals; Humans; Microbiota; Sewage | 2022 |
The Emerging Nosocomial Pathogen Klebsiella michiganensis
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Plasmids | 2023 |
Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in a Neonatal Intensive Care Unit.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Disease Outbreaks; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2023 |
Evaluation of three commercial methods of susceptibility testing for ceftolozane/tazobactam against carbapenem-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2023 |
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Carbapenems; Cohort Studies; Cross Infection; Escherichia coli; Hospitals; Humans; Intensive Care Units; Prospective Studies | 2023 |
Effect of daily chlorhexidine bathing on reducing infections caused by multidrug-resistant organisms in intensive care unit patients: A semiexperimental study with parallel controls.
Topics: Anti-Infective Agents, Local; Carbapenems; Chlorhexidine; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units | 2023 |
Analysis of risk factors associated with healthcare-associated carbapenem-resistant Klebsiella pneumoniae infection in a large general hospital: a case-case-control study.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Hospitals, General; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors | 2023 |
Modelling interventions and contact networks to reduce the spread of carbapenem-resistant organisms between individuals in the ICU.
Topics: Anti-Bacterial Agents; Bayes Theorem; Carbapenems; Cohort Studies; Cross Infection; Humans; Infection Control; Intensive Care Units | 2023 |
Epidemiology and risk factors of 28-day mortality of hospital-acquired bloodstream infection in Turkish intensive care units: a prospective observational cohort study.
Topics: Bacteremia; Carbapenems; Cohort Studies; COVID-19; Cross Infection; Female; Hospitals; Humans; Intensive Care Units; Male; Prospective Studies; Risk Factors; Sepsis | 2023 |
Carbapenem prescriptions: Compliance with guidelines in a pediatric hospital.
Topics: Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Cross Infection; Hospitals, Pediatric; Humans; Prescriptions; Retrospective Studies | 2023 |
Clinical outcomes and safety of intravenous polymyxin B-based treatment in critically ill patients with carbapenem-resistant Acinetobacter baumannii nosocomial pneumonia.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Critical Illness; Cross Infection; Healthcare-Associated Pneumonia; Humans; Polymyxin B; Retrospective Studies; Sulbactam; Tigecycline | 2023 |
Carbapenem-Resistant
Topics: Aged; Aged, 80 and over; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Klebsiella pneumoniae; Male; Retrospective Studies; Risk Factors | 2023 |
Association of ward-level antibiotic consumption with healthcare-associated Clostridioides difficile infections: an ecological study in five German university hospitals, 2017-2019.
Topics: Anti-Bacterial Agents; Carbapenems; Clostridioides difficile; Clostridium Infections; Cross Infection; Hospitals, University; Humans; Incidence; Retrospective Studies | 2023 |
Risk factors for nosocomial rectal colonisation with carbapenem-resistant Gram-negative bacilli in children with haematological malignancies: a case-control study.
Topics: Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Child; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Leukemia, Myeloid, Acute; Risk Factors; Tertiary Care Centers | 2023 |
Changing Genotypic Distribution, Antimicrobial Susceptibilities, and Risk Factors of Urinary Tract Infection Caused by Carbapenemase-Producing
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Genotype; Humans; Pseudomonas aeruginosa; Risk Factors; Urinary Tract Infections | 2024 |
Outbreak of OXA-232-producing carbapenem-resistant
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Cross Infection; Disease Outbreaks; Hospitals, Teaching; Humans; Klebsiella pneumoniae; Phylogeny | 2023 |
Excess mortality and long-term disability from healthcare-associated carbapenem-resistant Acinetobacter baumannii infections: A nationwide population-based matched cohort study.
Topics: Acinetobacter baumannii; Carbapenems; Cohort Studies; Cross Infection; Delivery of Health Care; Humans; Renal Dialysis; Retrospective Studies | 2023 |
Analysis of resistance genes of carbapenem-resistant Providencia rettgeri using whole genome sequencing.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Humans; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Whole Genome Sequencing | 2023 |
Acinetobacter baumannii in suspected bacterial infections: Association between multidrug resistance, virulence genes, & biofilm production.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Virulence; Virulence Factors | 2023 |
Incidence of infections caused by carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Brazil; Carbapenems; Cross Infection; Female; Hospitals, University; Humans; Incidence; Inpatients; Male; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Survival Analysis; Young Adult | 2019 |
Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013-2017.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Microbial Sensitivity Tests; Retrospective Studies; United States | 2019 |
Whole-Genome Sequencing To Identify Drivers of Carbapenem-Resistant Klebsiella pneumoniae Transmission within and between Regional Long-Term Acute-Care Hospitals.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prospective Studies; Whole Genome Sequencing | 2019 |
Colistin resistance emerges in pandrug-resistant Klebsiella pneumoniae epidemic clones in Rio de Janeiro, Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Membrane Proteins; Microbial Sensitivity Tests; Transcription Factors; Whole Genome Sequencing | 2019 |
Molecular characterization of carbapenem-resistant Acinetobacter baumannii using WGS revealed missed transmission events in Germany from 2012-15.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; Carbapenems; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Germany; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Retrospective Studies; Whole Genome Sequencing | 2019 |
Direct medical costs of urinary tract infections by Gram-negative bacilli resistant to beta-lactams in a tertiary care hospital in Medellín, Colombia
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cephalosporins; Cohort Studies; Colombia; Cross Infection; Diagnostic Imaging; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Health Expenditures; Hospitalization; Hospitals, Urban; Humans; Male; Middle Aged; Tertiary Care Centers; Urinary Tract Infections | 2019 |
Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa, Zhejiang Province, China.
Topics: Adolescent; Adult; Age Factors; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; China; Cross Infection; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Young Adult | 2019 |
Molecular characterization of clinical and environmental carbapenem resistant Acinetobacter baumannii isolates in a hospital of the Eastern Region of Saudi Arabia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Cross Infection; Female; Genes, Bacterial; Humans; Male; Phylogeny; Saudi Arabia | 2020 |
Emergence of colistin and carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii (CCR-Acb) complex in a neurological intensive care unit followed by successful control of the outbreak.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Aged; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests | 2020 |
Pharmacist recommendations for carbapenem de-escalation in urinary tract infection within an antimicrobial stewardship program.
Topics: Aged; Aged, 80 and over; Antimicrobial Stewardship; Carbapenems; Cross Infection; Female; Humans; Length of Stay; Male; Middle Aged; Pharmacists; Prospective Studies; Urinary Tract Infections | 2020 |
Environmental contamination by carbapenem-resistant
Topics: Acinetobacter baumannii; Carbapenems; Cross Infection; Disinfection; Drug Resistance, Multiple, Bacterial; Environmental Microbiology; Intensive Care Units; Patients' Rooms | 2020 |
Antimicrobial-resistant pathogens associated with pediatric healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015-2017.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Catheter-Related Infections; Catheters, Indwelling; Centers for Disease Control and Prevention, U.S.; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Equipment Contamination; Escherichia coli; Hospitals; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Pneumonia, Ventilator-Associated; Staphylococcus; Surgical Wound Infection; United States | 2020 |
Molecular Characteristics of GES-Type Carbapenemase-Producing
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genomic Islands; Hospitals, General; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pseudomonas aeruginosa; Republic of Korea; Residential Facilities | 2020 |
Molecular Surveillance of Multidrug-Resistant Acinetobacter baumannii.
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Humans; Microbial Sensitivity Tests | 2020 |
Faucet aerators as a reservoir for Carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Disease Outbreaks; Drinking Water; Drug Resistance, Bacterial; Fomites; Humans; Infection Control; Intensive Care Units; Microbial Sensitivity Tests; Neurosurgery; Trachea; Water Supply | 2019 |
Incidence and risk factors for acquired colonization and infection due to extended-spectrum beta-lactamase-producing Gram-negative bacilli: a retrospective analysis in three ICUs with low multidrug resistance rate.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; France; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Predictive Value of Tests; Prevalence; Retrospective Studies; Risk Factors | 2020 |
Origin of OXA-23 Variant OXA-239 from a Recently Emerged Lineage of Acinetobacter baumannii International Clone V.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Genomics; Honduras; Humans; Mexico; Microbial Sensitivity Tests | 2020 |
Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Risk Factors; Ubiquitin-Protein Ligases; Virginia | 2020 |
Patients with carbapenem-resistant Enterobacteriaceae in emergency room; is this a real problem?
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Enterobacteriaceae Infections; Humans; Patients | 2019 |
Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
Topics: Adaptation, Physiological; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cephalosporins; Clindamycin; Clostridioides difficile; Clostridium Infections; Cross Infection; Daptomycin; Doxycycline; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Retrospective Studies | 2020 |
Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabia, 2007-2016.
Topics: Acinetobacter; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Health Facilities; Hospitals; Humans; Klebsiella; Methicillin-Resistant Staphylococcus aureus; Prevalence; Prospective Studies; Pseudomonas; Saudi Arabia; Vancomycin | 2020 |
Drivers of press media response to healthcare-associated infections caused by multidrug-resistant organisms: A report from Brazil.
Topics: Acinetobacter baumannii; Brazil; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacterial Infections; Health Policy; Humans; Mass Media | 2020 |
Detection of carbapenem-resistant Klebsiella pneumoniae on the basis of matrix-assisted laser desorption ionization time-of-flight mass spectrometry by using supervised machine learning approach.
Topics: Algorithms; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; DNA, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Predictive Value of Tests; Random Amplified Polymorphic DNA Technique; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Supervised Machine Learning | 2020 |
Using comparative genomics to understand molecular features of carbapenem-resistant Acinetobacter baumannii from South Korea causing invasive infections and their clinical implications.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Genomics; Humans; Male; Middle Aged; Multilocus Sequence Typing; Republic of Korea; Virulence Factors | 2020 |
Surveillance of carbapenem-resistant Klebsiella pneumoniae in Chinese hospitals - A five-year retrospective study.
Topics: beta-Lactam Resistance; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Cross Infection; Epidemiological Monitoring; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Tertiary Care Centers | 2019 |
Community-acquired in name only: A cluster of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Boston; Burn Units; Carbapenems; Community-Acquired Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Tertiary Care Centers | 2020 |
Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; DNA, Bacterial; Enterobacteriaceae Infections; Epidemiological Monitoring; Female; Humans; Male; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; South Africa; Tertiary Care Centers | 2020 |
Intervention to reduce carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Humans; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; Microbial Sensitivity Tests | 2020 |
Outbreak of KPC-2-Producing
Topics: Adhesins, Bacterial; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gene Expression; Genome, Bacterial; Hospital Units; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neurosurgery; Plasmids; Sulfonamides; Trimethoprim; Whole Genome Sequencing | 2020 |
Genomic and Clinical Characterization of IMP-1-Producing Multidrug-Resistant
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Genomics; Humans; Integrons; Microbial Sensitivity Tests; Sepsis; Tertiary Care Centers | 2020 |
Transcriptional response of mar, sox and rob regulon against concentration gradient carbapenem stress within Escherichia coli isolated from hospital acquired infection.
Topics: Carbapenems; Cross Infection; DNA-Binding Proteins; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; India; Regulon; Trans-Activators | 2020 |
Characterization of Carbapenemase-Producing
Topics: Academic Medical Centers; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Bosnia and Herzegovina; Carbapenems; Cross Infection; Disease Outbreaks; Gene Expression; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Plasmids | 2020 |
Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012-2017.
Topics: Acinetobacter; Adolescent; Adult; Aged; Bacterial Infections; Carbapenems; Cephalosporin Resistance; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Health Surveys; Hospitalization; Humans; Incidence; Infant; Inpatients; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pseudomonas aeruginosa; United States; Vancomycin Resistance; Young Adult | 2020 |
Persuasive antimicrobial stewardship intervention in the context of a KPC outbreak: a controlled interrupted time series analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cross Infection; Disease Outbreaks; Female; Humans; Interrupted Time Series Analysis; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Patient Readmission; Tertiary Care Centers; Young Adult | 2020 |
Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Germany; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2020 |
Epidemiology of carbapenem-resistant Enterobacteriaceae in hospitals of a large healthcare system in Miami, Florida from 2012 to 2016: Five years of experience with an internal registry.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Delivery of Health Care; Enterobacteriaceae; Enterobacteriaceae Infections; Florida; Hospitals; Humans; Registries; Retrospective Studies | 2020 |
Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii Associated with Nosocomial Infection in the Pelotas, RS, Brazil.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Humans; Microbial Sensitivity Tests | 2020 |
Development of a LAMP method for detection of carbapenem-resistant Acinetobacter baumannii during a hospital outbreak.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Hospitals; Humans; Mexico; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Predictive Value of Tests; Sensitivity and Specificity | 2020 |
Control of a hospital-wide outbreak of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Disease Outbreaks; Hospitals; Humans; Infection Control | 2020 |
The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Europe; Female; Humans; Infant; Infant, Newborn; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2020 |
Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheter-Related Infections; China; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Respiratory Tract Infections; Risk Factors | 2020 |
Detection of several carbapenems resistant and virulence genes in classical and hyper-virulent strains of Klebsiella pneumoniae isolated from hospitalized neonates and adults in Khartoum.
Topics: Adult; beta-Lactam Resistance; Carbapenems; Cross Infection; Female; Genes, Bacterial; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Sudan; Virulence Factors | 2020 |
Containing Carbapenemase-producing Klebsiella pneumoniae in an endemic setting.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Endemic Diseases; Greece; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Prevalence; Tertiary Care Centers | 2020 |
Drug resistance of healthcare-associated pathogenic bacteria and carbapenem-resistant Acinetobacter baumannii homology in the general intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; China; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2020 |
A Diverse Panel of Clinical Acinetobacter baumannii for Research and Development.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Research | 2020 |
Epidemiological characteristics and risk factors of nosocomial carbapenem-resistant Enterobacteriaceae infections in children.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Cross Infection; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Risk Factors | 2020 |
Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brazil; Carbapenems; Case-Control Studies; Critical Illness; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors; Sepsis; Tertiary Care Centers; Young Adult | 2020 |
Extensively drug-resistant Acinetobacter baumannii carrying bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Disinfection; Drug Resistance, Multiple, Bacterial; Endemic Diseases; Humans; Intensive Care Units; Spain; Tertiary Care Centers | 2021 |
Risk factor for intestinal carriage of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; China; Cross Infection; Humans; Intensive Care Units; Pancreatitis; Retrospective Studies; Risk Factors | 2020 |
Cross-border emergence of clonal lineages of ST38 Escherichia coli producing the OXA-48-like carbapenemase OXA-244 in Germany and Switzerland.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Adhesion; Bacterial Proteins; beta-Lactamases; Carbapenems; Cell Line, Tumor; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Genome, Bacterial; Germany; HeLa Cells; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Switzerland; Whole Genome Sequencing | 2020 |
High mortality by nosocomial infections caused by carbapenem-resistant
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Brazil; Carbapenems; Child; Child, Preschool; Cohort Studies; Cross Infection; Female; Humans; Infant; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Type III Secretion Systems; Young Adult | 2020 |
Multicenter Evaluation of Xpert Carba-R Assay for Detection and Identification of the Carbapenemase Genes in Rectal Swabs and Clinical Isolates.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Female; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Diagnostic Techniques; Real-Time Polymerase Chain Reaction; Rectum; Reproducibility of Results; Sensitivity and Specificity | 2021 |
Investigation of an XDR-
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Lebanon; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Tertiary Care Centers | 2020 |
Infection control response to an outbreak of OXA-23 carbapenemase-producing carbapenem-resistant Acinetobacter baumannii in a skilled nursing facility in Utah.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Humans; Infection Control; Microbial Sensitivity Tests; Skilled Nursing Facilities; Utah | 2021 |
Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions - New Jersey, February-July 2020.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; COVID-19; Cross Infection; Drug Resistance, Bacterial; Female; Hospitals; Humans; Male; Middle Aged; New Jersey; Patient Admission | 2020 |
Risk factors for transmission of carbapenem-resistant Enterobacterales to healthcare personnel gloves and gowns in the USA.
Topics: Carbapenems; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Enterobacteriaceae; Equipment Contamination; Gloves, Protective; Humans; Prospective Studies; Protective Clothing; Risk Factors; United States | 2021 |
The role of the computerized tomography scanner in the cross-transmission of carbapenem-resistant Acinetobacter baumannii between hospitalized patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Equipment Contamination; Female; Genetic Carrier Screening; Humans; Inpatients; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2021 |
Nosocomial Non-fermentative gram negative bacteria bloodstream infections in children; Risk factors and clinical outcomes of carbapenem resistance.
Topics: Anti-Bacterial Agents; Carbapenems; Child; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Retrospective Studies; Risk Factors; Sepsis | 2021 |
Associated factors of Acinetobacter baumannii complex in hospitalized patients: A case-control study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brazil; Carbapenems; Case-Control Studies; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Risk Factors; Young Adult | 2021 |
Nosocomial transmission of a
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections | 2022 |
Development of a Nomogram for Carbapenem-Resistant Enterobacteriaceae Acquisition Risk Prediction Among Patients in the Intensive Care Unit of a Secondary Referral Hospital.
Topics: Aged; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Catheter-Related Infections; Cross Infection; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Logistic Models; Male; Models, Statistical; Nomograms; Risk Assessment; Risk Factors; Secondary Care Centers | 2021 |
Empiric Carbapenems for Nosocomial Pneumonia: Is Hindsight Clearer in 2020?
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Healthcare-Associated Pneumonia; Humans | 2021 |
Outbreak of endemic carbapenem-resistant
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; COVID-19; Cross Infection; Disease Outbreaks; Humans; Intensive Care Units; Microbial Sensitivity Tests | 2022 |
[The problem of global development of antibiotic resistant nosocomial pathogens].
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Microbial; Hospitals; Humans; Microbial Sensitivity Tests | 2020 |
Adaptations of carbapenem resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Physiological; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Environmental Microbiology; Female; Genes, Bacterial; Humans; Imipenem; Integrons; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Risk Factors; Virulence | 2021 |
Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Ciprofloxacin; Clone Cells; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Thailand | 2021 |
Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case-control study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Humans; Italy; Male; Middle Aged; Multivariate Analysis; Rectum; Retrospective Studies; Risk Factors; Tertiary Care Centers; Young Adult | 2021 |
A comprehensive approach to ending an outbreak of rare bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Hospitals, Community; Humans; Kansas; Microbial Sensitivity Tests | 2021 |
[Genomic subtyping of nosocomial transmission of carbapenem resistant
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny | 2021 |
A quasi-experimental study on stethoscopes contamination with multidrug-resistant bacteria: Its role as a vehicle of transmission.
Topics: Adult; Carbapenems; Cross Infection; Disinfection; Drug Contamination; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Equipment Contamination; Female; Health Personnel; Humans; Klebsiella pneumoniae; Male; Middle Aged; Physicians; Prospective Studies; Stethoscopes | 2021 |
Carriage of two carbapenem-resistance genes in Pseudomonas aeruginosa isolated from hospital-acquired infections in children from Costa Rica: the importance of local epidemiology.
Topics: beta-Lactamases; Carbapenems; Child; Costa Rica; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Whole Genome Sequencing | 2021 |
Surveillance cultures following a regional outbreak of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Humans; Microbial Sensitivity Tests | 2022 |
Isolated carbapenem resistant bacteria, their multidrug resistant profile, percentage of healthcare associated infection and associated mortality, in hospitalized patients in a University Hospital in Bratislava.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Cross Infection; Cross-Sectional Studies; Hospitals; Humans; Microbial Sensitivity Tests; Prospective Studies; Slovakia | 2021 |
Emergence of
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Canada; Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Phylogeny; Plasmids; Whole Genome Sequencing | 2021 |
Multimodal intervention to reduce acquisition of carbapenem-non-susceptible Gram-negative bacteria in intensive care units in the National Referral Hospital of Indonesia: An interrupted time series study.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Cross Infection; Gram-Negative Bacteria; Hospitals; Humans; Indonesia; Intensive Care Units; Interrupted Time Series Analysis; Microbial Sensitivity Tests; Referral and Consultation | 2021 |
Wall painting following terminal cleaning with a chlorine solution as part of an intervention to control an outbreak of carbapenem-resistant Acinetobacter baumannii in a neurosurgical intensive care unit in Israel.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Chlorine; Cross Infection; Disease Outbreaks; Humans; Intensive Care Units; Israel | 2021 |
[Risk factors and clinical prognosis analysis of carbapenem-resistant
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Humans; Prognosis; Risk Factors | 2021 |
Combined selective culture and molecular methods for the detection of carbapenem-resistant organisms from fecal specimens.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colony Count, Microbial; Cross Infection; Drug Resistance, Bacterial; Feces; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Polymerase Chain Reaction; Sensitivity and Specificity | 2021 |
Does enhanced environmental cleaning reduce carbapenem-resistant Acinetobacter baumannii colonization in the intensive care unit?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Humans; Intensive Care Units | 2021 |
Analysis of the molecular characteristics of a blaKPC-2-harbouring untypeable plasmid in Serratia marcescens.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Gene Transfer, Horizontal; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Serratia marcescens | 2022 |
Spread of Carbapenem-Resistant Klebsiella pneumoniae in an Intensive Care Unit: A Whole-Genome Sequence-Based Prospective Observational Study.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prospective Studies; Whole Genome Sequencing | 2021 |
Acinetobacter baumannii strains isolated from cerebrospinal fluid (CSF) and bloodstream analysed by cgMLST: the dominance of clonal complex CC92 in CSF infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Humans; Meningitis, Bacterial; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Tertiary Care Centers; Whole Genome Sequencing | 2021 |
Clinical characteristics and risk factors associated with secondary bloodstream infection in patients with intensive care unit-acquired pneumonia due to carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia; Risk Factors | 2021 |
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Antimicrobial Stewardship; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Hand Hygiene; Hand Sanitizers; Hospitals, University; Humans; Infection Control; Intensive Care Units; Italy; Tertiary Care Centers; Whole Genome Sequencing | 2021 |
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Febrile Neutropenia; Guidelines as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Tertiary Care Centers; Treatment Outcome; Turkey; Vancomycin | 2017 |
Evolution and Transmission of Carbapenem-Resistant Klebsiella pneumoniae Expressing the blaOXA-232 Gene During an Institutional Outbreak Associated With Endoscopic Retrograde Cholangiopancreatography.
Topics: beta-Lactamases; Carbapenems; Cholangiopancreatography, Endoscopic Retrograde; Cross Infection; Disease Outbreaks; Enzyme Activation; Genetic Variation; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Phylogeny; Plasmids; Whole Genome Sequencing | 2017 |
Modifiable Risk Factors for the Spread of Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Among Long-Term Acute-Care Hospital Patients.
Topics: Aged; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Comorbidity; Cross Infection; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Long-Term Care; Male; Middle Aged; Population Surveillance; Rectum; Risk Factors | 2017 |
Prevalence of Healthcare-Associated Infections and Antimicrobial Use Among Adult Inpatients in Singapore Acute-Care Hospitals: Results From the First National Point Prevalence Survey.
Topics: Age Factors; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Carbapenems; Cross Infection; Female; General Surgery; Health Surveys; Hospitals; Humans; Inpatients; Male; Middle Aged; Practice Patterns, Physicians'; Prevalence; Pseudomonas aeruginosa; Sex Factors; Singapore; Staphylococcus aureus | 2017 |
Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; DNA, Bacterial; Electronic Health Records; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Incidence; Inpatients; Klebsiella Infections; Klebsiella pneumoniae; Male; Surveys and Questionnaires; Young Adult | 2017 |
Molecular study of carbapenemase genes in clinical isolates of Enterobacteriaceae resistant to carbapenems and determining their clonal relationship using pulsed-field gel electrophoresis.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction | 2017 |
Circulation of
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Citrobacter freundii; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Hospitals; Humans; Italy; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids | 2017 |
Prevalence of Invasive Infections Due to Carbapenem-Resistant Enterobacteriaceae among Adult Patients in U.S. Hospitals.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Hospitals; Humans; Microbial Sensitivity Tests; Prevalence; Retrospective Studies; United States | 2017 |
Healthcare Antibiotic Resistance Prevalence - DC (HARP-DC): A Regional Prevalence Assessment of Carbapenem-Resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Cross Infection; District of Columbia; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitals; Humans; Male; Middle Aged; Nursing Homes; Prevalence; Real-Time Polymerase Chain Reaction; Skilled Nursing Facilities; Young Adult | 2017 |
A cold hard menace: A contaminated ice machine as a potential source for transmission of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Reservoirs; Equipment Contamination; Humans; Ice; Refrigeration | 2017 |
Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Comorbidity; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2017 |
A Novel Protocol Obviates Endoscope Sampling for Carbapenem-Resistant Enterobacteriaceae: Experience of a Center with a Prior Outbreak.
Topics: Adult; Aged; Carbapenems; Cholangiopancreatography, Endoscopic Retrograde; Cross Infection; Disease Outbreaks; Disinfectants; Drug Resistance, Bacterial; Duodenoscopes; Endosonography; Enterobacteriaceae; Enterobacteriaceae Infections; Equipment Contamination; Equipment Reuse; Ethylene Oxide; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pilot Projects; Program Evaluation; Rectum; Risk Factors; Sterilization; Wisconsin | 2017 |
Resolution of Carbapenemase-Producing Klebsiella pneumoniae Outbreak in a Tertiary Cancer Center; the Role of Active Surveillance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Epidemiological Monitoring; Humans; Klebsiella Infections; Klebsiella pneumoniae; Maryland; Tertiary Care Centers | 2017 |
Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Propensity Score; Retrospective Studies; Risk Factors; Treatment Outcome | 2018 |
Prevalence of a New Variant OXA-204 and OXA-48 Carbapenemases Plasmids Encoded in Klebsiella pneumoniae Clinical Isolates in Tunisia.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Gene Expression Regulation, Bacterial; Hospitals, Military; Humans; Isoenzymes; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Plasmids; Prevalence; Tunisia | 2018 |
Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae at a Turkish centre: Is the increase of resistance a threat for Europe?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Cross Infection; Europe; Female; Hospitalization; Hospitals; Humans; Infant; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Turkey; Young Adult | 2017 |
Emergence of carbapenem-resistant Enterobacteriaceae in Orange County, California, and support for early regional strategies to limit spread.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; California; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Young Adult | 2017 |
Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Egypt: Clonal Spread of blaOXA-23.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clone Cells; Cross Infection; Drug Resistance, Multiple, Bacterial; Egypt; Female; Gene Expression; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Tertiary Care Centers | 2018 |
Molecular epidemiology of Klebsiella pneumoniae invasive infections over a decade at Kilifi County Hospital in Kenya.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Community-Acquired Infections; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Hospitals, County; Kenya; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; R Factors; Rural Population | 2017 |
Virulence profiles and innate immune responses against highly lethal, multidrug-resistant nosocomial isolates of Acinetobacter baumannii from a tertiary care hospital in Mexico.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Immunity, Innate; Mexico; Microbial Sensitivity Tests; Tertiary Care Centers; Tumor Necrosis Factor-alpha; Virulence | 2017 |
IncX3 plasmid harboring a non-Tn4401 genetic element (NTE
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Interspersed Repetitive Sequences; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymyxins; Sequence Analysis, DNA | 2017 |
Effect of poly-hexamethylene biguanide hydrochloride (PHMB) treated non-sterile medical gloves upon the transmission of Streptococcus pyogenes, carbapenem-resistant E. coli, MRSA and Klebsiella pneumoniae from contact surfaces.
Topics: Biguanides; Carbapenems; Cross Infection; Disease Transmission, Infectious; Disinfectants; Drug Resistance, Bacterial; Escherichia coli; Gloves, Protective; Humans; Infection Control; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Streptococcus pyogenes | 2017 |
Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Germany; Humans; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tertiary Care Centers | 2018 |
Tn2008-driven carbapenem resistance in Acinetobacter baumannii isolates from a period of increased incidence of infections in a Southwest Virginia hospital (USA).
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Humans; Incidence; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Tertiary Care Centers; Virginia | 2018 |
Nosocomial, Multidrug-Resistant Klebsiella pneumoniae Strains Isolated from Mexico City Produce Robust Biofilms on Abiotic Surfaces but Not on Human Lung Cells.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Carbapenems; Cells, Cultured; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Fimbriae, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mexico; Virulence | 2018 |
Eliminating Duodenoscope-Associated Transmission of Carbapenem-Resistant Enterobacteriaceae (CRE): In Search of an Optimal Strategy.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Duodenoscopes; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2017 |
Carbapenemases among Acinetobacter species isolated from NICU of a tertairy care hospital in Karachi.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Cross-Sectional Studies; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Microbial Sensitivity Tests | 2017 |
Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Hospitals, University; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Taiwan | 2018 |
The Transmissibility of Antibiotic-Resistant Enterobacteriaceae in Intensive Care Units.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Intensive Care Units; Klebsiella Infections; Longitudinal Studies; Microbial Sensitivity Tests; Models, Theoretical; Prospective Studies | 2018 |
Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.
Topics: Aged; Aged, 80 and over; Carbapenems; Cephalosporins; Cohort Studies; Critical Illness; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Rectum | 2017 |
Clonal spread of carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cross Infection; Disease Transmission, Infectious; Female; Humans; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; Male; Molecular Typing | 2018 |
Selection of carbapenem-resistant Pseudomonas aeruginosa in a haematology unit?
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Transmission, Infectious; Hematologic Diseases; Hospital Departments; Hospitals, University; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Selection, Genetic; United Kingdom; Water Microbiology | 2018 |
Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Female; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Multivariate Analysis; Pneumonia; Prognosis; Stenotrophomonas maltophilia; Survival Analysis; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Molecular characterization of β-lactamase genes in clinical isolates of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Biofilms; Carbapenems; Cross Infection; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genotype; Hospitals; Humans; Integrons; Interspersed Repetitive Sequences; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Phenotype; Philadelphia; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic | 2017 |
Management of carbapenem-resistant Acinetobacter baumannii epidemic in an intensive care unit using multifaceted intervention strategy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Republic of Korea; Retrospective Studies | 2018 |
Findings from an outbreak of carbapenem-resistant Klebsiella pneumoniae emphasize the role of antibiotic treatment for cross transmission.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Germany; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors | 2018 |
Genomic Investigation of a Putative Endoscope-Associated Carbapenem-Resistant Enterobacter cloacae Outbreak Reveals a Wide Diversity of Circulating Strains and Resistance Mutations.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Endoscopy; Enterobacter cloacae; Enterobacteriaceae Infections; Equipment Contamination; Genetic Variation; Genomics; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation | 2018 |
Israeli National Policy for Carbapenem-Resistant Enterobacteriaceae Screening, Carrier Isolation and Discontinuation of Isolation.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; Cross Infection; Disease Outbreaks; Enterobacteriaceae Infections; Guidelines as Topic; Health Policy; Hospitals; Humans; Israel; Mandatory Reporting; Patient Isolation; Public Health Administration; Registries; Risk Factors | 2018 |
Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies | 2018 |
Pathogen Distribution and Antimicrobial Resistance Among Pediatric Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2011-2014.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Catheter-Related Infections; Catheters, Indwelling; Centers for Disease Control and Prevention, U.S.; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Equipment Contamination; Escherichia coli; Hospitals; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Pediatrics; Pneumonia, Ventilator-Associated; Staphylococcus; Surgical Wound Infection; United States | 2018 |
Evaluating the Risk Factors for Hospital-Onset Clostridium difficile Infections in a Large Healthcare System.
Topics: Anti-Bacterial Agents; Carbapenems; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitals; Humans; Male; Odds Ratio; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; United States; Young Adult | 2018 |
Emergence and establishment of KPC-2-producing ST11 Klebsiella pneumoniae in a general hospital in Shanghai, China.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Hospitals, General; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Primary Prevention; Sequence Analysis, DNA | 2018 |
Extensively drug-resistant ArmA-producing Acinetobacter baumannii in an Italian intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Italy; Microbial Sensitivity Tests | 2018 |
Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; France; Glycopeptides; Guidelines as Topic; Hospitals; Humans; Intensive Care Units; Logistic Models; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Prescriptions; Probability; Retrospective Studies | 2018 |
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Surveys and Questionnaires | 2018 |
High Prevalence of Extensively Drug-resistant Acinetobacter baumannii at a Children Hospital in Bolivia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Biofilms; Bolivia; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Prevalence | 2018 |
Evolution of carbapenem resistance in Acinetobacter baumannii during a prolonged infection.
Topics: Acinetobacter baumannii; Bacterial Proteins; beta-Lactamases; Carbapenems; Ciprofloxacin; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymorphism, Single Nucleotide; Protein Conformation; Sequence Analysis, DNA | 2018 |
The Economic Value of the Centers for Disease Control and Prevention Carbapenem-Resistant Enterobacteriaceae Toolkit.
Topics: California; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Centers for Disease Control and Prevention, U.S.; Computer Simulation; Cost of Illness; Cost-Benefit Analysis; Cross Infection; Enterobacteriaceae Infections; Health Expenditures; Hospitals; Humans; Infection Control; United States | 2018 |
Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Communicable Diseases, Emerging; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Genotype; Hospitals, Teaching; Humans; Intensive Care Units; Iran; Minocycline; Molecular Typing; Tigecycline | 2018 |
Long-Term Impact of Universal Contact Precautions on Rates of Multidrug-Resistant Organisms in ICUs: A Comparative Effectiveness Study.
Topics: Academic Medical Centers; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Humans; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; New York City; Retrospective Studies; Staphylococcal Infections; Universal Precautions; Vancomycin-Resistant Enterococci | 2018 |
[Nosocomial infections caused by multiresistant Pseudomonas aeruginosa (carbapenems included): predictive and prognostic factors. A prospective study (2016-2017))].
Topics: Aged; Aged, 80 and over; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Incidence; Intensive Care Units; Leukocytosis; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Resuscitation | 2018 |
Acinetobacter baumannii Resistance Trends in Children in the United States, 1999-2012.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Child; Child, Preschool; Cross Infection; Databases, Factual; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Logistic Models; Male; Microbial Sensitivity Tests; Prevalence; Regression Analysis; United States | 2019 |
Duodenoscope-Related Outbreak of a Carbapenem-Resistant Klebsiella pneumoniae Identified Using Advanced Molecular Diagnostics.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cholangiopancreatography, Endoscopic Retrograde; Cross Infection; Disease Outbreaks; Disinfection; Duodenoscopes; Equipment Contamination; Female; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pathology, Molecular; Young Adult | 2017 |
Environmental colonization and onward clonal transmission of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Hygiene; Intensive Care Units; Intubation; Male; Mass Screening; Microbial Sensitivity Tests | 2018 |
Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cross Infection; Female; Germany; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Prevalence; Retrospective Studies; Treatment Outcome | 2018 |
Healthcare-Associated Infections after Lower Urinary Tract Endoscopic Surgery: Analysis of Risk Factors, Associated Microorganisms and Patterns of Antibiotic Resistance.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Comorbidity; Cross Infection; Drug Resistance, Bacterial; Endoscopy; Enterobacteriaceae; Enterococcus; Escherichia coli; Female; Fluoroquinolones; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Postoperative Period; Prospective Studies; Pseudomonas aeruginosa; Risk Factors; Tertiary Care Centers; Urinary Catheters; Urinary Tract; Urinary Tract Infections; Young Adult | 2018 |
ISAba1 Regulated OXA-23 Carbapenem Resistance in Acinetobacter baumannii Strains in Durban, South Africa.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Child; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; South Africa | 2018 |
Risk factors for fecal carriage of IMP-6-producing Enterobacteriaceae at a long-term care hospital in Japan: A follow-up report from the northern Osaka multicentre study group.
Topics: Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; Cross Infection; Enterobacteriaceae Infections; Feces; Female; Follow-Up Studies; Hospitals; Humans; Inosine Monophosphate; Japan; Long-Term Care; Male; Prevalence; Risk Factors | 2018 |
Identifying Risk Factors for Healthcare-Associated Infections Caused by Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Egypt; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Microbial Sensitivity Tests; Odds Ratio; Prospective Studies; Risk Factors | 2018 |
Detection of Antibiotic Resistance Determinants and Their Transmissibility among Clinically Isolated Carbapenem-Resistant Escherichia coli from South India.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Databases, Nucleic Acid; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; India; Male; Middle Aged; Polymerase Chain Reaction; Tertiary Care Centers; Young Adult | 2018 |
Long-Term, Low-Frequency Cluster of a German-Imipenemase-1-Producing Enterobacter hormaechei ssp. steigerwaltii ST89 in a Tertiary Care Hospital in Germany.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Enterobacter cloacae; Enterobacteriaceae Infections; Germany; Humans; Integrons; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Prospective Studies; Retrospective Studies; Tertiary Care Centers | 2018 |
Genomic and Geographic Context for the Evolution of High-Risk Carbapenem-Resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genome, Bacterial; Genomics; Humans; Microbial Sensitivity Tests; Phylogeny; Plasmids; United States | 2018 |
Whole genome sequence revealed the fine transmission map of carbapenem-resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Critical Care; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Retrospective Studies; Whole Genome Sequencing | 2018 |
Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii in the Intensive Care Unit of Uruguay's University Hospital Identifies the First rmtC Gene in the Species.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Genes, Bacterial; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; RNA, Ribosomal, 16S; Uruguay | 2018 |
Carbapenem non-susceptibility of
Topics: Adult; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gentamicins; Germany; Hospitals; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Tertiary Care Centers; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2018 |
The emergence of bla
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Infant; Iran; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Tertiary Care Centers; Young Adult | 2018 |
Multi-drug resistant Pseudomonas aeruginosa nosocomial strains: Molecular epidemiology and evolution.
Topics: Base Sequence; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Epidemiology; Phylogeny; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Rome; Sequence Alignment | 2018 |
Development and validation of a bedside instrument to predict carbapenem resistance among gram-negative pathogens in complicated urinary tract infections.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Catheter-Related Infections; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Logistic Models; Male; Middle Aged; Models, Theoretical; Prognosis; Retrospective Studies; Risk Assessment; Severity of Illness Index; United States; Urinary Tract Infections | 2018 |
Implementing an infection control and prevention program decreases the incidence of healthcare-associated infections and antibiotic resistance in a Russian neuro-ICU.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Carbapenems; Child; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Incidence; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Russia; Young Adult | 2018 |
Fast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitals.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Mass Screening; Models, Theoretical; Polymerase Chain Reaction; United Kingdom | 2018 |
NDM-1-producing Enterobacter aerogenes isolated from a patient with a JJ ureteric stent in situ.
Topics: Aged; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Humans; Microbial Sensitivity Tests; Stents; Ureteral Obstruction; Urinary Tract Infections | 2019 |
Molecular and Phenotypic Study of Carbapenem Resistant E. coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests | 2018 |
Related carbapenemase-producing Klebsiella isolates detected in both a hospital and associated aquatic environment in Sweden.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Hospitals; Humans; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Phylogeny; Rivers; Sweden; Wastewater; Water Microbiology; Whole Genome Sequencing | 2018 |
Resistance pattern and distribution of carbapenemase and antiseptic resistance genes among multidrug-resistant Acinetobacter baumannii isolated from intensive care unit patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests | 2018 |
Extended-spectrum β-lactamase-producing E. coli septicemia among rectal carriers in the ICU.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Carrier State; Case-Control Studies; Cephalosporins; China; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Hospital Mortality; Hospitals; Humans; Intensive Care Units; Male; Middle Aged; Rectal Diseases; Retrospective Studies; Risk Factors | 2018 |
Increased Relative Abundance of Klebsiella pneumoniae Carbapenemase-producing Klebsiella pneumoniae Within the Gut Microbiota Is Associated With Risk of Bloodstream Infection in Long-term Acute Care Hospital Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Female; Gastrointestinal Microbiome; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Longitudinal Studies; Male; Middle Aged; Proportional Hazards Models; ROC Curve | 2019 |
Implementation of an empirical antimicrobial protocol in a critical care setting: A single-center retrospective observational cohort study in bacteremic patients.
Topics: Aged, 80 and over; Anti-Infective Agents; Antimicrobial Stewardship; Bacteremia; Carbapenems; Cohort Studies; Community-Acquired Infections; Critical Care; Cross Infection; Female; Humans; Male; Retrospective Studies; Treatment Outcome | 2018 |
Results from the Canadian Nosocomial Infection Surveillance Program for detection of carbapenemase-producing Acinetobacter spp. in Canadian hospitals, 2010-16.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Canada; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Epidemiological Monitoring; Female; Hospitals; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2019 |
Changes in the early mortality of adult patients with carbapenem-resistant Acinetobacter baumannii bacteremia during 11 years at an academic medical center.
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Catheter-Related Infections; Cross Infection; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Retrospective Studies; Risk Factors | 2019 |
Gastrointestinal Microbiota Disruption and Risk of Colonization With Carbapenem-resistant Pseudomonas aeruginosa in Intensive Care Unit Patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Carrier State; Cross Infection; Drug Resistance, Bacterial; Female; Gastrointestinal Microbiome; Humans; Intensive Care Units; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Young Adult | 2019 |
Comparative Analysis of Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing | 2019 |
High frequency and molecular epidemiology of metallo-β-lactamase-producing gram-negative bacilli in a tertiary care hospital in Lahore, Pakistan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Pakistan; Public Health Surveillance; Tertiary Care Centers; Young Adult | 2018 |
Carbapenem-resistant Acinetobacter baumannii: Current status of the problem in four Bulgarian university hospitals (2014-2016).
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bulgaria; Carbapenems; Child; Child, Preschool; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2019 |
A Case-Control Study: Clinical Characteristics of Nosocomial Bloodstream Infections Versus Non-bloodstream Infections of Acinetobacter spp.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Hospitals, Teaching; Humans; Male; Medical Records; Middle Aged; Respiratory Tract Infections; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult | 2018 |
Carbapenem-resistant Isolates of the Klebsiella pneumoniae Complex in Western China: The Common ST11 and the Surprising Hospital-specific Types.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; China; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids | 2018 |
An intervention to control an ICU outbreak of carbapenem-resistant Acinetobacter baumannii: long-term impact for the ICU and hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; APACHE; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Female; Humans; Infection Control; Intensive Care Units; Israel; Male; Middle Aged | 2018 |
Dialysis drains as a possible source for carbapenem-resistant pathogens causing an ICU outbreak.
Topics: Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Germany; Intensive Care Units; Renal Dialysis; Tertiary Care Centers | 2019 |
Whole Genome Sequencing detects Inter-Facility Transmission of Carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Asymptomatic Infections; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Health Facilities; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Movement; North Carolina; Prevalence; Whole Genome Sequencing | 2019 |
One-year molecular surveillance of carbapenem-susceptible
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Bacterial Proteins; Carbapenems; Cross Infection; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Female; Genotyping Techniques; Germany; Humans; Infection Control; Intensive Care Units; Male; Middle Aged; Molecular Epidemiology; Molecular Typing; Multilocus Sequence Typing; Multiplex Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Tertiary Care Centers; Whole Genome Sequencing; Young Adult | 2018 |
Molecular epidemiology of multidrug-resistant Acinetobacter baumannii infection in two hospitals in Central Brazil: the role of ST730 and ST162 in clinical outcomes.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Genetic Variation; Hospitals; Humans; Infant; Male; Middle Aged; Molecular Epidemiology; Norepinephrine; Respiratory Tract Infections; Young Adult | 2019 |
The impact of carbapenem-resistant Pseudomonas aeruginosa on clinical and economic outcomes in a Chinese tertiary care hospital: A propensity score-matched analysis.
Topics: Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; China; Cross Infection; Female; Health Care Costs; Humans; Inpatients; Length of Stay; Male; Middle Aged; Patient Readmission; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Survival Analysis; Tertiary Care Centers; Treatment Outcome | 2019 |
Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Genotype; Hospitals; Humans; India; Intensive Care Units; Microbial Sensitivity Tests; Microbiological Techniques; Molecular Typing; Phenotype; Prevalence; Prospective Studies; Respiratory Tract Infections; Species Specificity; Virulence | 2019 |
Societal willingness to pay to avoid mortality and morbidity from Clostridioides difficile and carbapenem-resistant Enterobacteriaceae infections in the United States.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Clostridium; Clostridium Infections; Cross Infection; Enterobacteriaceae Infections; Humans; Klebsiella pneumoniae; Morbidity; United States | 2019 |
Identification of
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gene Expression; Genes, Bacterial; Hospitals; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Macrolides; Microbial Sensitivity Tests; Penicillins; Tetracyclines; Whole Genome Sequencing | 2019 |
Carbapenemases: The never-ending story.
Topics: Antimicrobial Stewardship; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Humans; R Factors | 2019 |
Characterize carbapenem-resistant Klebsiella pneumoniae isolates for nosocomial pneumonia and their Gram-negative bacteria neighbors in the respiratory tract.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gram-Negative Bacteria; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Pneumonia; Respiratory System; Retrospective Studies | 2019 |
Risk Factors Affecting Patterns of Antibiotic Resistance and Treatment Efficacy in Extreme Drug Resistance in Intensive Care Unit-Acquired Klebsiella Pneumoniae Infections: A 5-Year Analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Microbial; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Retrospective Studies; Risk Factors; Survival Rate; Tigecycline; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Genetic characterization of multiple NDM-1-producing clinical isolates in Mexico.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genome, Bacterial; Humans; Integrons; Mexico; Microbial Sensitivity Tests | 2019 |
Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Young Adult | 2019 |
Do antimicrobial stewardship programme interventions reduce the rate of and protect against Clostridium difficile infection?
Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Utilization; Female; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Singapore; Tertiary Care Centers | 2019 |
Preemptive isolation and active surveillance in the prevention and control of nosocomial infection reduce the incidence of carbapenem-resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Epidemiological Monitoring; Humans; Incidence; Patient Isolation; Risk Factors; Tertiary Care Centers | 2019 |
Reply to Kaier, Mutters, and Wolkewitz.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Hospital Costs; Humans; Klebsiella pneumoniae | 2019 |
Putative horizontal transfer of carbapenem resistance between Klebsiella pneumoniae and Kluyvera ascorbata during abdominal infection: A case report.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Bile Ducts; Brazil; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Kluyvera; Male; Microbial Sensitivity Tests | 2019 |
Risk Assessment After a Severe Hospital-Acquired Infection Associated With Carbapenemase-Producing Pseudomonas aeruginosa.
Topics: Aged; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Environmental Microbiology; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Assessment | 2019 |
Molecular Study of Klebsiella Pneumoniae Virulence Genes from Patients with Hospital Acquired Sepsis.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sepsis; Virulence | 2019 |
Incidence of metallo-beta-lactamase-producing Klebsiella pneumoniae isolates from hospital setting in Pakistan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitalization; Humans; Incidence; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Pakistan; Young Adult | 2018 |
A Combination Antibiogram Evaluation for
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; United States | 2019 |
Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Catheter-Related Infections; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Male; Middle Aged; Mortality; Pneumonia; Retrospective Studies; Risk Factors | 2019 |
Nosocomial bloodstream infection and the emerging carbapenem-resistant pathogen Ralstonia insidiosa.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Male; Microbial Sensitivity Tests; Phylogeny; Polymerase Chain Reaction; Ralstonia; RNA, Ribosomal, 16S; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Whole Genome Sequencing | 2019 |
Evolutionary dynamics of carbapenem-resistant Acinetobacter baumannii circulating in Chilean hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Cross Infection; Evolution, Molecular; Hospitals, Pediatric; Humans; Phylogeny | 2019 |
Epidemiology and successful containment of a carbapenem-resistant Enterobacteriaceae outbreak in a Southern Italian Transplant Institute.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Disease Outbreaks; Enterobacteriaceae Infections; Humans; Infection Control; Italy; Organ Transplantation; Regression Analysis; Risk Factors; Transplant Recipients | 2019 |
Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in ICU of the eastern Heilongjiang Province, China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterobacteriaceae; Female; Gene Transfer, Horizontal; Humans; Infection Control; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged | 2019 |
Derivation and validation of a simple score to predict the presence of bacteria requiring carbapenem treatment in ICU-acquired bloodstream infection and pneumonia: CarbaSCORE.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; France; Hospitals, University; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Predictive Value of Tests; Prospective Studies; Retrospective Studies; Severity of Illness Index; Young Adult | 2019 |
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Bacteremia; beta-Lactam Resistance; Carbapenems; Comorbidity; Cross Infection; Disease Management; Drug Resistance, Multiple, Bacterial; Female; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Patient Outcome Assessment; Proportional Hazards Models; Prospective Studies; Tertiary Care Centers | 2019 |
Emergence of Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Hong Kong; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Retrospective Studies | 2019 |
Carbapenem and Cephalosporin Resistance among Enterobacteriaceae in Healthcare-Associated Infections, California, USA
Topics: beta-Lactam Resistance; California; Carbapenems; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Geography, Medical; Humans; Microbial Sensitivity Tests | 2019 |
In vitro interaction of various antibiotic combinations recommended by Chinese consensus statement against carbapenems-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefoperazone; Ceftazidime; China; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2019 |
Assessing the relevance of carbapenem prescriptions by an antibiotic stewardship team.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacterial Infections; beta-Lactamases; Carbapenems; Cross Infection; Drug Prescriptions; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Female; France; Guideline Adherence; Hospital Departments; Hospitals, University; Humans; Inappropriate Prescribing; Intensive Care Units; Internal Medicine; Male; Middle Aged; Practice Guidelines as Topic; Prospective Studies; Surgery Department, Hospital; Young Adult | 2020 |
Antimicrobial consumption in three pediatric and neonatal intensive care units in Saudi Arabia: 33-month surveillance study.
Topics: Adolescent; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cephalosporins; Child; Child, Preschool; Cross Infection; Epidemiological Monitoring; Female; Humans; Infant; Intensive Care Units, Neonatal; Male; Pediatrics; Prospective Studies; Saudi Arabia; Vancomycin | 2019 |
Antibiotics with activity against intestinal anaerobes and the hazard of acquired colonization with ceftriaxone-resistant Gram-negative pathogens in ICU patients: a propensity score-based analysis.
Topics: Aged; Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Ceftriaxone; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Intestines; Male; Meropenem; Middle Aged; Propensity Score; Retrospective Studies | 2019 |
Rapid screening and early precautions for carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Female; Humans; Incidence; Infection Control; Intensive Care Units; Japan; Male; Middle Aged; Molecular Diagnostic Techniques; Non-Randomized Controlled Trials as Topic; Nucleic Acid Amplification Techniques; Watchful Waiting | 2019 |
Imipenemase-producing carbapenem-resistant Enterobacteriaceae transmission in a long-term-care facility during a community-wide multidrug resistant organism outbreak-North Carolina, 2017.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Humans; Long-Term Care; Male; Middle Aged; North Carolina; Nursing Homes; Young Adult | 2020 |
Extended spectrum beta-lactamase producing
Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged | 2019 |
The origin of Acinetobacter baumannii TYTH-1: a comparative genomics study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Genome, Bacterial; Genomics; Humans; Microbial Sensitivity Tests; Phylogeny; Retrospective Studies; Sequence Analysis, DNA; Taiwan | 2013 |
Notes from the field: hospital outbreak of carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase--Denver, Colorado, 2012.
Topics: Adult; Aged; beta-Lactamases; Carbapenems; Colorado; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Young Adult | 2013 |
Outbreak of carbapenem-resistant Klebsiella pneumoniae: two-year epidemiologic follow-up in a tertiary hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross Infection; Disease Outbreaks; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Tertiary Care Centers; Young Adult | 2013 |
[Surveillance of carbapenem-resistant enterobacteria in stool cultures in a university hospital in Santiago, Chile].
Topics: Anti-Bacterial Agents; Carbapenems; Chile; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Hospitals, University; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prospective Studies | 2013 |
Clonal spread of carbapenem resistant Acinetobacter baumannii ST92 in a Chinese Hospital during a 6-year period.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; China; Cluster Analysis; Cross Infection; DNA Fingerprinting; Genes, Bacterial; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction | 2013 |
Vital signs: carbapenem-resistant Enterobacteriaceae.
Topics: Adolescent; Adult; Aged; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Klebsiella Infections; Middle Aged; Population Surveillance; United States; Young Adult | 2013 |
"Down the drain": carbapenem-resistant bacteria in intensive care unit patients and handwashing sinks.
Topics: Australia; beta-Lactamases; Carbapenems; Confidence Intervals; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae; Equipment and Supplies, Hospital; Equipment Contamination; Female; Gram-Negative Bacterial Infections; Hand Disinfection; Humans; Incidence; Infection Control; Intensive Care Units; Male; Microbial Sensitivity Tests; Risk Assessment | 2013 |
Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Cross Infection; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pneumonia; Retrospective Studies; Risk Factors | 2013 |
Carbapenem-resistant Klebsiella pneumoniae in the CSF: smile, please! We are taking photos.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Cerebral Ventricles; Cross Infection; Diagnosis, Differential; Drug Resistance, Bacterial; Endoscopy; Female; Humans; Hydrocephalus; Klebsiella Infections; Klebsiella pneumoniae | 2013 |
Whole genome sequence analysis of the first Australian OXA-48-producing outbreak-associated Klebsiella pneumoniae isolates: the resistome and in vivo evolution.
Topics: Anti-Bacterial Agents; Australia; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Genome, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Polymorphism, Single Nucleotide; Sequence Analysis, DNA; Transcription, Genetic; Virulence | 2013 |
In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Rifampin | 2013 |
Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients.
Topics: Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cross Infection; Female; Gram-Negative Bacterial Infections; Greece; Humans; Intensive Care Units; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors | 2013 |
Health-care associated infection: USA on the right track.
Topics: Carbapenems; Cross Infection; Databases, Factual; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Infection Control; United States | 2013 |
Acinetobacter pittii and Acinetobacter nosocomialis among clinical isolates of the Acinetobacter calcoaceticus-baumannii complex in Sichuan, China.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; China; Cross Infection; Female; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing | 2013 |
First detection in Europe of the metallo-β-lactamase IMP-15 in clinical strains of Pseudomonas putida and Pseudomonas aeruginosa.
Topics: Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cross Infection; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas putida; Retrospective Studies; Spain | 2013 |
Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Cohort Studies; Colombia; Cross Infection; Female; Health Care Costs; Humans; Length of Stay; Male; Middle Aged; Prospective Studies; Survival Analysis; Treatment Outcome | 2014 |
Pharmacokinetic analysis of doripenem in elderly patients with nosocomial pneumonia.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Chromatography, Liquid; Cross Infection; Doripenem; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Plasma; Pneumonia, Bacterial; Tandem Mass Spectrometry; Time Factors | 2013 |
Multidrug-resistant Acinetobacter baumannii clone, France.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Algeria; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clone Cells; Cross Infection; Egypt; France; Humans; Tunisia | 2013 |
The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Patient Isolation | 2013 |
Carbapenem-resistant Enterobacteriaceae: a growing threat.
Topics: Carbapenems; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Practice Guidelines as Topic; United States | 2013 |
Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity.
Topics: Adult; Aged; Aged, 80 and over; Anal Canal; beta-Lactam Resistance; Carbapenems; Carrier State; Case-Control Studies; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Female; Hospitals, University; Hospitals, Urban; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases; Male; Middle Aged; New York City; Prevalence; Respiration, Artificial; Risk Factors; Young Adult | 2013 |
Outcomes associated with a thrice-weekly antimicrobial stewardship programme in a 253-bed community hospital.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Hospitals, Community; Humans; Retrospective Studies; Vancomycin | 2013 |
In vitro activity of sitafloxacin against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Asia, Southeastern; beta-Lactam Resistance; Carbapenems; Cross Infection; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial | 2013 |
Emergence and spread of carbapenem-resistant Acinetobacter baumannii sequence type 191 in a Korean hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cluster Analysis; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Republic of Korea | 2013 |
Emergence of a VIM-1 MBL and CTX-M-15 ESbL-producing Klebsiella pneumoniae clone from acute and rehabilitation hospitals in Italy.
Topics: Anti-Infective Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Rehabilitation Centers | 2013 |
Outbreak of NDM-1-producing Acinetobacter baumannii in France, January to May 2013.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Carrier State; Contact Tracing; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; France; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Travel | 2013 |
Managing transmission of carbapenem-resistant enterobacteriaceae in healthcare settings: a view from the trenches.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Disease Transmission, Infectious; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genome, Bacterial; Humans; Infection Control | 2013 |
Carbapenem resistance in Acinetobacter baumannii: where is it heading?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Hospitals, University; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Prognosis; Risk Factors; Thienamycins; Turkey | 2013 |
Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
Topics: Adult; Aged; Carbapenems; Cross Infection; Databases, Factual; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; United States; Young Adult | 2013 |
Colonization pressure as a risk factor for colonization by multiresistant Acinetobacter spp and carbapenem-resistant Pseudomonas aeruginosa in an intensive care unit.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacterial Load; beta-Lactam Resistance; Brazil; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Time Factors; Young Adult | 2013 |
Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan.
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; DNA Transposable Elements; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genotype; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Prevalence; Taiwan | 2015 |
Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Cross Infection; Female; Hospitals; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Pakistan; Young Adult | 2014 |
[Analysis of resistance tendency of bloodstream-infecting pathogens in China].
Topics: Acinetobacter baumannii; Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests | 2013 |
Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Greece; Humans; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Pseudomonas aeruginosa; Pseudomonas Infections | 2013 |
Carbapenem-resistant strains from the family Enterobacteriaceae isolated in the period 2006-2011 from clinical specimens of patients treated at the university hospital in northeastern Poland.
Topics: Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Hospitals, University; Humans; Microbial Sensitivity Tests; Poland; Retrospective Studies; Species Specificity | 2013 |
Pseudohemoptysis due to Serratia marcescens.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Diagnosis, Differential; Doripenem; Hemoptysis; Humans; Male; Serratia Infections; Serratia marcescens; Sputum; Treatment Outcome | 2014 |
[Evaluation of a hospital outbreak related to carbapenem-resistant Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospital Units; Humans; Infection Control; Intensive Care Units; Logistic Models; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Surgery, Plastic; Turkey | 2013 |
Surveillance and correlation of antimicrobial usage and resistance of Pseudomonas aeruginosa: a hospital population-based study.
Topics: Anti-Bacterial Agents; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2013 |
Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Hospitals, Community; Humans; Male; Middle Aged; Texas | 2013 |
In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Tigecycline | 2013 |
Hospital clonal dissemination of Enterobacter aerogenes producing carbapenemase KPC-2 in a Chinese teaching hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Case-Control Studies; China; Cluster Analysis; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology | 2014 |
Nosocomial outbreak of a multiresistant Acinetobacter baumannii expressing OXA-23 carbapenemase in Spain.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Gene Expression; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Spain; Survival Analysis; Tigecycline | 2014 |
Notes from the Field: New Delhi metallo-β-lactamase-producing Escherichia coli associated with endoscopic retrograde cholangiopancreatography - Illinois, 2013.
Topics: beta-Lactamases; Carbapenems; Case-Control Studies; Cholangiopancreatography, Endoscopic Retrograde; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Equipment Contamination; Escherichia coli; Humans; Illinois | 2014 |
Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Prescriptions; Drug Resistance, Multiple, Bacterial; Drug Utilization; Female; Humans; Infection Control; Intensive Care Units; Male; Middle Aged; Organizational Policy; Prevalence; Retrospective Studies; Young Adult | 2014 |
Rates of fecal transmission of extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care units in Korea.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Genotype; Humans; Intensive Care Units; Polymerase Chain Reaction; Prevalence; Republic of Korea | 2014 |
Emergence of carbapenem-resistant Klebsiella spp. infections in a Turkish university hospital: epidemiology and risk factors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Female; Hospitals, University; Humans; Incidence; Klebsiella; Klebsiella Infections; Male; Middle Aged; Retrospective Studies; Risk Factors; Turkey; Young Adult | 2014 |
Characterization of KPC-2-producing Escherichia coli, Citrobacter freundii, Enterobacter cloacae, Enterobacter aerogenes, and Klebsiella oxytoca isolates from a Chinese Hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; China; Cross Infection; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Expression; Hospitals; Humans; Methyltransferases; Microbial Sensitivity Tests; Plasmids; Survival Analysis | 2014 |
NDM-1-producing strains, family Enterobacteriaceae, in hospital, Beijing, China.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Expression; Humans; Plasmids; Tertiary Care Centers | 2014 |
Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Critical Illness; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Republic of Korea; Retrospective Studies; Risk Factors | 2014 |
Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Saudi Arabia; Tertiary Care Centers; Young Adult | 2014 |
Successful containment and infection control of a Carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Containment of Biohazards; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Hospitals; Humans; Infection Control; Italy; Klebsiella Infections; Klebsiella pneumoniae | 2014 |
Improving the efficiency of the modified Hodge test in KPC-producing Klebsiella pneumoniae isolates by incorporating an EDTA disk.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Edetic Acid; Genotype; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Sensitivity and Specificity | 2014 |
The emerging threat from carbapenem-resistant enterobacteriaceae.
Topics: Anti-Bacterial Agents; Carbapenems; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hand Hygiene; Humans; Infection Control; Practice Guidelines as Topic; Risk Assessment; United States | 2013 |
Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Michigan; Middle Aged; Population Surveillance; Young Adult | 2014 |
Establishment of a statewide network for carbapenem-resistant enterobacteriaceae prevention in a low-incidence region.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Clinical Laboratory Techniques; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Incidence; Oregon; Population Surveillance; Real-Time Polymerase Chain Reaction | 2014 |
Carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-β-lactamase at an acute care hospital, Colorado, 2012.
Topics: Adult; Aged; beta-Lactamases; Carbapenems; Colorado; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Sequence Analysis, DNA; Young Adult | 2014 |
Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities.
Topics: Aged; Aged, 80 and over; Carbapenems; Case-Control Studies; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Female; Hospitalization; Hospitals, Urban; Humans; Long-Term Care; Male; Michigan; Middle Aged; Multivariate Analysis; Odds Ratio; Retrospective Studies; Risk Factors | 2014 |
Environmental exposure to carbapenem-resistant Acinetobacter baumannii as a risk factor for patient acquisition of A. baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Environmental Exposure; Female; Florida; Humans; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Risk Factors | 2014 |
Thirty-day laboratory-based surveillance for carbapenem-resistant Enterobacteriaceae in the Minneapolis-St. Paul metropolitan area.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Child; Child, Preschool; Clinical Laboratory Techniques; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feasibility Studies; Female; Humans; Infant; Male; Middle Aged; Minnesota; Population Surveillance; Urban Population; Young Adult | 2014 |
Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Polymerase Chain Reaction; Sicily | 2014 |
Correlation between antibiotic consumption and carbapenem-resistant Acinetobacter baumannii causing health care-associated infections at a hospital from 2005 to 2010.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Drug Utilization; Fluoroquinolones; Hospitals; Humans; Incidence; Taiwan | 2015 |
Nosocomial transmission of carbapenem-resistant Pseudomonas aeruginosa among burn patients.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; Burns; Carbapenems; Cross Infection; Disk Diffusion Antimicrobial Tests; Female; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Tunisia | 2014 |
Monoclonal outbreak of VIM-1-carbapenemase-producing Enterobacter cloacae in intensive care unit, University Hospital Centre Split, Croatia.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Critical Illness; Croatia; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gene Expression; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Survival Analysis | 2014 |
A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.
Topics: Acinetobacter baumannii; Aged; Aged, 80 and over; Anti-Bacterial Agents; C-Reactive Protein; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Humans; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Thienamycins | 2014 |
Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization.
Topics: Aged; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier State; Critical Illness; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Middle Aged; Risk Factors | 2014 |
Carbapenem-resistant Enterobacteriaceae: a call for cultural change.
Topics: Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infection Control; National Institutes of Health (U.S.); United States | 2014 |
The Balkan region: NDM-1-producing Klebsiella pneumoniae ST11 clonal strain causing outbreaks in Greece.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Base Sequence; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genotype; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Sequence Analysis, DNA | 2014 |
Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Burns; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Random Amplified Polymorphic DNA Technique | 2014 |
Potential synergy activity of the novel ceragenin, CSA-13, against carbapenem-resistant Acinetobacter baumannii strains isolated from bacteremia patients.
Topics: Acinetobacter baumannii; Carbapenems; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Steroids | 2014 |
[In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Synergism; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 2014 |
Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: a matched case-control study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Republic of Korea; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2014 |
Management and control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anal Canal; Anti-Bacterial Agents; Carbapenems; Carrier State; Cross Infection; Decontamination; Disease Outbreaks; Disinfectants; Disinfection; Drug Resistance, Microbial; Equipment and Supplies, Hospital; Equipment Contamination; France; Hospitals, General; Humans; Hydrogen Peroxide; Intensive Care Units; Male; Patient Isolation; Patients' Rooms; Personnel, Hospital; Pharynx; Sphygmomanometers; Universal Precautions | 2014 |
Emergence of carbapenem-resistant Klebsiella Pneumoniae strains producing KPC-3 in Brescia Hospital, Italy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Hospitals; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Young Adult | 2014 |
Characterization of carbapenem-resistant Acinetobacter baumannii in Brazil (2008-2011): countrywide spread of OXA-23-producing clones (CC15 and CC79).
Topics: Acinetobacter baumannii; Acinetobacter Infections; Alleles; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Geography, Medical; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Multiplex Polymerase Chain Reaction | 2014 |
A national intervention to prevent the spread of carbapenem-resistant Enterobacteriaceae in Israeli post-acute care hospitals.
Topics: Aged; Aged, 80 and over; Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Infection Control; Israel; Male; Middle Aged; Organizational Policy; Prospective Studies | 2014 |
Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infection Control; Intensive Care Units; Outcome Assessment, Health Care; United States; Virginia | 2014 |
Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011).
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Vietnam | 2014 |
A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Female; Genotype; Humans; Israel; Male; Middle Aged; Molecular Typing; Risk Factors; Sequence Analysis, DNA; Survival Analysis | 2014 |
Rapid containment of coincident outbreaks with 2 carbapenem-resistant Klebsiella pneumoniae strains in an intensive care unit.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Humans; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae | 2014 |
Mathematical model to quantify the effects of risk factors on carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Humans; Models, Statistical; Prevalence; Reproducibility of Results; Risk Factors | 2014 |
The determination of carbapenem resistance in Escherichia coli and Pneumoniae isolates related to nosocomial infections and the evaluation of risk factors.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Risk Factors | 2014 |
Molecular methods require for confirmation in bla AIM (Adelaide imipenemase) producing Pseudomonas aeruginosa.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Burns; Carbapenems; Cross Infection; Genes, Bacterial; Humans; Pseudomonas aeruginosa; Pseudomonas Infections | 2014 |
Reply to: Molecular methods require for confirmation blaAIM (Adelaide imipenemase) producing Pseudomonas aeruginosa.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Burns; Carbapenems; Cross Infection; Genes, Bacterial; Humans; Pseudomonas aeruginosa; Pseudomonas Infections | 2014 |
Molecular epidemiology of NDM-1-producing Enterobacteriaceae and Acinetobacter baumannii isolates from Pakistan.
Topics: Acinetobacter baumannii; Amdinocillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Doripenem; Enterobacteriaceae; Fosfomycin; Humans; Meropenem; Methyltransferases; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Pakistan; Thienamycins | 2014 |
Characteristics and costs of carbapenemase-producing enterobacteria carriers (2012/2013).
Topics: Aged; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; Disease Outbreaks; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Hospital Costs; Hospital Units; Hospitals, General; Humans; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Patient Isolation; Personnel, Hospital; Retrospective Studies | 2014 |
Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States.
Topics: Asymptomatic Infections; beta-Lactam Resistance; Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Community; Humans; Microbial Sensitivity Tests; Prevalence; Retrospective Studies; Southeastern United States | 2014 |
Much to do about carbapenem-resistant Enterobacteriaceae: why supplementing surveillance may be the key to stopping spread.
Topics: Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Community; Humans | 2014 |
Risk factors for carbapenem-resistant Acinetobacter baumanii blood stream infections in a neonatal intensive care unit, Delhi, India.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacteremia; beta-Lactam Resistance; Carbapenems; Cross Infection; Female; Humans; India; Infant, Newborn; Intensive Care, Neonatal; Male; Risk Factors; Survival Analysis | 2014 |
Common clinical substitutions enhance the carbapenemase activity of OXA-51-like class D β-lactamases from Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Catalytic Domain; Cross Infection; Humans; Protein Folding | 2014 |
High diversity of beta-lactamases in the General Hospital Vienna verified by whole genome sequencing and statistical analysis.
Topics: Anti-Bacterial Agents; Austria; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Frequency; Genetic Variation; Genome, Bacterial; Hospitals, General; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2014 |
Predictors of use of infection control precautions for multiresistant gram-negative bacilli in Australian hospitals: analysis of a national survey.
Topics: Anti-Bacterial Agents; Australia; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Hospitals; Humans; Infection Control | 2014 |
Successful control of carbapenem-resistant Acinetobacter baumannii in a Korean university hospital: a 6-year perspective.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hand Hygiene; Hospitals, University; Humans; Incidence; Infection Control; Intensive Care Units; Republic of Korea | 2014 |
Risk factors for colonization with carbapenemase-producing Klebsiella pneumoniae in hospital: a matched case-control study.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Prospective Studies; Risk Factors | 2014 |
Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; Carbapenems; Cohort Studies; Colistin; Colony Count, Microbial; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Incidence; Male; Middle Aged; Spain | 2014 |
An outbreak of extremely drug-resistant Pseudomonas aeruginosa in a tertiary care pediatric hospital in Italy.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals, Pediatric; Humans; Infant; Italy; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Tertiary Healthcare; Young Adult | 2014 |
Efforts mount to curb carbapenem-resistant infections.
Topics: Carbapenems; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Bacterial; Escherichia coli Infections; Humans; Infection Control; Klebsiella Infections; Practice Guidelines as Topic; United States | 2014 |
New Delhi metallo-β-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactamases; Carbapenems; Case-Control Studies; Cohort Studies; Cross Infection; Disease Outbreaks; Disinfection; Drug Resistance, Bacterial; Duodenoscopes; Enterobacteriaceae Infections; Equipment Contamination; Escherichia coli; Female; Hospitals; Humans; Illinois; Male; Middle Aged | 2014 |
Nosocomial infections by Klebsiella pneumoniae carbapenemase producing enterobacteria in a teaching hospital.
Topics: Adolescent; Adult; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction; Retrospective Studies; Young Adult | 2014 |
Genomic epidemiology of Klebsiella pneumoniae in Italy and novel insights into the origin and global evolution of its resistance to carbapenem antibiotics.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymorphism, Single Nucleotide; Sequence Analysis, DNA | 2015 |
Molecular analysis of carbapenem-resistant strains of Pseudomonas aeruginosa isolated from patients hospitalized in various transplantation wards between 2008 and 2011.
Topics: Adult; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Microbial Sensitivity Tests; Middle Aged; Organ Transplantation; Polymorphism, Restriction Fragment Length; Pseudomonas aeruginosa; Pseudomonas Infections | 2014 |
Description of the OXA-23 β-lactamase gene located within Tn2007 in a clinical isolate of Acinetobacter baumannii from Spain.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Spain | 2015 |
Prevalence of carbapenem-resistant organisms and other Gram-negative MDRO in German ICUs: first results from the national nosocomial infection surveillance system (KISS).
Topics: Bacterial Infections; beta-Lactam Resistance; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Germany; Gram-Negative Bacterial Infections; Humans; Incidence; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Population Surveillance; Prevalence; Staphylococcal Infections; Vancomycin-Resistant Enterococci | 2015 |
A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cohort Studies; Critical Illness; Cross Infection; Decision Support Techniques; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis; Risk Factors; Surgical Procedures, Operative; Systemic Inflammatory Response Syndrome; Urinary Tract Infections | 2014 |
Multidrug-resistant Pseudomonas aeruginosa infections pose growing threat to health care-associated infection control in the hospitals of Southern China: a case-control surveillance study.
Topics: Anti-Bacterial Agents; Carbapenems; Case-Control Studies; China; Communicable Diseases; Cross Infection; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Female; Hospitalization; Hospitals; Humans; Infection Control; Intubation, Intratracheal; Logistic Models; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors | 2014 |
Evaluation of carbapenem-resistant Enterobacteriaceae in an Italian setting: report from the trench.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Italy; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Prospective Studies; Random Amplified Polymorphic DNA Technique | 2015 |
Molecular mechanisms associated with nosocomial carbapenem-resistant Acinetobacter baumannii in Mexico.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biological Transport; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Hydrazones; Imipenem; Meropenem; Mexico; Microbial Sensitivity Tests; Thienamycins | 2014 |
Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Analysis of Variance; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Risk Factors | 2015 |
Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Containment of Biohazards; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Imipenem; Incidence; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phenotype; Prevalence; Prospective Studies; Republic of Korea; Retrospective Studies; Thienamycins | 2014 |
Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; Body Fluids; Carbapenems; Carrier State; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Laboratories, Hospital; Microbial Sensitivity Tests; Phenotype; Proteomics | 2014 |
Complete Sequence of Four Multidrug-Resistant MOBQ1 Plasmids Harboring blaGES-5 Isolated from Escherichia coli and Serratia marcescens Persisting in a Hospital in Canada.
Topics: Aged; Aged, 80 and over; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Canada; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Endodeoxyribonucleases; Escherichia coli; Escherichia coli Infections; Female; Gene Expression Regulation, Bacterial; Genome, Bacterial; Hospitals; Humans; Interspersed Repetitive Sequences; Male; Middle Aged; Molecular Sequence Data; Phylogeny; Plasmids; Replicon; Sequence Alignment; Sequence Analysis, DNA; Serratia Infections; Serratia marcescens | 2015 |
Detection of the frequency of PER-1 type extended-spectrum β-lactamase-producing Acinetobacter baumannii clinical isolates in Turkey: a multicenter study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Prevalence; Real-Time Polymerase Chain Reaction; Seroepidemiologic Studies; Turkey | 2014 |
Mechanisms of Carbapenem Resistance in Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa from a Croatian Hospital.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; Carbapenems; Croatia; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Hospitals; Humans; Membrane Proteins; Membrane Transport Proteins; Phylogeny; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2015 |
Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a serious threat in ICUs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Automation; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Software; Young Adult | 2015 |
Nursing Home as a Reservoir of Carbapenem-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Clone Cells; Croatia; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gene Expression Regulation, Bacterial; Homes for the Aged; Humans; Male; Microbial Sensitivity Tests; Nursing Homes; Phylogeny; Plasmids; Sequence Analysis, DNA | 2015 |
Transmission of carbapenem-resistant Enterobacteriaceae during ERCP: time to revisit the current reprocessing guidelines.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cholangiopancreatography, Endoscopic Retrograde; Cross Infection; Disinfection; Duodenoscopes; Equipment Contamination; Escherichia coli; Escherichia coli Infections; Female; Guidelines as Topic; Humans; Male; Middle Aged; Young Adult | 2015 |
A novel New Delhi metallo-β-lactamase variant, NDM-14, isolated in a Chinese Hospital possesses increased enzymatic activity against carbapenems.
Topics: Acinetobacter; Acinetobacter Infections; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Humans; Imipenem; Intensive Care Units; Kinetics; Meropenem; Molecular Sequence Data; Plasmids; Thienamycins | 2015 |
Impact of carbapenem heteroresistance among clinical isolates of invasive Escherichia coli in Chongqing, southwestern China.
Topics: Aged; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; China; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Genetic Variation; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Prevalence; Risk Factors | 2015 |
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Incidence; Italy; Population Surveillance; Seasons | 2015 |
No carbapenem resistance in pneumonia caused by Klebsiella species.
Topics: Aged; Carbapenems; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Male; Pneumonia, Bacterial; Retrospective Studies | 2015 |
Spread of KPC-producing carbapenem-resistant Enterobacteriaceae: the importance of super-spreaders and rectal KPC concentration.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; Disease Transmission, Infectious; Environmental Microbiology; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Rectum | 2015 |
Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; China; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multilocus Sequence Typing; Odds Ratio; Retrospective Studies; Risk Factors; Tracheostomy | 2015 |
Molecular epidemiology of carbapenem non-susceptible Acinetobacter nosocomialis in a medical center in Taiwan.
Topics: Acinetobacter; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Conjugation, Genetic; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Taiwan | 2015 |
High endemic rates of OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates caused by the persistence of major clones in hospitals in a Brazilian city 5 years after an outbreak.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Disease Outbreaks; DNA, Bacterial; Endemic Diseases; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Tertiary Care Centers; Time Factors | 2015 |
Low prevalence of metallo-beta-lactamase in Pseudomonas aeruginosa isolated from a tertiary burn care center in Tehran.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; Cross Infection; Humans; Iran; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Tertiary Care Centers | 2015 |
Reduction in the prevalence of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in New York City.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Hospitals; Humans; Infection Control; New York City; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections | 2015 |
Detection and termination of an extended low-frequency hospital outbreak of GIM-1-producing Pseudomonas aeruginosa ST111 in Germany.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Environmental Monitoring; Equipment Contamination; Female; Genotype; Germany; Humans; Male; Middle Aged; Prospective Studies; Pseudomonas Infections; Retrospective Studies; Tertiary Care Centers | 2015 |
Coproduction of KPC-2 and IMP-10 in Carbapenem-Resistant Serratia marcescens Isolates from an Outbreak in a Brazilian Teaching Hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Child, Preschool; Cross Infection; Disease Outbreaks; DNA, Bacterial; Female; Genes, Bacterial; Hospitals, Teaching; Humans; Infant; Integrons; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Serratia Infections; Serratia marcescens; Tigecycline | 2015 |
Dissemination of VIM-2 producing Pseudomonas aeruginosa ST233 at tertiary care hospitals in Egypt.
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Egypt; Genotype; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA; Tertiary Care Centers | 2015 |
[Clinical characteristics and molecular epidemiology of carbapenem- resistant Acinetobacter baumannii infections at Shenzhen People's Hospital during an 8-year period].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Genotype; Hospitals; Humans; Intensive Care Units; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction | 2015 |
A novel case of Raoultella planticola urinary tract infection in a female: comment on 'Nosocomial pneumonia caused by carbapenem-resistant Raoultella planticola: a case report and literature review'.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male | 2015 |
Long-term effectiveness of infection and antibiotic control programs on the transmission of carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex in central Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Cross Infection; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Taiwan; Time Factors; Treatment Outcome; Young Adult | 2015 |
Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Community-Acquired Infections; Cross Infection; Female; Hospital Mortality; Humans; Male; Middle Aged; Needs Assessment; Organizational Policy; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Prognosis; Pseudomonas Infections | 2015 |
Carbapenem-resistant Enterobacteriaceae carriers in acute care hospitals and postacute-care facilities: The effect of organizational culture on staff attitudes, knowledge, practices, and infection acquisition rates.
Topics: Anti-Bacterial Agents; Attitude of Health Personnel; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Guideline Adherence; Health Facilities; Health Knowledge, Attitudes, Practice; Health Personnel; Hospitals; Humans; Infection Control; Israel; Organizational Culture | 2015 |
Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Containment of Biohazards; Cross Infection; Drug Resistance, Multiple, Bacterial; Gentamicins; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Tertiary Care Centers; Tigecycline | 2015 |
[Investigation of oxacillinase genes in nosocomial multidrug-resistant Acinetobacter baumannii isolates by multiplex PCR and evaluation of their clonal relationship with Rep-PCR].
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Multiplex Polymerase Chain Reaction; Polymerase Chain Reaction | 2015 |
Managing a nosocomial outbreak of carbapenem-resistant Klebsiella pneumoniae: an early Australian hospital experience.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Australia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Female; Hospital Mortality; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Young Adult | 2015 |
Determining the resistance of carbapenem-resistant Klebsiella pneumoniae to common disinfectants and elucidating the underlying resistance mechanisms.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Disinfectants; Drug Resistance, Bacterial; Hospitals; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Treatment Outcome | 2015 |
Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cephalosporins; Ciprofloxacin; Cross Infection; Female; Hospitals; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Mortality; Multivariate Analysis; Odds Ratio; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Severity of Illness Index; Taiwan; Thienamycins | 2017 |
Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case-control study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cohort Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Israel; Male; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; Socioeconomic Factors; Young Adult | 2015 |
Carbapenem-Resistant Enterobacteriaceae: A Case Series of Infections at Hartford Hospital.
Topics: Aged; Aged, 80 and over; Carbapenems; Connecticut; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors | 2015 |
Effect of daily chlorhexidine bathing on acquisition of carbapenem-resistant Acinetobacter baumannii (CRAB) in the medical intensive care unit with CRAB endemicity.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Baths; beta-Lactam Resistance; Carbapenems; Chlorhexidine; Cross Infection; Disinfectants; Disinfection; Female; Humans; Intensive Care Units; Interrupted Time Series Analysis; Male; Microbial Sensitivity Tests; Middle Aged; Non-Randomized Controlled Trials as Topic; Prevalence; Retrospective Studies; Young Adult | 2015 |
Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Genomic Instability; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Plasmids; Retrospective Studies; Tertiary Care Centers | 2015 |
Genetic basis of antimicrobial resistance and clonal dynamics of carbapenem-resistant Acinetobacter baumannii sequence type 191 in a Korean hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acyltransferases; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Typing; Mutation; Phenotype; Republic of Korea | 2015 |
Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Sulbactam; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2016 |
Do Results of Surveillance Cultures Impact the Choice of Empirical Antibiotics Among Patients with Carbapenem-Resistant Acinetobacter baumannii Infections?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Florida; Hospitals, Teaching; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Young Adult | 2015 |
Acinetobacter baumannii in Southern Croatia: clonal lineages, biofilm formation, and resistance patterns.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Biofilms; Carbapenems; Croatia; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Intensive Care Units; Microbial Sensitivity Tests; Monte Carlo Method; Respiratory System; Respiratory Tract Infections; Sulbactam; Urine; Wounds and Injuries | 2015 |
Electronic Public Health Registry of Extensively Drug-Resistant Organisms, Illinois, USA.
Topics: Carbapenems; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Health Information Exchange; Humans; Illinois; Population Surveillance; Public Health; Registries; United States | 2015 |
Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitals, University; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Thailand; Young Adult | 2015 |
Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Carrier State; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Hospitalization; Humans; Incidence; Infection Control; Intensive Care Units; Male; Middle Aged; Prevalence; Risk Factors; Tertiary Healthcare | 2015 |
MALDI-TOF mass spectrometry and blakpc gene phylogenetic analysis of an outbreak of carbapenem-resistant K. pneumoniae strains.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Genotype; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Phylogeny; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tandem Mass Spectrometry | 2015 |
Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012.
Topics: Adolescent; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infant; Intensive Care Units; Prevalence; United States | 2015 |
Klebsiella oxytoca-producing IMP-1 Detected as the First Strain of Carbapenem-resistant Enterobacteriaceae in Our Hospital.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Hospitals; Humans; Inosine Monophosphate; Klebsiella Infections; Klebsiella oxytoca; Microbial Sensitivity Tests; Middle Aged | 2015 |
Outbreak of KPC-3 Producing Carbapenem-Resistant Klebsiella pneumoniae in a US Pediatric Hospital.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Multilocus Sequence Typing; Polymerase Chain Reaction; United States | 2015 |
Lessons learned from initial reporting of carbapenem-resistant Enterobacteriaceae in New York State hospitals, 2013-2014.
Topics: beta-Lactam Resistance; Carbapenems; Cross Infection; Data Collection; Disease Notification; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Health Personnel; Hospitals, State; Humans; Incidence; Medical Audit; National Health Programs; New York; Public Health Surveillance | 2016 |
Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Hospitalization; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Nursing Homes; Rhode Island; Risk Factors; Young Adult | 2016 |
Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Lithuania; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2016 |
Risk Factors and Outcomes for Intestinal Carriage of AmpC-Hyperproducing Enterobacteriaceae in Intensive Care Unit Patients.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Intestines; Length of Stay; Male; Middle Aged; Retrospective Studies; Risk Factors | 2015 |
Identifying Patients at High Risk for Carbapenem-Resistant Enterobacteriaceae at Admission: Nurse-Led or Doctor-Led?
Topics: Carbapenems; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Humans; Infection Control; Nurses; Physicians; Sentinel Surveillance; Singapore | 2016 |
[Analysis of pathogen spectrum and resistance of clinical common organisms causing bloodstream infections, hospital-acquired pneumonia and intra-abdominal infections from thirteen teaching hospitals in 2013].
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefepime; Cephalosporins; China; Cross Infection; Hospitals, Teaching; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Minocycline; Pneumonia; Tigecycline; Vancomycin | 2015 |
Loop-mediated isothermal amplification: Rapid and sensitive detection of the antibiotic resistance gene ISAba1-blaOXA-51-like in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Sequence Analysis, DNA | 2016 |
Predicting Antimicrobial Resistance Prevalence and Incidence from Indicators of Antimicrobial Use: What Is the Most Accurate Indicator for Surveillance in Intensive Care Units?
Topics: Anti-Bacterial Agents; Carbapenems; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Humans; Intensive Care Units, Neonatal; Pseudomonas; Pseudomonas Infections; Retrospective Studies | 2015 |
Characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex isolates from nosocomial bloodstream infections in southern Iran.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Genetic Variation; Genotype; Humans; Iran | 2016 |
Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?
Topics: Aged; beta-Lactamases; Carbapenems; Cause of Death; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Outcome Assessment, Health Care; Population Surveillance; Proportional Hazards Models | 2016 |
Development and Distribution of Educational Materials for Carbapenem-Resistant Enterobacteriaceae Among Acute and Long-term Care Facilities.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Health Facilities; Health Personnel; Humans; Infection Control; Long-Term Care; Needs Assessment; Population Surveillance; Surveys and Questionnaires; Wisconsin | 2015 |
Molecular characteristics of extended spectrum β-lactamase and carbapenemase genes carried by carbapenem-resistant Enterobacter cloacae in a Chinese university hospital.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; Catheter-Related Infections; China; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Parenteral Nutrition; Respiration, Artificial; Retrospective Studies; Urinary Catheterization; Young Adult | 2015 |
Ertapenem resistance in 2 tertiary-care hospitals: Microbiology, epidemiology, and risk factors.
Topics: Aged; Antimicrobial Stewardship; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cefepime; Colombia; Cross Infection; Diagnosis-Related Groups; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2017 |
ISAba1/blaOXA-23: A serious obstacle to controlling the spread and treatment of Acinetobacter baumannii strains.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Genetic Variation; Genotype; Hospitals; Humans; Microbial Sensitivity Tests | 2016 |
Carbapenem-Resistant Klebsiella pneumoniae: Results of a Laboratory Surveillance Program in an Italian General Hospital (August 2014-January 2015) : Surveillance of Carbapenem-resistant Klebsiella pneumoniae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Infant; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Phylogeny; Young Adult | 2016 |
[Study on genotype and clinical characteristics of infection of carbapenemase-producing Enterobacter cloacae].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Enterobacter cloacae; Genotype; Humans; Microbial Sensitivity Tests | 2015 |
Impact of ethylene oxide gas sterilization of duodenoscopes after a carbapenem-resistant Enterobacteriaceae outbreak.
Topics: Carbapenems; Cholangiopancreatography, Endoscopic Retrograde; Cross Infection; Disease Outbreaks; Disinfection; Drug Resistance, Bacterial; Duodenoscopes; Enterobacteriaceae; Enterobacteriaceae Infections; Equipment Contamination; Ethylene Oxide; Gases; Humans; Infection Control; Sterilization | 2016 |
The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit.
Topics: California; Carbapenems; Centers for Disease Control and Prevention, U.S.; Computer Simulation; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Forecasting; Health Facilities; Hospitalization; Humans; Infection Control; Models, Theoretical; Population Surveillance; Prevalence; United States | 2016 |
Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Chi-Square Distribution; Cross Infection; Disinfection; Drug Resistance, Multiple, Bacterial; Endemic Diseases; Hand Disinfection; Humans; Incidence; Infection Control; Microbial Sensitivity Tests; Odds Ratio; Patient Isolation; Program Evaluation; Republic of Korea; Risk Factors; Tertiary Care Centers; Time Factors; Treatment Outcome | 2016 |
Compliance with carbapenem guidelines in a university hospital.
Topics: Bacterial Infections; Carbapenems; Community-Acquired Infections; Cross Infection; Female; Guideline Adherence; Hospitals, University; Humans; Male; Middle Aged; Prospective Studies | 2016 |
Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Kidney Transplantation; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Surgical Wound Infection; Thienamycins | 2016 |
Determining the Independent Risk Factors and Mortality Rate of Nosocomial Infections in Pediatric Patients.
Topics: Candida; Carbapenems; Child; Child, Preschool; Cross Infection; Female; Humans; Infant; Intensive Care Units, Pediatric; Male; Mortality; Pediatrics; Respiration, Artificial; Risk Factors | 2016 |
Clinical Significance of Community- and Healthcare-Acquired Carbapenem-Resistant Enterobacteriaceae Isolates.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Female; Humans; Male; Microbial Sensitivity Tests | 2016 |
A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cross Infection; Female; Hospitals, Teaching; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Risk Factors; Tertiary Care Centers | 2016 |
Carbapenem-Resistant Acinetobacter baumannii: Concomitant Contamination of Air and Environmental Surfaces.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Air Microbiology; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Environmental Exposure; Humans; Intensive Care Units; Patients' Rooms; Rectum; Respiratory System | 2016 |
Antibiotic Resistance Profiles and Genetic Similarities Within a New Generation of Carbapenem-Resistant Acinetobacter calcoaceticus-A. baumannii Complex Resistotypes in Bosnia and Herzegovina.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; Bosnia and Herzegovina; Carbapenems; Clone Cells; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Phylogeny; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
[The Prevalence of Metallo-β-Lactamases and Efflux-Mediated Mechanisms in Carbapenem Nonsusceptible Nosocomial Pseudomonas aeruginosa Isolated in Moscow in 2012-2015].
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Communicable Disease Control; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Moscow; Pseudomonas aeruginosa; Pseudomonas Infections | 2015 |
Infections due to Carbapenem Resistant Enterobacteriaceae among Saudi Arabian Hospitalized Patients: A Matched Case-Control Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Risk Factors; Saudi Arabia; Survival Rate; Treatment Outcome; Young Adult | 2016 |
A rare cause of infection, Raoultella planticola: emerging threat and new reservoir for carbapenem resistance.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Middle Aged; Retrospective Studies; Risk Factors; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Young Adult | 2016 |
Appropriateness of empirical therapy in carbapenem-resistant Klebsiella pneumoniae intensive care unit acquired infection: role of surveillance cultures.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cross Infection; Female; Humans; Inappropriate Prescribing; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Public Health Surveillance | 2016 |
Comparative in vitro activity of carbapenems against clinical isolates of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Doripenem; Humans; Imipenem; Iran; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2016 |
Clinical epidemiology and resistance mechanisms of carbapenem-resistant Acinetobacter baumannii, French Guiana, 2008-2014.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Disk Diffusion Antimicrobial Tests; Electrophoresis, Gel, Pulsed-Field; Female; French Guiana; Hospitals; Humans; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Retrospective Studies; Young Adult | 2016 |
Spread of carbapenem-resistant international clones of Acinetobacter baumannii in Turkey and Azerbaijan: a collaborative study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Azerbaijan; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Genetic Variation; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Multiplex Polymerase Chain Reaction; Turkey | 2016 |
Whole-Genome Comparative Analysis of Two Carbapenem-Resistant ST-258 Klebsiella pneumoniae Strains Isolated during a North-Eastern Ohio Outbreak: Differences within the High Heterogeneity Zones.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Genetic Heterogeneity; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2016 |
Environmental sampling protocol devised and implemented to resolve a nosocomial outbreak due to carbapenem-resistant Klebsiella oxytoca.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Environmental Microbiology; Humans; Klebsiella Infections; Klebsiella oxytoca; Specimen Handling | 2016 |
Rise and fall of KPC-producing Klebsiella pneumoniae in New York City.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catheters; Cross Infection; Disease Outbreaks; DNA, Bacterial; Hospitals; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; New York City; Surveys and Questionnaires | 2016 |
Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak Clone.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Clone Cells; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Gene Expression; Gene Transfer, Horizontal; Greece; Humans; Male; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Plasmids; Providencia; Quinolones; Replicon; Survival Analysis | 2016 |
High prevalence of hospital-acquired infections caused by gram-negative carbapenem resistant strains in Vietnamese pediatric ICUs: A multi-centre point prevalence survey.
Topics: Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Hospitals, Pediatric; Humans; Infant; Intensive Care Units, Pediatric; Male; Prevalence; Vietnam | 2016 |
Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; China; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Treatment Outcome | 2016 |
Carbapenem-Resistant Enterobacteriaceae Transmission in Health Care Facilities - Wisconsin, February-May 2015.
Topics: Aged; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Health Facilities; Humans; Male; Middle Aged; Wisconsin | 2016 |
Molecular epidemiology of carbapenem resistant gram-negative bacilli from infected pediatric population in tertiary - care hospitals in Medellín, Colombia: an increasing problem.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Hospitalized; Child, Preschool; Colombia; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Humans; Infant; Male; Molecular Epidemiology; Multilocus Sequence Typing; Tertiary Care Centers | 2016 |
Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Canada; Carbapenems; Child; Child, Preschool; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gene Expression; Hospitals; Humans; Infant; Infant, Newborn; Male; Middle Aged; Multilocus Sequence Typing; Plasmids; Polymorphism, Restriction Fragment Length; Prevalence; Public Health Surveillance; Survival Analysis; Travel | 2016 |
Invasive carbapenem-resistant Enterobacteriaceae infection at a paediatric hospital: A case series.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child, Preschool; Cross Infection; Enterobacteriaceae Infections; Escherichia coli; Female; Hospitals, Pediatric; Humans; Infant; Infection Control; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Retrospective Studies; Severity of Illness Index; South Africa; Survival Analysis | 2016 |
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam | 2016 |
Differences in Biofilm Mass, Expression of Biofilm-Associated Genes, and Resistance to Desiccation between Epidemic and Sporadic Clones of Carbapenem-Resistant Acinetobacter baumannii Sequence Type 191.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Biofilms; Carbapenems; Cross Infection; Desiccation; Epidemics; Genes, Bacterial; Humans; Republic of Korea | 2016 |
blaOXA-48 carrying clonal colistin resistant-carbapenem resistant Klebsiella pneumoniae in neonate intensive care unit, India.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cluster Analysis; Colistin; Cross Infection; Drug Resistance, Bacterial; Genotype; Humans; India; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Molecular Typing | 2016 |
ST147 NDM-1-producing Klebsiella pneumoniae spread in two Tunisian hospitals.
Topics: Adult; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Tunisia; Urinary Tract Infections; Young Adult | 2017 |
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antimicrobial Stewardship; Carbapenems; Cross Infection; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Italy; Referral and Consultation; Rehabilitation Centers; Spinal Injuries | 2017 |
Combination of Tigecycline and Levofloxacin for Successful Treatment of Nosocomial Pneumonia Caused by New Delhi Metallo-β-Lactamase-1-Producing Raoultella planticola.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Gene Expression; Humans; Levofloxacin; Male; Minocycline; Plasmids; Polymerase Chain Reaction; Sputum; Tigecycline; Treatment Outcome | 2017 |
A cluster of KPC-2 and VIM-2-producing Klebsiella pneumoniae ST833 isolates from the pediatric service of a Venezuelan Hospital.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Hospitals; Humans; Infant; Infant, Newborn; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Pediatrics; Venezuela | 2016 |
Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Utilization; Fluoroquinolones; Hand Hygiene; Hospitals; Humans; Infection Control; Middle Aged; Prevalence; Scotland | 2017 |
Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Ciprofloxacin; Clone Cells; Cross Infection; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Gene Expression; Hospitals, Teaching; Humans; Isoenzymes; Malaysia; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Plasmids; Sequence Analysis, DNA | 2017 |
Clinical Experience of Patients Receiving Doripenem-Containing Regimens for the Treatment of Healthcare-Associated Infections.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Carbapenems; Cross Infection; Doripenem; Female; Hospital Mortality; Humans; Intraabdominal Infections; Male; Middle Aged; Respiratory Tract Infections; Retrospective Studies; Soft Tissue Infections; Tertiary Care Centers; Treatment Outcome; Urinary Tract Infections | 2016 |
Use of organs from donors with bloodstream infection, pneumonia, and influenza: Results of a survey of infectious diseases practitioners.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Candidemia; Carbapenems; Clinical Decision-Making; Cross Infection; Donor Selection; Drug Resistance, Bacterial; Humans; Influenza, Human; Pneumonia; Practice Guidelines as Topic; Surveys and Questionnaires; Tissue Donors; Transplants | 2017 |
Frequency of antiseptic resistance genes and reduced susceptibility to biocides in carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Benzalkonium Compounds; beta-Lactamases; Carbapenems; Chlorhexidine; Cross Infection; Disinfectants; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; RNA, Ribosomal, 16S; Sequence Analysis, RNA | 2017 |
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Biofilms; Carbapenems; Cross Infection; Disk Diffusion Antimicrobial Tests; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Hemolysis; Humans; Lebanon; Microbial Sensitivity Tests; Peptide Hydrolases; Phenotype; Polymerase Chain Reaction; Siderophores; Virulence; Virulence Factors | 2016 |
Evaluation of a modified cleaning procedure in the prevention of carbapenem-resistant Acinetobacter baumannii clonal spread in a burn intensive care unit using a high-sensitivity luminometer.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Burn Units; Carbapenems; Cross Infection; Disease Transmission, Infectious; Disinfectants; Disinfection; Environmental Microbiology; Guideline Adherence; Hospitals, Teaching; Housekeeping, Hospital; Humans; Intensive Care Units; Italy; Luminescent Measurements; Quality Control | 2017 |
Notes from the Field: New Delhi Metallo-β-Lactamase-Producing Carbapenem-Resistant Enterobacteriaceae Identified in Patients Without Known Health Care Risk Factors - Colorado, 2014-2016.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactamases; Carbapenems; Colorado; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Middle Aged; Risk Factors; Travel; Young Adult | 2016 |
Application of Bacteriophage-containing Aerosol against Nosocomial Transmission of Carbapenem-Resistant Acinetobacter baumannii in an Intensive Care Unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aerosols; Bacteriophages; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Incidence; Infection Control; Intensive Care Units; Prospective Studies | 2016 |
Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Network of Long-Term Acute Care Hospitals.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Comorbidity; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; United States; Young Adult | 2017 |
Prevalence of multidrug-resistant organisms in refugee patients, medical tourists and domestic patients admitted to a German university hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Germany; Hospitals, University; Humans; Hygiene; Infection Control; Intensive Care Units; Male; Medical Tourism; Middle Aged; Patient Admission; Prevalence; Refugees; Retrospective Studies; Young Adult | 2017 |
Molecular epidemiology of bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Follow-Up Studies; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing | 2017 |
Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Egypt; Humans; Imipenem; Inosine Monophosphate; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2017 |
Bloodstream infections in children caused by carbapenem-resistant versus carbapenem-susceptible gram-negative microorganisms: Risk factors and outcome.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Child, Preschool; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2017 |
Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Carbapenems; Child; Child, Preschool; Cross Infection; Female; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Immunocompromised Host; Infant; Infant, Newborn; Japan; Male; Middle Aged; Retrospective Studies; Stenotrophomonas maltophilia; Young Adult | 2017 |
Risk factors and medical costs for healthcare-associated carbapenem-resistant Escherichia coli infection among hospitalized patients in a Chinese teaching hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Case-Control Studies; Catheterization, Central Venous; Child; Child, Preschool; China; Cross Infection; Drug Costs; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Health Care Costs; Hemoglobins; Hospitals, Teaching; Humans; Hyperglycemia; Incidence; Infant; Infant, Newborn; Length of Stay; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Tertiary Care Centers; Tracheostomy; Urologic Diseases; Young Adult | 2017 |
Multi-institute analysis of carbapenem resistance reveals remarkable diversity, unexplained mechanisms, and limited clonal outbreaks.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Boston; Carbapenems; Clone Cells; Cross Infection; Disease Outbreaks; DNA Transposable Elements; Enterobacteriaceae; Enterobacteriaceae Infections; Genetic Variation; Genome, Bacterial; Humans; Prospective Studies; R Factors; Sequence Alignment; Transformation, Bacterial | 2017 |
Prospective study analyzing risk factors and characteristics of healthcare-associated infections in a Urology ward.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catheters, Indwelling; Cross Infection; Cystectomy; Drug Resistance, Microbial; Enterococcus; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Hospital Units; Humans; Immunosuppression Therapy; Incidence; Klebsiella; Klebsiella Infections; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Surgical Wound Infection; Urinary Catheters; Urinary Tract Infections; Urology; Vancomycin | 2017 |
Outbreak of carbapenem-resistant Providencia rettgeri in a tertiary hospital.
Topics: Adult; Carbapenems; Coinfection; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Pressure Ulcer; Providencia; South Africa; Tertiary Care Centers; Urinary Tract Infections; Wound Infection | 2016 |
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections | 2017 |
Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae elucidated by single-nucleotide variation analysis: a case investigation.
Topics: Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Cross Infection; Genotyping Techniques; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Molecular Epidemiology; Molecular Typing | 2017 |
Factors associated with carriage of carbapenem-non-susceptible Enterobacteriaceaein North-Eastern France and outcomes of infected patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; Case-Control Studies; Cross Infection; Enterobacter cloacae; Enterobacteriaceae Infections; Female; France; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors | 2017 |
Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
Topics: Anti-Infective Agents; beta-Lactamases; Carbapenems; Cross Infection; Cross-Sectional Studies; Escherichia coli; Escherichia coli Infections; Female; Hospitals, Teaching; Humans; Incidence; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Sri Lanka; Urinary Tract Infections | 2017 |
Molecular epidemiology and antimicrobial resistance phenotypes of Acinetobacter baumannii isolated from patients in three hospitals in southern Vietnam.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Imipenem; Longitudinal Studies; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Phenotype; Prevalence; Tandem Repeat Sequences; Vietnam; Young Adult | 2017 |
Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: Can it predict and reduce subsequent infections and the use of colistin?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Patient Isolation; Population Surveillance; Predictive Value of Tests; Prospective Studies | 2017 |
Epidemiological surveillance of multidrug-resistant gram-negative bacteria in a solid organ transplantation department.
Topics: Acinetobacter baumannii; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Guideline Adherence; Humans; Incidence; Infection Control; Klebsiella pneumoniae; Non-Randomized Controlled Trials as Topic; Organ Transplantation; Practice Guidelines as Topic; Prospective Studies; Pseudomonas aeruginosa; Retrospective Studies | 2017 |
Broad-spectrum antibiotics in Norwegian hospitals.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization Review; Guideline Adherence; Hospitals; Humans; Norway; Piperacillin; Quinolones; Respiratory Tract Infections | 2017 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Characterization of Acinetobacter baumannii carrying bla(OXA-23), bla(PER-1) and armA in a Korean hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Typing Techniques; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Korea; Microbial Sensitivity Tests; Minocycline; Polymerase Chain Reaction; Sequence Analysis, DNA | 2008 |
Clonal spread of carbapenem-resistant OXA-23-positive Acinetobacter baumannii in a Bulgarian university hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Bulgaria; Carbapenems; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genes, Bacterial; Genotype; Hospitals, University; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction | 2008 |
Incidence of metallo beta lactamase producing Pseudomonas aeruginosa in ICU patients.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Incidence; India; Intensive Care Units; Pseudomonas aeruginosa; Pseudomonas Infections | 2008 |
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Blood; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Taiwan | 2008 |
Observations on carbapenem resistance by minimum inhibitory concentration in nosocomial isolates of Acinetobacter species: an experience at a tertiary care hospital in North India.
Topics: Acinetobacter; Acinetobacter Infections; Carbapenems; Colony Count, Microbial; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; India; Microbial Sensitivity Tests; Treatment Outcome | 2008 |
Differential susceptibility to carbapenems due to the AdeABC efflux pump among nosocomial outbreak isolates of Acinetobacter baumannii in a Chinese hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Child; China; Cross Infection; Disease Outbreaks; Genes, Bacterial; Humans; Intensive Care Units; Isoelectric Focusing; Membrane Transport Proteins; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2008 |
Investigation and management of an outbreak of multidrug-carbapenem-resistant Acinetobacter baumannii in Cambridge, UK.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Hospitals, Teaching; Humans; Infection Control; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; United Kingdom | 2008 |
Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Cross Infection; Culture Media; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; New York City; Population Surveillance | 2008 |
[Transmission and molecular characteristics of carbapenem-resistant Acinetobacter baumannii].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Genotype; Humans | 2008 |
Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Odds Ratio; Risk Factors | 2008 |
Molecular characterization of carbapenem-resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Female; Hospitals, University; Humans; Ireland; Male; Middle Aged; Molecular Epidemiology; Prevalence | 2009 |
Carbapenem resistance mechanism and risk factors of Pseudomonas aeruginosa clinical isolates from a University Hospital in Xi'an, China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; China; Cross Infection; DNA Primers; Drug Resistance, Bacterial; Genes, Bacterial; Hospitals, University; Humans; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors | 2009 |
Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Female; Genotype; Hospitals; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; New York City; Polymyxin B; Ribotyping; Sequence Analysis, DNA | 2009 |
Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Fatal Outcome; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged | 2009 |
Superior in vitro activity of carbapenems over anti-methicillin-resistant Staphylococcus aureus (MRSA) and some related antimicrobial agents for community-acquired MRSA but not for hospital-acquired MRSA.
Topics: Anti-Infective Agents; Carbapenems; Community-Acquired Infections; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections | 2009 |
Investigation of carbapenem-resistant Acinetobacter baumannii isolates in a district hospital in Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; DNA Fingerprinting; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genotype; Hospitals, District; Humans; Plasmids; Taiwan | 2009 |
Colonization of a medical center in Southern Taiwan by epidemic strains of carbapenem- and multidrug-resistant Acinetobacter baumannii and the genetic organization of their integrons.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Genotype; Humans; Integrons; Molecular Epidemiology; Random Amplified Polymorphic DNA Technique; Taiwan | 2009 |
KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone.
Topics: Amidohydrolases; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Greece; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance | 2009 |
Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Environmental Microbiology; Humans; Incidence; Intensive Care Units; Microbial Sensitivity Tests; Middle Aged; Minocycline; Molecular Epidemiology; Tigecycline; Young Adult | 2009 |
Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Risk Factors | 2009 |
Carbapenem-resistant Enterobacter cloacae and the emergence of metallo-beta-lactamase-producing strains in a third-level hospital (Santiago de Compostela, NW Spain).
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Gene Amplification; Genotype; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Spain | 2009 |
Endemic carbapenem-resistant Acinetobacter baumannii in a Brazilian intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; beta-Lactam Resistance; Brazil; Carbapenems; Cross Infection; Endemic Diseases; Environmental Microbiology; Humans; Intensive Care Units | 2009 |
Multiplex PCR for rapid detection of genes encoding oxacillinases and metallo-beta-lactamases in carbapenem-resistant Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Time Factors | 2009 |
Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre.
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Germany; Humans; Infection Control; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Young Adult | 2009 |
Efficacy of intravenous infusion of doripenem.
Topics: Carbapenems; Cross Infection; Doripenem; Humans; Imipenem; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated | 2009 |
Safety of intravenous infusion of doripenem.
Topics: Anti-Bacterial Agents; Area Under Curve; Carbapenems; Cross Infection; Doripenem; Drug Stability; Drug-Related Side Effects and Adverse Reactions; Humans; Hypersensitivity; Infusions, Intravenous; Injections, Intravenous; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Quality Control | 2009 |
Clinical and economic consequences of ventilator-associated pneumonia.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Health Care Costs; Hospital Mortality; Humans; Imipenem; Intensive Care Units; Length of Stay; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Severity of Illness Index | 2009 |
Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter?
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Critical Illness; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies | 2009 |
Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Korea; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA | 2009 |
Swab cultures across three different body sites among carriers of carbapenem-resistant P. aeruginosa and Acinetobacter species: a poor surveillance strategy.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Cross Infection; Humans; Mass Screening; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
[Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].
Topics: Acinetobacter; Acinetobacter Infections; Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Microbial Sensitivity Tests; Turkey | 2009 |
Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Integrons; Microbial Sensitivity Tests; Phenotype; Population Surveillance; Porins; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Doxycycline; Drug Utilization; Health Services Research; Hospitals; Humans; Infection Control; Organizational Policy; Prevalence; Quinolones | 2010 |
Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefotaxime; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Humans; Imipenem; Iran; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins | 2009 |
Economic evaluation of doripenem for the treatment of nosocomial pneumonia in the US: discrete event simulation.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Humans; Pneumonia; United States | 2010 |
The changing face of antibiotic therapy.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Delayed-Action Preparations; Doripenem; Drug Resistance, Bacterial; Humans; Infection Control; Treatment Outcome | 2009 |
Genesis of a KPC-producing Klebsiella pneumoniae after in vivo transfer from an imported Greek strain.
Topics: Aged; beta-Lactamases; Carbapenems; Catheterization; Cross Infection; Drug Resistance, Bacterial; France; Greece; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Transformation, Bacterial | 2010 |
In vitro activities of doripenem and other carbapenems against clinically important bacteria isolated in intensive care units: nationwide data from the SMART Programme.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals, Teaching; Humans; Intensive Care Units; Microbial Sensitivity Tests; Prevalence; Taiwan | 2010 |
Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cluster Analysis; Critical Care; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Environmental Microbiology; Germany; Hospitals, University; Humans; Intensive Care Units; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors | 2010 |
Control of an outbreak of carbapenem-resistant Acinetobacter baumannii in Australia after introduction of environmental cleaning with a commercial oxidizing disinfectant.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Australia; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Disinfectants; Housekeeping, Hospital; Humans; Infection Control; Intensive Care Units; Microbial Sensitivity Tests; Peroxides; Sulfuric Acids | 2010 |
Molecular characterization of acinetobacter isolates collected in intensive care units of six hospitals in Florence, Italy, during a 3-year surveillance program: a population structure analysis.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Amplified Fragment Length Polymorphism Analysis; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Genotype; Humans; Infant, Newborn; Intensive Care Units; Italy; Molecular Epidemiology; Polymorphism, Genetic; Young Adult | 2010 |
Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2009 |
Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheter-Related Infections; Cross Infection; Drug Resistance, Bacterial; Female; Greece; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Regression Analysis; Risk Factors | 2010 |
Clonal spread of carbapenem resistant Acinetobacter baumannii in the patients and their environment at BMA Medical College and Vajira Hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Patients' Rooms; Prospective Studies; Thailand; Young Adult | 2009 |
Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection.
Topics: Carbapenems; Communicable Disease Control; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospital Mortality; Hospitals, Teaching; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Population Surveillance | 2010 |
Carbapenem resistance via the blaKPC-2 gene in Enterobacter cloacae blood culture isolate.
Topics: beta-Lactam Resistance; Blood; Carbapenems; Child, Preschool; Cross Infection; Enterobacter cloacae; Humans; Klebsiella pneumoniae; Male | 2010 |
Endoscopy-associated transmission of carbapenem-resistant Klebsiella pneumoniae producing KPC-2 beta-lactamase.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Endoscopy; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2010 |
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2010 |
Outbreak of resistant Acinetobacter baumannii- measures and proposal for prevention and control.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Risk Factors; Severity of Illness Index | 2009 |
Correlation between rates of carbapenem consumption and the prevalence of carbapenem-resistant Pseudomonas aeruginosa in a tertiary care hospital in Brazil: a 4-year study.
Topics: Brazil; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
[Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae strains isolated between 2004-2007 in Ankara University Hospital, Turkey].
Topics: beta-Lactam Resistance; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Restriction Mapping; Turkey | 2010 |
Risk factors for 30-day mortality in patients with carbapenem-resistant Acinetobacter baumannii during an outbreak in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Female; Humans; Intensive Care Units; Male; Risk Factors; Shock, Septic | 2011 |
Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; Carbapenems; Child; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Female; Genes, Bacterial; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Molecular Sequence Data; Ohio; Sequence Analysis, DNA; Young Adult | 2010 |
In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Humans; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Minocycline; Sulbactam; Thienamycins; Tigecycline | 2010 |
[Carbapenem and multidrug-resistant Acinetobacter baumannii colonisation/infection: epidemiology and factors associated with infection].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Prospective Studies; Young Adult | 2010 |
[A case of hospital-acquired pneumonia caused by intermediately susceptible carbapenem Acinetobacter baumannii].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Carbapenems; Cross Infection; Humans; Male; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Quinolones | 2010 |
Risk factors for carbapenem-resistant Acinetobacter baumannii infections at a tertiary care hospital in New Caledonia, South Pacific.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Female; Hospitals; Humans; Male; Middle Aged; New Caledonia; Risk Factors; Treatment Outcome | 2010 |
A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheterization, Central Venous; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Hospitalization; Humans; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Taiwan; Treatment Outcome; Young Adult | 2010 |
Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain.
Topics: Adult; Aged; Anti-Bacterial Agents; Bahrain; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Urine | 2009 |
Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genotype; Greece; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Polymerase Chain Reaction | 2010 |
Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacteremia; Blood; Carbapenems; Cross Infection; Culture Media; Disease Outbreaks; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged | 2010 |
[Implication of extended-spectrum beta-lactamase enterobacteriaceae in nosocomial infections in neonates].
Topics: Anal Canal; beta-Lactamases; Carbapenems; Cross Infection; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella pneumoniae; Paris; Prospective Studies; Rectum | 2010 |
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia.
Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Europe; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Piperacillin; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Quinolones; Respiration, Artificial; Severity of Illness Index; Treatment Outcome | 2011 |
[Carbapenem-resistant Acinetobacter baumannii strains].
Topics: Acinetobacter baumannii; Adult; Bronchoalveolar Lavage Fluid; Carbapenems; Child; Cross Infection; Drug Resistance, Microbial; Hospitals, University; Humans; Opportunistic Infections; Pharynx; Poland; Species Specificity; Wounds and Injuries | 2010 |
Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Community-Acquired Infections; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Female; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Polymerase Chain Reaction; Recurrence; Sequence Analysis, DNA; Urinary Tract Infections | 2010 |
Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Greece; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Metalloproteins; Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Risk Factors; Treatment Outcome; Young Adult | 2010 |
[Carbapenem resistance in gram-negative bacteria].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Colony Count, Microbial; Cross Infection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Prevalence | 2010 |
Clusters of infection due to metallo-β-lactamase-producing Pseudomonas aeruginosa in stem cell transplant and haematology units.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Cross Infection; DNA, Bacterial; Genotype; Hand Disinfection; Hematologic Neoplasms; Humans; Immunocompromised Host; Infection Control; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Stem Cell Transplantation; Transplantation | 2011 |
Genetic characterization of ESBL producing strains of Klebsiella pneumoniae from Tehran hospitals.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Hospitals; Humans; Iran; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction; Polymorphism, Genetic | 2010 |
Carbapenem-non-susceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB gene.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; DNA-Directed RNA Polymerases; DNA, Bacterial; Genotype; Hospitals; Humans; Korea; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Polymerase Chain Reaction | 2011 |
[Investigation of presence of class 1 integrons in clinical isolates of carbapenem-resistant Acinetobacter baumannii].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Integrons; Polymerase Chain Reaction | 2010 |
[In vitro tigecycline and carbapenem susceptibilities of clinical Acinetobacter baumannii isolates].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Nosocomial infections: new therapeutic alternatives.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic | 2010 |
Detection of NDM-1-producing Klebsiella pneumoniae in Kenya.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Kenya; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction | 2011 |
Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Genotype; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Michigan; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2011 |
Should polymyxin be used empirically to treat infections in patients under high risk for carbapenem-resistant Acinetobacter?
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Brazil; Carbapenems; Child; Cross Infection; Female; Humans; Male; Middle Aged; Polymyxins; Survival Analysis; Young Adult | 2011 |
Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
Topics: Age Factors; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Chi-Square Distribution; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Factors; Thienamycins | 2011 |
Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Health Policy; Hospitals; Humans; Incidence; Infection Control; Israel; Klebsiella Infections; Klebsiella pneumoniae | 2011 |
Emergence of metallo-β-lactamases and carbapenem resistance.
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Microbial Sensitivity Tests; Polymyxin B | 2011 |
Comparative activity of carbapenem testing: the COMPACT study.
Topics: Africa; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Middle East; Thienamycins | 2011 |
Molecular and epidemiological characterisation of clinical isolates of carbapenem-resistant Acinetobacter baumannii from public and private sector intensive care units in Karachi, Pakistan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Humans; Integrases; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Pakistan; Private Sector; Public Sector; Young Adult | 2011 |
Intrahospital dissemination of carbapenem-resistant Acinetobacter baumannii and analysis of the infected patients' prognosis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cerebrovascular Disorders; Cross Infection; Drug Resistance, Microbial; Female; Humans; Intensive Care Units; Male; Middle Aged; Prognosis; Pulmonary Disease, Chronic Obstructive; Risk Factors | 2011 |
[Molecular characterization of carbapenemases in Pseudomonas aeruginosa infection. Clinical study in three oncological patients].
Topics: Aged; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Breast Neoplasms; Carbapenems; Carcinoma, Ductal, Breast; Carcinoma, Renal Cell; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Immunocompromised Host; Kidney Neoplasms; Laryngeal Neoplasms; Male; Multiple Myeloma; Postoperative Complications; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Bladder Neoplasms; Urinary Tract Infections | 2011 |
Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Chi-Square Distribution; Cluster Analysis; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Republic of Korea; Risk Factors; Statistics, Nonparametric; Thienamycins | 2012 |
Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cross Infection; Ertapenem; Hand Disinfection; Hospitals, University; Humans; Incidence; Pseudomonas aeruginosa; Pseudomonas Infections; Regression Analysis | 2011 |
Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Hospitalization; Hospitals, University; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Risk Factors; Treatment Outcome; Young Adult | 2010 |
Molecular and epidemiological analysis of nosocomial carbapenem-resistant Klebsiella spp. using repetitive extragenic palindromic-polymerase chain reaction and matrix-assisted laser desorption/ionization-time of flight.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2011 |
Clinical efficacy of carbapenems on hospital-acquired pneumonia in accordance with the Japanese Respiratory Society Guidelines for management of HAP.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Female; Guideline Adherence; Humans; Japan; Male; Middle Aged; Pneumonia, Bacterial; Practice Guidelines as Topic; Prognosis; Prospective Studies; Reproducibility of Results; Treatment Outcome | 2011 |
Clinical and molecular microbiological characteristics of carbapenem-resistant Acinetobacter baumannii strains in an NICU.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Typing Techniques; beta-Lactam Resistance; Carbapenems; China; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Incidence; Infant, Newborn; Intensive Care Units, Neonatal; Male; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction | 2011 |
[Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Turkey | 2011 |
Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011.
Topics: Africa; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Notification; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; France; Greece; Humans; India; Paris; Population Surveillance; Retrospective Studies; Travel | 2011 |
Institutional control measures to curtail the epidemic spread of carbapenem-resistant Klebsiella pneumoniae: a 4-year perspective.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Cross Infection; Epidemics; Hospitals, University; Humans; Infection Control; Israel; Klebsiella Infections; Klebsiella pneumoniae; Patient Isolation; Population Surveillance; Prospective Studies | 2011 |
[Microbial spectrum of nosocomial pneumonia in traumatological patients].
Topics: Acetamides; Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bacteria; Carbapenems; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Female; Hospitals; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin; Wounds and Injuries | 2011 |
Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Germany; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Plasmids; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals.
Topics: Anti-Bacterial Agents; Carbapenems; Cluster Analysis; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Genetic Variation; Genotype; Hospitals; Humans; Molecular Epidemiology; Molecular Typing; Multilocus Sequence Typing; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Spain | 2011 |
Spread of multidrug carbapenem-resistant Acinetobacter baumannii in different wards of an Italian hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cluster Analysis; Cross Infection; Disease Outbreaks; Female; Hospitals; Humans; Italy; Male; Middle Aged; Multilocus Sequence Typing; Young Adult | 2011 |
Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; China; Citrobacter freundii; Cluster Analysis; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Female; Genotype; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Polymerase Chain Reaction | 2011 |
Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacteremia; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Incidence; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Thailand; Treatment Outcome; Young Adult | 2011 |
Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis | 2012 |
Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Chromosome Mapping; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Minocycline; Sequence Analysis, DNA; Tigecycline; Urinary Tract Infections | 2012 |
Control of an outbreak of carbapenem-resistant Pseudomonas aeruginosa in a haemato-oncology unit.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Hematologic Neoplasms; Humans; Incidence; Infection Control; Japan; Pseudomonas aeruginosa; Pseudomonas Infections | 2011 |
Acinetobacter calcoaceticus-Acinetobacter baumannii complex species in clinical specimens in Singapore.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; Hospitals; Humans; Molecular Typing; Prevalence; Singapore | 2012 |
Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Databases, Factual; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 2011 |
Clinical outcomes of patients infected with carbapenem-resistant Acinetobacter baumannii treated with single or combination antibiotic therapy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Retrospective Studies; Thailand; Treatment Outcome; Young Adult | 2011 |
Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009.
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Republic of Korea | 2011 |
Spread of carbapenem-resistant Klebsiella pneumoniae in a tertiary hospital in Sao Paulo, Brazil.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Brazil; Carbapenems; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Female; Genotype; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2011 |
Clonal spread of carbapenem-resistant OXA-72-positive Acinetobacter baumannii in a Croatian university hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Croatia; Cross Infection; Drug Resistance, Bacterial; Genotyping Techniques; Hospitals, University; Humans; Microbial Sensitivity Tests | 2011 |
First isolation and outbreak of OXA-48-producing Klebsiella pneumoniae in an Irish hospital, March to June 2011.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Female; Hospitals, University; Humans; Intensive Care Units; Ireland; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction; Treatment Outcome | 2011 |
Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Female; Hospital Mortality; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Polymyxins; Retrospective Studies; Treatment Outcome | 2011 |
Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Genotype; Hospitals; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Republic of Korea; Species Specificity; Thienamycins | 2012 |
An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: from theory to practice.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Epidemics; Hospitals, University; Humans; Incidence; Infection Control; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Program Evaluation | 2011 |
Emergence and clonal dissemination of carbapenem-hydrolysing OXA-58-producing Acinetobacter baumannii isolates in Bolivia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Bolivia; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Imipenem; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Young Adult | 2012 |
Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Humans; Infection Control; Intensive Care Units; Italy; Klebsiella Infections; Klebsiella pneumoniae; Molecular Typing | 2011 |
Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Prevalence | 2012 |
Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cross Infection; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Risk Factors | 2012 |
Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cluster Analysis; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Humans; Molecular Epidemiology; Molecular Typing; United States | 2011 |
Reduction in fluoroquinolone use following introduction of ertapenem into a hospital formulary is associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: a 10-year study.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; Formularies, Hospital as Topic; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; North Carolina; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies | 2011 |
A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Carrier State; Cluster Analysis; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Endemic Diseases; Female; Genotype; Humans; Incidence; Infection Control; Male; Middle Aged; Molecular Typing; Pseudomonas aeruginosa; Pseudomonas Infections | 2011 |
Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; Carbapenems; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Real-Time Polymerase Chain Reaction; Republic of Korea | 2012 |
Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Disease Outbreaks; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Risk Factors; Spain; Survival Rate; Treatment Outcome | 2012 |
Susceptibility profiles and resistance genes for carbapenems (cfiA) and metronidazole (nim) among Bacteroides species in a Turkish University Hospital.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides Infections; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hospitals, University; Humans; Metronidazole; Microbial Sensitivity Tests; Turkey | 2012 |
A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in Southern Israel.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Feces; Female; Humans; Infection Control; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Nursing Homes; Patient Isolation; Thienamycins; Young Adult | 2011 |
Emergence of carbapenem-resistant non-baumannii species of Acinetobacter harboring a blaOXA-51-like gene that is intrinsic to A. baumannii.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Taiwan; Young Adult | 2012 |
[Analysis of clinical characteristics and antimicrobial resistance of carbapenem-resistant Acinetobacter baumannii infections in children].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Anti-Infective Agents; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Retrospective Studies | 2011 |
Multidrug and carbapenem-resistant Acinetobacter baumannii infections: Factors associated with mortality.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Young Adult | 2012 |
Changes in the dependence of Pseudomonas aeruginosa O serogroup strains and their resistance to antibiotics in a university hospital during a 5-year period.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Hospitals, University; Humans; Lithuania; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Serotyping | 2011 |
Nosocomial outbreak of carbapenem-resistant Enterobacter cloacae highlighting the interspecies transferability of the blaOXA-48 gene in the gut flora.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Disease Outbreaks; Enterobacter cloacae; Enterobacteriaceae Infections; Gastrointestinal Tract; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests | 2012 |
Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.
Topics: Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Germany; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quality Control; Thienamycins | 2012 |
Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin.
Topics: Carbapenems; Colistin; Cross Infection; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fosfomycin; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Retrospective Studies; Time Factors | 2012 |
The epidemiology of the first described carbapenem-resistant Klebsiella pneumoniae outbreak in a tertiary care hospital in Saudi Arabia: how far do we go?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cluster Analysis; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Typing; Prospective Studies; Retrospective Studies; Risk Factors; Saudi Arabia; Survival Analysis; Tertiary Care Centers; Young Adult | 2012 |
Stenotrophomonas maltophilia--the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Female; Fermentation; France; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Risk Factors; Stenotrophomonas maltophilia; Treatment Outcome | 2012 |
Mortality attributable to carbapenem-resistant nosocomial Acinetobacter baumannii infections in a Turkish university hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Penicillins; Proportional Hazards Models; Retrospective Studies; Risk Factors; Turkey | 2012 |
Comparative activity of carbapenem testing (the COMPACT study) in Turkey.
Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Hospitals; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Turkey; Young Adult | 2012 |
Three distinct clones of carbapenem-resistant Acinetobacter baumannii with high diversity of carbapenemases isolated from patients in two hospitals in Kuwait.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, Teaching; Humans; Kuwait; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2012 |
Emergence of Proteus mirabilis harboring blaKPC-2 and qnrD in a Chinese Hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Ciprofloxacin; Clone Cells; Conjugation, Genetic; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA | 2012 |
[Frequency of enzymes associated with reduced sensitivity to beta-lactam antibiotics in enterobacteria isolates, Caracas, Venezuela].
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Genotype; Hospitals, Urban; Humans; Microbial Sensitivity Tests; Phenotype; Substrate Specificity; Venezuela | 2011 |
Characteristics of carbapenem-resistant Pseudomonas aeruginosa strains in patients with ventilator-associated pneumonia in intensive care units.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Lithuania; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections | 2011 |
Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Gram-Negative Bacterial Infections; Hospitals; Humans; Infection Control; Klebsiella pneumoniae; Length of Stay; New York City; Prevalence; Pseudomonas aeruginosa | 2012 |
Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study.
Topics: Anti-Bacterial Agents; Asia; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Geography; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Inhibitory Concentration 50; Intensive Care Units; Microbial Sensitivity Tests; Pacific Islands; Population Surveillance; Prevalence | 2012 |
Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP).
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Canada; Carbapenems; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Molecular Typing; Plasmids; Polymerase Chain Reaction; Prevalence; Sequence Analysis, DNA | 2012 |
Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Logistic Models; Male; Middle Aged; Molecular Epidemiology; Multivariate Analysis; Risk Factors; Singapore; Treatment Outcome; Young Adult | 2012 |
What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Critical Illness; Cross Infection; Doripenem; Humans; Kidney; Metabolic Clearance Rate; Pneumonia; Pneumonia, Ventilator-Associated; Randomized Controlled Trials as Topic | 2012 |
Carbapenemase-producing Enterobacteriaceae: a call for action!
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans | 2012 |
Nosocomial occurrence of OXA-48-producing enterobacterial isolates in a Moroccan hospital.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross Infection; Enterobacter cloacae; Enterobacteriaceae Infections; Hospitals, University; Humans; Klebsiella oxytoca; Klebsiella pneumoniae; Middle Aged; Morocco | 2012 |
Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Imipenem; Integrons; Iran; Microbial Sensitivity Tests; Molecular Epidemiology; Multiplex Polymerase Chain Reaction; Polymerase Chain Reaction; Sequence Analysis, DNA | 2012 |
Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hospitals, General; Humans; Imipenem; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2012 |
Correlation between levofloxacin consumption and the incidence of nosocomial infections due to fluoroquinolone-resistant Escherichia coli.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2016 |
Outbreak of carbapenem-resistant Providencia stuartii in an intensive care unit.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Biomarkers; Brazil; Carbapenems; Cross Infection; Disease Outbreaks; Enterobacteriaceae Infections; Female; Humans; Infection Control; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Providencia | 2012 |
Bacteremia caused by Acinetobacter junii at a medical center in Taiwan, 2000-2010.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheter-Related Infections; Central Venous Catheters; Colony Count, Microbial; Cross Infection; Drug Resistance, Bacterial; Female; Hospital Mortality; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; RNA, Ribosomal, 16S; Sequence Analysis, RNA; Taiwan; Tertiary Care Centers; Tigecycline | 2012 |
Increase of carbapenem-resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: association with hospital antimicrobial usage.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Databases, Factual; Drug Resistance, Bacterial; Hospitals; Humans; Incidence; Prevalence; Taiwan | 2012 |
AbaR4-type resistance island including the blaOXA-23 gene in Acinetobacter nosocomialis isolates.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Republic of Korea; Thailand | 2012 |
Correlation between the consumption of meropenem or doripenem and meropenem susceptibility of Pseudomonas aeruginosa in a university hospital in Japan.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Hospitals, University; Humans; Japan; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
Persistence of carbapenem-resistant Acinetobacter baumannii strains in an Italian intensive care unit during a forty-six month study period.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitalization; Humans; Intensive Care Units; Italy; Male; Middle Aged | 2012 |
Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: the last therapeutic challenge.
Topics: beta-Lactam Resistance; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Fatty Liver; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Peritonitis | 2012 |
Carbapenem-susceptible Acinetobacter baumannii carrying the ISAba1 upstream blaOXA-51-like gene in Porto Alegre, southern Brazil.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Brazil; Carbapenems; Cross Infection; Disease Outbreaks; DNA Transposable Elements; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrases; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology | 2013 |
Carbapenem-resistant Enterobacteriaceae containing New Delhi metallo-beta-lactamase in two patients - Rhode Island, March 2012.
Topics: beta-Lactamases; Cambodia; Carbapenems; Cross Infection; Drug Resistance, Multiple; Female; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Rhode Island; Travel | 2012 |
Control of an outbreak of Acinetobacter baumannii infections using vaporized hydrogen peroxide.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Cross Infection; Disease Outbreaks; Disinfectants; Disinfection; Electrophoresis, Gel, Pulsed-Field; Humans; Hydrogen Peroxide; Intensive Care Units; Male; Microbial Sensitivity Tests; Molecular Typing; Volatilization | 2012 |
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Binding Sites; Carbapenems; Ceftazidime; Cephalosporins; Cross Infection; Gene Expression; Humans; Imipenem; Kinetics; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Protein Binding; Protein Isoforms; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitalization; Humans; Intraabdominal Infections; Liver Diseases; Longitudinal Studies; Microbial Sensitivity Tests; Prevalence; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Taiwan; Time Factors | 2012 |
[Risk factors for acquired multidrug-resistant Acinetobacter baumannii colonization in respiratory intensive care unit].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Respiration, Artificial; Respiratory Care Units; Retrospective Studies; Risk Factors; Young Adult | 2012 |
Study on the resistant genes to carbapenems and epidemiological characterization of multidrug-resistant Acinetobacter baumannii isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Equipment and Supplies, Hospital; Humans; Intensive Care Units; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2013 |
Detection of P. aeruginosa harboring bla CTX-M-2, bla GES-1 and bla GES-5, bla IMP-1 and bla SPM-1 causing infections in Brazilian tertiary-care hospital.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Genotype; Humans; Molecular Typing; Pseudomonas aeruginosa; Pseudomonas Infections; Tertiary Healthcare | 2012 |
Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit.
Topics: Aged; Antibiotic Prophylaxis; beta-Lactam Resistance; Carbapenems; Carrier State; Community-Acquired Infections; Cross Infection; Enterobacteriaceae Infections; Escherichia coli Infections; Female; France; Humans; Intensive Care Units; Male; Middle Aged; Multivariate Analysis; Prevalence; Prospective Studies; Risk Factors | 2012 |
Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Hospitals, General; Humans; Intensive Care Units; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Patients' Rooms; Polymerase Chain Reaction | 2012 |
Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing.
Topics: Adult; Aged; Carbapenems; Colistin; Contact Tracing; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Genome, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Sequence Data; Mutation; Polymorphism, Single Nucleotide; Sequence Analysis, DNA; United States; Young Adult | 2012 |
Acinetobacter baumannii as a cause of sepsis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Sepsis | 2012 |
Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing Klebsiella pneumoniae in patients on maintenance hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2012 |
Molecular characterization of the bla(KPC-2) gene in clinical isolates of carbapenem-resistant Klebsiella pneumoniae from the pediatric wards of a Chinese hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; China; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Gene Transfer, Horizontal; Genes, Bacterial; Genotype; Hospitals, Pediatric; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Methyltransferases; Microbial Sensitivity Tests; Plasmids | 2012 |
ESBL- and MBL-mediated resistance in Acinetobacter baumannii: a global threat to burn patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Burn Units; Burns; Carbapenems; Ceftazidime; Child; Child, Preschool; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Infant; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Prevalence; Young Adult | 2012 |
Outbreak of carbapenem-resistant enterobacteriaceae containing blaNDM-1, Ontario, Canada.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Ontario; Rectum | 2012 |
Genome sequence of Acinetobacter baumannii AC12, a polymyxin-resistant strain isolated from Terengganu, Malaysia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Genome, Bacterial; Malaysia; Molecular Sequence Data; Polymyxins; Sequence Analysis, DNA | 2012 |
Activities of doripenem against nosocomial bacteremic drug-resistant Gram-negative bacteria in a medical center in Taiwan.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Taiwan; Thienamycins | 2012 |
Risk factors and outcomes in patients with carbapenem-resistant Acinetobacter infection.
Topics: Acinetobacter; Acinetobacter Infections; Aged; Analysis of Variance; Anti-Bacterial Agents; Carbapenems; Critical Care; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Lung Diseases; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; Risk Factors; Treatment Outcome | 2013 |
Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study.
Topics: Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier State; Case-Control Studies; Chicago; Community-Acquired Infections; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multilocus Sequence Typing; Odds Ratio; Prevalence; Propensity Score; Rectum; Respiration, Artificial; Skilled Nursing Facilities | 2012 |
Multidrug resistance genes, including bla(KPC) and bla(CTX)-M-2, among Klebsiella pneumoniae isolated in Recife, Brazil.
Topics: Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Genes, MDR; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction | 2012 |
First report of blaNDM-1 in Raoultella ornithinolytica.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Male; Minocycline; Molecular Sequence Data; Tigecycline | 2013 |
Early identification and control of carbapenemase-producing Klebsiella pneumoniae, originating from contaminated endoscopic equipment.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Endoscopy; Equipment Contamination; Female; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged | 2013 |
Nosocomial spread of carbapenem-resistant Acinetobacter baumannii (types ST75 and ST137) carrying blaOXA-23-like gene with an upstream ISAba1 in a Chinese hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Alleles; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Cross Infection; Gene Expression; Humans; Multilocus Sequence Typing | 2013 |
Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Cluster Analysis; Cross Infection; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2013 |
Screening for carbapenem-resistant Acinetobacter baumannii colonization sites: an implication for combination of horizontal and vertical approaches.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Carrier State; Cohort Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Female; Humans; Infection Control; Male; Mass Screening; Middle Aged; Organs at Risk; Prevalence; Prospective Studies | 2013 |
Dissemination of a carbapenem-resistant Acinetobacter baumannii strain belonging to international clone II/sequence type 2 and harboring a novel AbaR4-like resistance island in Latvia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; DNA Transposable Elements; Genes, MDR; Genomic Islands; Integrons; Latvia; Methyltransferases; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data | 2013 |
Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Hospitalized; Child, Preschool; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Klebsiella; Klebsiella Infections; Male; Pseudomonas; Pseudomonas Infections; Survival Analysis | 2013 |
Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Continuity of Patient Care; Cross Infection; Disease Outbreaks; Emergency Service, Hospital; Female; Humans; Incidence; Infant; Klebsiella Infections; Klebsiella pneumoniae; Los Angeles; Male; Middle Aged; Population Surveillance; Skilled Nursing Facilities; Young Adult | 2013 |
Complete sequence of a bla(KPC-2)-harboring IncFII(K1) plasmid from a Klebsiella pneumoniae sequence type 258 strain.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; New York; Plasmids; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2013 |
Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cross Infection; Female; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2013 |
Imported and intensive care unit-born Acinetobacter baumannii clonal complexes: one-year prospective cohort study in intensive care patients.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Brazil; Carbapenems; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, University; Humans; Intensive Care Units; Multilocus Sequence Typing; Polymerase Chain Reaction; Prospective Studies; Random Amplified Polymorphic DNA Technique | 2013 |
A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection.
Topics: Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Hospital Mortality; Humans; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors | 2013 |
The resistance mechanisms of b-lactam antimicrobials in clinical isolates of Acinetobacter baumannii.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans | 2002 |
Nosocomial infections caused by multidrug-resistant isolates of pseudomonas putida producing VIM-1 metallo-beta-lactamase.
Topics: Aged; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Integrons; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Pseudomonas Infections; Pseudomonas putida; Urinary Tract Infections | 2002 |
Environmental contamination during a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Disease Reservoirs; Environmental Microbiology; Environmental Monitoring; Epidemiological Monitoring; Equipment Contamination; Humans; Infection Control; Intensive Care Units; Microbial Sensitivity Tests; Turkey | 2002 |
Endemic carbapenem-resistant Acinetobacter baumannii in a London hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Infection Control; London; Phenotype | 2003 |
An outbreak of carbapenem-resistant Pseudomonas aeruginosa in a urology ward.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Equipment Contamination; Female; Humans; Infection Control; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Urinary Tract Infections | 2003 |
Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Humans; Italy; Microbial Sensitivity Tests | 2004 |
Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex in a Chinese hospital.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Clavulanic Acid; Cloxacillin; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enzyme Inhibitors; Genes, Bacterial; Genotype; Imipenem; Isoelectric Focusing; Isoelectric Point; Microbial Sensitivity Tests; Molecular Epidemiology; Sequence Analysis, DNA | 2004 |
[Carbapenem resistance and Acinetobacter baumannii].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Multicenter Studies as Topic; Spain | 2004 |
[Carbapenemase detection in Acinetobacter baumannii clones resistant to imipenem].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Multicenter Studies as Topic; Spain; Thienamycins | 2004 |
Morphological changes induced by imipenem and meropenem at sub-inhibitory concentrations in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Carbapenems; Cross Infection; Histocytochemistry; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pneumonia; Thienamycins | 2004 |
Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Glucosyltransferases; Humans; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; New York City; Plasmids; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
Carbapenem-resistant Pseudomonas aeruginosa outbreak in an intensive care unit of a teaching hospital.
Topics: Adult; Aged; Anti-Bacterial Agents; Brazil; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Hospital Bed Capacity, 100 to 299; Hospitals, Teaching; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections | 2004 |
A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Burn Units; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; France; Hospitals, University; Humans; Imipenem; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2005 |
Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997-2002.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Hospital Mortality; Humans; Incidence; Israel | 2005 |
Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Catheterization, Peripheral; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Hypotension; Imipenem; Logistic Models; Male; Risk Factors; Shock; Spain | 2005 |
Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.
Topics: beta-Lactam Resistance; Carbapenems; Carrier State; Cross Infection; Disease Outbreaks; Humans; Klebsiella Infections; Klebsiella pneumoniae; New York City; Prevalence; Ribotyping | 2005 |
Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii isolated from burn wounds and in vitro activities of antibiotic combinations against these isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Burn Units; Burns; Carbapenems; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Opportunistic Infections; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Canada; Carbapenems; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
Topics: Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Disease Outbreaks; Disease Transmission, Infectious; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymorphism, Restriction Fragment Length; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
Acquired metallo-beta-lactamases: an increasing clinical threat.
Topics: Anti-Bacterial Agents; Australia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans | 2005 |
Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Australia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged | 2005 |
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Length of Stay; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Taiwan | 2005 |
Clinical features of nosocomial infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Taiwan; Treatment Outcome | 2005 |
Epidemiology of extended-spectrum beta-lactamase producing gram-negative bacilli at Siriraj Hospital, Thailand, 2003.
Topics: beta-Lactamases; Carbapenems; Cross Infection; Cross-Sectional Studies; Disease Susceptibility; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitalization; Humans; Male; Middle Aged; Prevalence; Risk Assessment; Risk Factors; Thailand; Treatment Outcome | 2005 |
Screening for antibiotic resistant Gram-negative bacteria.
Topics: Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infection Control | 2006 |
Emergence of Proteus mirabilis carrying the bla metallo-beta-lactamase gene.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Humans; Imipenem; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis | 2006 |
The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants.
Topics: Blood; Candidiasis; Carbapenems; Catheterization, Central Venous; Central Nervous System Fungal Infections; Cephalosporins; Cerebrospinal Fluid; Comorbidity; Cross Infection; Enterocolitis, Necrotizing; Fungemia; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Prospective Studies; Registries; Risk Factors; Superinfection | 2006 |
Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia.
Topics: Adult; Aged; Bacteremia; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Middle Aged; Retrospective Studies; Risk Factors | 2006 |
Nosocomial spread of OXA-58-positive carbapenem-resistant Acinetobacter baumannii isolates in a paediatric hospital in Greece.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Carbapenems; Child; Cross Infection; Disease Outbreaks; Drug Resistance; Greece; Hospitals, Pediatric; Hospitals, Urban; Humans; Risk Factors | 2006 |
Frequency and predictors of colonization of the respiratory tract by VIM-2-producing Pseudomonas aeruginosa in patients of a newly established intensive care unit.
Topics: Acute Disease; beta-Lactamases; beta-Lactams; Bronchi; Carbapenems; Carrier State; Cross Infection; Female; Genes, Bacterial; Gram-Negative Bacteria; Greece; Hospitals, General; Humans; Intensive Care Units; Male; Middle Aged; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Time Factors; Trachea; Urban Population | 2006 |
[Problems of prevalance and resistance of nosocomial Klebsiella pneumonia in hospitals of Russia].
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Russia | 2005 |
Contaminated oral intubation equipment associated with an outbreak of carbapenem-resistant Pseudomonas in an intensive care unit.
Topics: Carbapenems; Cross Infection; Disease Outbreaks; Disinfection; Drug Resistance, Bacterial; Equipment Contamination; Equipment Reuse; Hospitals, University; Humans; Immunocompromised Host; Intensive Care Units; Intubation, Intratracheal; Japan; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Respiration, Artificial | 2007 |
The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Resistance, Multiple; Empiricism; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Missouri; Penicillins; Pneumonia, Bacterial; Prospective Studies; Survival Rate; Urinary Tract Infections; Ventilators, Mechanical | 2006 |
Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Australia; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Hospitals, University; Humans; Infection Control; Intensive Care Units; Length of Stay; Male; Middle Aged; Retrospective Studies; Risk Factors | 2007 |
Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; beta-Lactamases; Carbapenems; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Poland; Retrospective Studies | 2007 |
[Susceptibility to chemotherapeutics and the occurrence of metallo-beta-lactamases in hospital Pseudomonas aeruginosa strains].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Hospitals; Humans; Microbial Sensitivity Tests; Poland; Pseudomonas aeruginosa; Pseudomonas Infections | 2006 |
Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Incidence; Male; Microbial Sensitivity Tests; New York City; Polymerase Chain Reaction; Population Surveillance | 2007 |
Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; beta-Lactamases; Carbapenems; Community-Acquired Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals, University; Humans; Intensive Care Units; Italy; Male; Microbial Sensitivity Tests | 2007 |
Molecular findings and antibiotic-resistance in an outbreak of Acinetobacter baumannii in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Disinfection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Intensive Care Units; Male; Middle Aged; Patient Isolation; Rifampin; Rome; Sulbactam | 2007 |
Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Colistin; Cross Infection; Disease Outbreaks; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Hand Disinfection; Humans; Intensive Care Units; Logistic Models; Male; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Risk Factors; Suction | 2007 |
Is combination therapy with betalactam plus aminoglycoside (AGL) improving the outcome of nosocomial meningitis in children?
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Therapy, Combination; Glycopeptides; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Prognosis; Retrospective Studies; Treatment Outcome | 2007 |
Insufficient therapy for nosocomial meningitis negatively affects survival, sequellae and has social consequences.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Retrospective Studies; Treatment Failure; Vancomycin | 2007 |
Problematic clinical isolates of Pseudomonas aeruginosa from the university hospitals in Sofia, Bulgaria: current status of antimicrobial resistance and prevailing resistance mechanisms.
Topics: Anti-Bacterial Agents; beta-Lactamases; Bulgaria; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Escherichia coli Proteins; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2007 |
Utilization rate of carbapenems at intensive care units is not major determinant of gram-negative bacteria resistance to these antibiotics.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Gram-Negative Bacteria; Humans; Intensive Care Units | 2007 |
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blotting, Southern; Carbapenems; China; Chloramphenicol; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Rifampin; Sequence Analysis, DNA | 2007 |
Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
Topics: Adult; Aged; Aminoglycosides; Bacteremia; Carbapenems; Case-Control Studies; Cross Infection; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Texas; Vancomycin Resistance | 2007 |
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Integrons; Molecular Epidemiology; Molecular Sequence Data; Mutation; Plasmids; Polymerase Chain Reaction; Porins; Pseudomonas aeruginosa; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Spain | 2007 |
Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prospective Studies | 2008 |
Outbreak of multidrug-resistant Acinetobacter baumannii in a Belgian university hospital after transfer of patients from Greece.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Belgium; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Greece; Hospitals, University; Humans; Male; Middle Aged; Patient Isolation; Patient Transfer; Respiratory Tract Infections; Travel | 2007 |
Detection of blaVIM-2 carbapenemase in Pseudomonas aeruginosa in Ireland.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Humans; Ireland; Pseudomonas aeruginosa; Pseudomonas Infections | 2008 |
[Resistance epidemiology of gramnegative nonfermenting pathogens of nosocomial infections in intensive care units and surgical departments].
Topics: Acinetobacter baumannii; Adolescent; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoperazone; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Genes, Bacterial; Gram-Negative Bacterial Infections; Humans; Infant; Intensive Care Units; Microbial Sensitivity Tests; Molecular Epidemiology; Moscow; Pseudomonas aeruginosa; Sulbactam; Surgery Department, Hospital | 2006 |
[Imipenem resistance in Gram-negative rods and its consumption between 1999 and 2005].
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2007 |
Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; Carbapenems; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Europe; Genetic Variation; Geography; Humans; Imipenem; Microbial Sensitivity Tests; Random Amplified Polymorphic DNA Technique | 2008 |
Nosocomial bloodstream infection in a pediatric intensive care unit.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Incidence; India; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Medical Records; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome; Vancomycin | 2008 |
Outbreak of Acinetobacter baumannii with chromosomally encoded VIM-1 undetectable by imipenem-EDTA synergy tests.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Edetic Acid; Greece; Humans; Imipenem; Integrons; Isoelectric Focusing; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2008 |
Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97.
Topics: Acinetobacter baumannii; Africa; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Models, Genetic; Molecular Sequence Data; Polymerase Chain Reaction; Tunisia | 2008 |
Characterisation of carbapenem-resistant Acinetobacter calcoaceticus--A. baumannii complex isolates in a third-level hospital in Bogotá, Colombia.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colombia; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Plasmids; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
[Antibiotic susceptibility and molecular mechanisms of cephalosporins resistance in Klebsiella isolates from patients with hospital-acquired infections].
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporin Resistance; Cross Infection; Humans; Imipenem; Klebsiella; Klebsiella Infections; Meropenem; Thienamycins | 2006 |
How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross Infection; DNA, Bacterial; Hospitals; Humans; Integrons; Middle Aged; Taiwan | 2008 |
Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ampicillin; APACHE; beta-Lactam Resistance; Bronchoalveolar Lavage Fluid; Carbapenems; Child; Child, Preschool; Cross Infection; Female; Hospitals, Teaching; Humans; Infant; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polymyxins; Prognosis; Renal Insufficiency; Retrospective Studies; Risk Factors; Shock, Septic; Sulbactam; Time Factors; Treatment Outcome | 2008 |
Emergence and spread of carbapenem-resistant Acinetobacter baumannii in a tertiary care hospital in Turkey.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Intensive Care Units; Turkey | 2008 |
[Prevalence of infection by carbapenem-resistant Acinetobacter baumannii in Spain (1999-2005)].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Prevalence | 2008 |
A study of Clostridium difficile-associated disease at King Chulalongkorn Memorial Hospital, Thailand.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Cephalosporins; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitals, Public; Humans; Infant; Male; Metronidazole; Middle Aged; Retrospective Studies; Risk Factors; Thailand; Treatment Outcome | 2008 |
Biofilm production by clinical strains of Acinetobacter baumannii isolated from patients hospitalized in two tertiary care hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Biofilms; Carbapenems; Cross Infection; DNA, Bacterial; Humans; Microbial Sensitivity Tests; Random Amplified Polymorphic DNA Technique; Retrospective Studies | 2008 |
[Losing no time in suspected sepsis. Every emergency bag should have a broad spectrum antibiotic! (interview by Dr. med. Horst Gross)].
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Community-Acquired Infections; Cross Infection; Emergencies; Family Practice; Humans; Infusions, Intravenous; Penicillins; Sepsis | 2008 |
Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; DNA Primers; DNA Transposable Elements; DNA, Bacterial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Promoter Regions, Genetic; Transformation, Genetic | 2008 |
Doripenem (doribax)--a new parenteral carbapenem.
Topics: Carbapenems; Cross Infection; Doripenem; Female; Humans; Pneumonia; Pneumonia, Ventilator-Associated; Urinary Tract Infections | 2008 |
Dissemination of the blaIMP-1 and blaVIM-2 metallo-beta-lactamase genes among genetically unrelated Pseudomonas aeruginosa isolates in a South Korean hospital.
Topics: beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Integrons; Korea; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amplified Fragment Length Polymorphism Analysis; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; Czech Republic; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Hospitals; Humans; Intensive Care Units; Microbial Sensitivity Tests; Prospective Studies; Sequence Analysis, DNA | 2008 |
The in vitro activity of FCE 22101 against gram-negative aerobic isolates resistant to third generation cephalosporins.
Topics: Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; Humans; Microbial Sensitivity Tests | 1994 |
PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams.
Topics: Alcaligenes; Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; Base Sequence; beta-Lactamases; Carbapenems; Ceftazidime; Cross Infection; DNA Primers; Drug Resistance, Microbial; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Japan; Klebsiella pneumoniae; Molecular Epidemiology; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas putida; Serratia marcescens | 1996 |
Increasing incidence of carbapenem-resistant Pseudomonas aeruginosa bacteraemia in a cancer centre over a seven-year period.
Topics: Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Incidence; Pseudomonas Infections; Retrospective Studies; Thienamycins | 1997 |
[Anti-anaerobic activity of carbapenems].
Topics: Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Cross Infection; Drug Resistance, Microbial; Humans; Hydrogen-Ion Concentration; Meropenem; Microbial Sensitivity Tests; Thienamycins | 1997 |
Nosocomial spread of cephem-resistant Escherichia coli strains carrying multiple Toho-1-like beta-lactamase genes.
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cloning, Molecular; Conjugation, Genetic; Cross Infection; Escherichia coli; Gene Transfer Techniques; Isoelectric Focusing; Kinetics | 1997 |
Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Blood; Carbapenems; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Saudi Arabia; Urinary Tract Infections; Wounds and Injuries | 1997 |
Strategies and options for minimizing resistance emergence in pulmonary infections.
Topics: Acinetobacter; Anti-Infective Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Fluoroquinolones; Hospitals; Humans; Lung Diseases; Macrolides; Microbial Sensitivity Tests; Penicillin Resistance; Respiratory Tract Infections; Scotland; Streptococcus pneumoniae | 1998 |
Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems.
Topics: Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cefoxitin; Cephalosporins; Cephamycins; Cross Infection; Disease Outbreaks; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; Spain | 1998 |
The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen.
Topics: Bacteremia; Carbapenems; Cross Infection; Gram-Negative Bacterial Infections; Humans; Kuwait; Microbial Sensitivity Tests; Prospective Studies; Wound Infection; Xanthomonas | 1999 |
Resistance patterns of Pseudomonas aeruginosa to carbapenems and piperacillin/tazobactam.
Topics: Carbapenems; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Incidence; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Pseudomonas aeruginosa; Risk Factors | 1999 |
Bacterial resistance, beta-lactam antibiotics and gramnegative bacteria at ICUs.
Topics: Anti-Bacterial Agents; Austria; beta-Lactam Resistance; Carbapenems; Contraindications; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units | 1999 |
[Focus on Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple; Humans; Intensive Care Units | 1999 |
[Evaluation of resistance patterns of gram-negative rods from personal clinical materials].
Topics: Anti-Infective Agents; Carbapenems; Cross Infection; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Humans; Infant, Newborn; Microbial Sensitivity Tests; Species Specificity | 1999 |
Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Carbapenems; Child; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Hydrolysis; Imipenem; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Thienamycins | 2000 |
Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Brazil; Carbapenems; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Intensive Care Units; Lactams; Microbial Sensitivity Tests; Sentinel Surveillance | 2000 |
Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child, Preschool; Cross Infection; Disease Outbreaks; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Female; Humans; Italy; Male; Metalloproteins; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections | 2000 |
Antimicrobial use and susceptibility rates in isolates from intensive care unit and other nosocomial inpatient and outpatient areas.
Topics: Ambulatory Care Facilities; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Cross Infection; Disease Susceptibility; Drug Resistance, Microbial; Enterococcus; Escherichia coli; Humans; Intensive Care Units; Monobactams; Prevalence; Pseudomonas aeruginosa; Staphylococcus aureus | 2001 |
Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Canada; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple; Europe; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Latin America; Male; Microbial Sensitivity Tests; Middle Aged; Seasons; Stenotrophomonas maltophilia; United States | 2001 |
[Antimicrobial susceptibility of Pseudomonas aeruginosa isolated in Fukushima Prefecture].
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Microbial; Humans; Japan; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sputum | 2001 |
Nosocomial bloodstream infections in a Turkish university hospital: study of Gram-negative bacilli and their sensitivity patterns.
Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; In Vitro Techniques; Turkey | 2001 |
Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new bla(IMP) allele, bla(IMP-7).
Topics: Amino Acid Sequence; beta-Lactam Resistance; beta-Lactamases; Canada; Carbapenems; Cross Infection; Disease Outbreaks; Humans; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Homology, Amino Acid; Spermidine | 2002 |
Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Middle Aged; United Kingdom | 2002 |